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T
INTRODUCTION
The capacity to absorb substances from the external environment is one of the feature s
that differentiates animate from inanimate matter. In mammalian species, this is
p redominantly the function of the small intestine. The absorbing surface of the small
intestine is made up of innumerable villi, which greatly increase the surface area ava i l a b l e
for absorption. The villi are cove red by a layer of absorbing cells which themselves have
a surface which is greatly increased by the presence of microvilli which are the major
f e a t u re of the absorbing surface of the small intestine. During the twentieth century, the
re m a rkable functions of the cells of the small intestine have been the subject of intensive
re s e a rch. At first, there we re many who considered that the absorption of substances
f rom the intestinal tract was a process of passive diffusion, in which nutrients passed
f rom the lumen of the intestine without the interposition of any active process on the
p a rt of the cells of the intestinal mucosa. The pro g ress of re s e a rch has shown, howe ve r,
that absorption from the intestine is for the most part an active process, invo l v i n g
specific transport systems that carry sugars, amino acids, peptides, lipids and other
substances into the body. Fu rt h e r m o re, the intestinal cells themselves are highly active
m e t a b o l i c a l l y, utilizing energy as do other cells for performing their functions. In
addition, the process of digestion, originally thought to occur entirely within the
intestinal lumen, has been shown to occur also within the microvilli of the intestinal
cells. In addition, the cells themselves have an important function in transforming
substances, for example lipids, during their passage across the intestinal mucosa. 
The understanding of how the small intestine functions has been a major interest of
physiologists throughout the past century. In addition, clinical re s e a rch workers fro m
d i f f e rent disciplines have also made major contributions. Renal physicians have show n
h ow the reabsorption of substances in the renal tubule has mirro red absorption in the
small intestine. Ga s t ro e n t e rologists have studied how absorption may be influenced by
clinical pro c e d u res such as resection of the small intestine, as well as how dietary changes
may affect absorptive processes. Haematologists have made major contributions to our
understanding of the complex mechanisms invo l ved in the absorption of iron or vitamin
B12. Others have studied disorders such as cholera in order to find out how best to
re h ydrate those unfortunate sufferers from fluid loss due to intense diarrhoea.
This Witness Seminar brings together scientists and clinicians who have been involved
in recent years in unravelling the ways in which the process of absorption takes place
in the small intestine. It has been a fascinating enterprise for all those involved, many
of whom have taken part in this meeting. We are grateful for the time they gave us,
not only in planning and holding this meeting, but also during the lengthy editorial
process, which is described below.
Sir Christopher Booth
Wellcome Institute for the History of Medicine
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* The following text also appears in the ‘Introduction’ to recent volumes of Wellcome Witnesses to Twentieth
Century Medicine published by The Wellcome Trust.
WITNESS SEMINARS: MEETINGS AND PUBLICATIONS*
In 1990 the Wellcome Trust created the History of Twentieth Century Medicine
Group to bring together clinicians, scientists, historians and others interested in
contemporary medical history. Amongst a number of other initiatives, the format of
Witness Seminars – used by the Institute of Contemporary British History to address
issues of recent political history – was adopted, to promote interaction between these
different groups, to emphasize the potentials of working jointly, and to encourage the
creation and deposit of archival sources for present and future use.
The Witness Seminar is a particularly specialized form of oral history where several
people associated with a particular set of circumstances or events are invited to meet
together to discuss, debate, and agree or disagree about their memories. To date, the
History of Twentieth Century Medicine Group has held 24 such meetings, most of
which have been published, as listed in the Table below.
Subjects for such meetings are usually proposed by, or through, members of the St e e r i n g
Committee of the Gro u p, and once an appropriate topic has been agreed, suitable
p a rticipants are identified and invited. These inevitably lead to further contacts, and more
suggestions of people to invite. As the organization of the meeting pro g resses, a flexible
outline plan for the meeting is devised, usually with assistance from the meeting’s
chairman, and some participants are invited to ‘set the ball ro l l i n g’ on particular themes,
by speaking for a short period of time to initiate and stimulate further discussion. 
Each meeting is fully re c o rded, the tapes are transcribed and the unedited transcript is
immediately sent to eve ry participant. Each is asked to check their own contributions and
to provide brief biographical details. The editors turn the transcript into readable text,
and part i c i p a n t s’ minor corrections and comments are incorporated into that text, while
biographical and bibliographical details are added as footnotes, as are more substantial
comments and additional material provided by participants. The final scripts are then
sent to eve ry contributor, accompanied by copyright assignment forms. All additional
c o r respondence re c e i ved during the editorial process is deposited along with the re c o rd s
of this meeting in the Contemporary Medical Arc h i ves Centre of the Wellcome Library.
As with all our meetings, we hope that even if the precise details of some of the
technical sections are not clear to the non-specialist, the sense and significance of the
e vents are understandable. Our aim is for the volumes that emerge from these meetings
to inform those with a general interest in the history of modern medicine and medical
science, to provide for historians new insights, fresh material for study, and pro m p t
f resh themes for re s e a rch, and to emphasize to the participants that events of the re c e n t
past, of their own working lives, are of proper and necessary concern to historians. 
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Professor Sir Leslie Turnberg:1 Thank you very much, Tilli [Tansey],2 for inviting me
to chair this meeting and for giving us the opportunity of getting together and
meeting old friends. The idea behind this meeting is to try and fill in the background
to some of the advances that were made in the field of intestinal absorption by people
who were actually involved in the work at the time these advances were being made.
I hope we will get a personal view from the people here today. We can get the cold
facts from the published literature of course, but the excitement of the discoveries, the
humour, the debates that went on, are very much in people’s minds rather than on
paper. It would be nice to try to capture the way the ideas emerged, how they came
about. It’s interesting that intestinal absorption is relatively new: it’s within living
memory that most advances in the field seem to have been made; within the living
memory of at least some of us. So before we all forget, it would be nice to have a
record of it. 
The programme is divided roughly into two halves: the first half is rather more basic
and animal based, whereas the second half focuses more on the ‘human’; and we’ve
asked a number of individuals to lead the discussion on various subjects. 
Chris Booth has kindly agreed to give us a historical introduction, on which he is such
an expert and authority, and it’s a delight to welcome him and to ask him to do that. 
Sir Christopher Booth:3 Well, Sir Leslie, thank you for your very kind introduction
and also for chairing this meeting. I am a stand-in for Dennis Parsons4 and no
substitute, as I am sure you will all recognize. If anybody really wants to know about
the development of methods and techniques for the study of intestinal transport, I
would refer them to Dennis Parsons’s excellent article in the 1968 Handbook of
1 Professor Sir Leslie Turnberg Kt FRCP FRCS (now Lord Turnberg of Cheadle) (b. 1934) was Professor of
Medicine, University of Manchester, from 1973 to 1997, President of the Royal College of Physicians from 1992
to 1997, and Chairman, Public Health Laboratory Health Board, since 1997. 
2 Dr Tilli Tansey is Convenor of the History of Twentieth Century Medicine Group and Historian of Modern
Medical Science, Academic Unit, The Wellcome Trust.
3 Sir Christopher Booth Kt FRCP (b. 1924) trained as a gastroenterologist and was the first Convenor of the
Wellcome Trust’s History of Twentieth Century Medicine Group, from 1990 to 1996, and Harveian Librarian at
the Royal College of Physicians from 1989 to 1997. He was Professor of Medicine, Royal Postgraduate Medical
School, Hammersmith Hospital, London, from 1966 to 1977 and Director of the Medical Research Council’s
Clinical Research Centre, Northwick Park Hospital, Harrow, from 1978 to 1988. See Booth C C, Neale G. (eds)
(1985) Disorders of the Small Intestine. Oxford: Blackwell Scientific Publications.
4 Dr Dennis Parsons (b. 1917) worked in the Department of Biochemistry, University of Oxford, from 1946 to
1984 and was Fellow of Merton College, Oxford, from 1950 to 1984. He worked mainly on membrane and
epithelial transport of fluid and solutes, on cell volume regulation, on distribution and functions of carbonic
anhydrase isoenzymes and on models of epithelial transport. See, for example, Fisher R B, Parsons D S. (1950)
The gradient of mucosal surface area in the small intestine of the rat. Journal of Anatomy 84: 272–282. op. cit.
notes 5, 46, 47 and 129.
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Physiology on intestinal absorption.5 That article sets out the story of the development
of methods for studying transport extraordinarily well. I think, though, that he was unduly
modest in that article in the sense that he didn’t deal as much with his own work with 
R B Fi s h e r,6 which was ve ry important, as I would have expected him to do, but he showe d
a lot of the long past studies of intestinal absorption in the eighteenth and nineteenth
centuries which we re matters of ve ry great concern to many people at the time.
One of the major things that people we re interested in, for example, was the extent to
which the lacteals we re invo l ved in absorption. People would link dyes to substances in the
intestinal lumen in an experimental animal and then study the lacteals and find out what
happened. T h e re we re also interesting experiments by people like Sanctorius Sa n c t o r i u s
who managed to weigh himself in a ve ry sensitive balance and worked out what happened
to his weight when he fed. And there we re those who put food, for example, bread, into
containers with holes in the side of them and swallowed them and then brought them back
up again and found out how much digestion had occurred within the stomach or in the
gut lumen. Many experiments of that sort took place from time to time.7
So far as our century is concerned, I think the people who we re important we re, first,
the Professor of Physiology in the Un i versity of St Andrews in Dundee, Wa y m o u t h
Reid, who was the first man to develop an in vitro system in which he separated the
external mucosal from the internal serosal side of the intestine and was able to show that
d i f f e rences in pre s s u re gradients would develop across them.8 Waymouth Re i d’s work ,
which strongly suggested that absorption of fluids and other substances in the intestine
was an active process, was forgotten completely for a ve ry long time. By the 1930s,
Ve rz á r, working in Sw i t zerland with his colleague Mc Dougall, had published a book9 i n
which after many decades of investigating intestinal absorption, mostly in experimental
animals, and particularly the dog, they concluded that all absorption could be explained
on the basis of osmosis and diffusion and that no active processes we re invo l ved. Now
5 Parsons D S. (1968) Methods for investigation of intestinal absorption. In Code C F. (ed.) Handbook of
Physiology, Alimentary Canal III, ch. 64. Washington: American Physiological Society, 1177–1216.
6 Professor Michael Gardner wrote: ‘Reginald Brettauer (David) Fisher CBE (1907–1986) gained his DPhil in
1933 under Sir Rudolph Peters in Oxford where he was University Demonstrator in biochemistry from 1933 to
1959. He held the Chair of Biochemistry in Edinburgh from 1959 to 1976, being the first non-medical man to
be Dean of the Faculty of Medicine, and in retirement held an honorary position in the Department of Physiology,
Oxford. He worked on numerous topics of physiological biochemistry, especially with whole-organ and
quantitative approaches, including creatine metabolism, intestinal absorption, action of insulin; he influenced 
H W Davenport (when Davenport was a Rhodes scholar in Oxford in 1937) in elucidating the mechanism of
gastric acid secretion.’ Letter to Dr Daphne Christie, 28 April 2000.
7 See, for example, Kleinzeller A, Kotyk A. (eds) (1961) Membrane Transport and Metabolism. Proceedings of a
Symposium held in Prague, August 22–27, 1960. London: Academic Press. Wiseman G. (1964) Absorption from
the Intestine. London: Academic Press. See also note 5.
8 Ed w a rd Waymouth Reid FRS (1862–1948) was first Professor of Physiology at Un i versity College, Dundee, fro m
1889 to 1935. He carried out many experiments on intestinal absorption in vitro, including experiments with
e ve rted intestine. See, for example, Reid E W. (1900) On intestinal absorption, especially on the absorption of
s e rum, peptone, and glucose. Philosophical Transactions of the Royal Society 1 0 2: 211–297. See also Cathcart E P,
Ga r ry R C. (1948) Ed w a rd Waymouth Reid. Ob i t u a ry Notices of Fe l l ows of the Royal Society 6: 213–218. 
9 Verzár F, McDougall E J. (1936) Absorption from the Intestine. London: Longmans, Green & Co.
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that conclusion was interesting, because it certainly shaped the thinking for the next
decade. What has happened in our lifetime, I think, is the transformation of what was
re g a rded as a passive membrane into an organ, an organ that has metabolic functions,
and intense activity in terms of its turnover and active processes for transport. Pa s s i ve
p rocesses turn out to be of minor importance in terms of transfer of nutrients across the
intestine, although they must be ve ry much more important in the absorption of drugs. 
There was one observation in Verzár’s work that confused him. This was the report by
von Tappeiner in 1878, that bile acids were selectively absorbed in the distal part of
the intestine.10 Now once somebody had suggested selective absorption in a different
area of the intestine, that strongly indicated there must be some receptor, some active
process involved in picking up that substance. Verzár was so confused by that, that in
1932 he invited a young research fellow of his, called Fröhlicher, to repeat the
experiments that Tappeiner had done. Fr ö h l i c h e r’s experiments completely
corroborated what Tappeiner had shown, namely that if you put conjugated bile acids
into the distal intestine of a dog they are absorbed better than in the jejunum.11 Verzár
explained that anomaly, suggesting that something must have happened to the
physico-chemical nature of the bile acid within the intestinal lumen. In the post-war
period, the most important experiment was that carried out by Fisher and Parsons in
1949 and demonstrated at one Physiological Society Me e t i n g .1 2 They developed an i n
v i t ro system of studying absorption from the isolated intestine of the rat (Fi g u re 1). T h e y
p e rfused the intestine with va rying concentrations of glucose and galactose, and we re able
to show that the absorption was not linear which is what you would, of course, expect if
it was passive transport, but that it was a saturable phenomenon of some sort. T h a t
experiment opened up a whole new era in which people we re looking at kinetic re s p o n s e s
in the intestine to determine whether or not there we re active processes invo l ved. 
New techniques were then developed, such as the everted sac preparation, isolated
brush-border techniques, the use of isolated segments of intestine, and Sheff and
Smyth’s in vivo observation of recirculation of the intestine that allowed people to look
at saturation kinetics.13 And all of those things seem to me to have developed following
the Fisher and Parsons’s experiment. 
Turnberg: Thank you very much, Chris; that was a very nice general introduction. We
are going to get down to specifics later on, but does anyone have any comments or
questions on this broad-based introduction?
10 Tappeiner H. (1878) Über die aufsaugung der gallensauren alkalien im dünndarme. Sitzungsberichte der
Kaiserlichen Akademie der Wissenschaften 77: 281–304. op. cit. note 9, 218–219.
11 Fröhlicher E. (1936) Die resorption von gallensäuren aus verschiedenen dünndarmabachnitten. Biochemische
Zeitschrift 283: 273–279.
12 See Fisher R B, Parsons D S. (1949) A preparation of surviving rat small intestine for the study of absorption.
Journal of Physiology 110: 36–46. 
13 These techniques are discussed later in the meeting, see, for example, pages 23 and 31. Sheff M F, Smyth D H.
(1955) An apparatus for the study of in vivo intestinal absorption in the rat. Journal of Physiology 128: 67P. See
also Wilson T H. (1962) (ed.) Methods, ch. 2. In Intestinal Absorption. London: W B Saunders Company, 20–39.
Dr Derek Holdsworth:14 I agree with Sir Christopher that Verzár concluded that
osmosis and diffusion accounted for almost all intestinal absorption, but in Verzár’s
book he shows his own data which demonstrated selective absorption for glucose and
galactose, as compared with other monosaccharides, including fructose.15
B o o t h : Yes. I have never quite understood that. You are quite right that in the 1920s, I
think, differential absorption rates had been shown between different sugars. T h i s
o bviously indicated that something funny was going on, rather more than just diffusion,
because equimolecular substances we re absorbed at different rates and that had been
s h own long before. I think Cori had shown that, hadn’t he, in respect of sugars?1 6
Dr Roy Levin:17 I think the other feature is the huge concentration of sugars that the
early people used; they weren’t low levels, they were often one molar, half molar, or
something like that. They were very, very large, so that it wasn’t easy to sort out
mechanisms. It was so much easier to look at it and say it was diffusion because of the
large concentrations often put inside the intestine. So I think it wasn’t until we began
using much lower concentrations that one could start looking at active transport.18
Professor Timothy Peters:19 I think you are absolutely right. One of the other
observations that really nailed the diffusion hypothesis was the demonstration that
14 Dr Derek Holdsworth FRCP (b. 1933) qualified in medicine at the University of Leeds in 1957. While Medical
Registrar at the Royal Free Hospital, London, he wrote his MD thesis on monosaccharide absorption in man.
Following a year (1964–1965) on an MRC Fellowship in the Physiology Department of Harvard University in the
laboratory of Tom Hastings Wilson, he returned to London as Senior Lecturer in Medicine on the Medical Unit
at St Bartholomew’s Hospital in London. He moved to Sheffield in 1970, one attraction being the opportunity
there to continue his interest in the physiology of absorption, whilst pursuing a clinical career.
15 Dr De rek Ho l d s w o rth wrote: ‘He [Ve rzár] concluded that an “a c t i ve pro c e s s” was invo l ved in the absorption of
these two sugars, attributing the selective absorption of glucose and galactose to their capacity for phosphory l a t i o n ,
which reduced the concentration of hexose within the cell, there by keeping the diffusion gradient high. In coming to
this conclusion, he quoted earlier experiments that showed inhibition of glucose absorption by metabolic inhibitors.’
Note on draft transcript, 25 October 1999. See Ve rzár F, Mc Dougall E J. (eds) (1936) op. cit. note 9, 113–149. 
16 Dr Derek Holdsworth wrote: ‘...The Coris [husband and wife (see note 67)] showed equal rates of absorption
of these sugars, an artifact because they used intragastric introduction of the sugars – the rate was then dependent
on gastric emptying as the rate-limiting factor.’ Note on draft transcript, 25 October 1999. See Cori C F. (1925)
The fate of sugar in the animal body. I. The rate of absorption of hexoses and pentoses from the intestinal tract.
Journal of Biological Chemistry 66: 691–715. idem (1926) The rate of absorption of a mixture of glucose and
galactose. Proceedings of the Society for Experimental Biology 23: 290–291. See also note 67.
17 Dr Roy Levin (b. 1935) has been a Reader in Physiology at the University of Sheffield since 1977. He took his
original degrees (BSc and MSc) in the Department of Physiology at the University of Liverpool studying with
Professor Rod Gregory from 1953 to 1959. He moved to the Department of Physiology (now Department of
Biomedical Science) at Sheffield University initially to work with Professor David Smyth on the effects of
hormones and diet on intestinal absorption, and obtained his doctorate in 1964. His later studies involved
investigating the effects of hormones and of changes in dietary intake on intestinal secretory function.
18 Debnam E S, Levin R J. (1975) An experimental method of identifying and quantifying the active transfer
electrogenic component during sugar absorption measured in vivo. Journal of Physiolog y 246: 181–196.
19 Professor Timothy Peters DSc FRCP FRCPath (b. 1939) has been Professor and Head of Department of Clinical
Biochemistry, King’s College School of Medicine and Dentistry, London, since 1988 and was Clinical Director of
Pathology, King’s Healthcare, from 1992 to 1999. He was Head of the Division of Clinical Cell Biology, MRC
Clinical Research Centre, Harrow, from 1979 to 1988 and Sub-Dean for Postgraduates and Higher Degrees,
King’s College School of Medicine, London, since 1988. 
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absorption is energy requiring. Fisher, Parsons and other people, using metabolic
inhibitors, showed that if they inhibited ATP production, then absorption was
markedly inhibited.20 I think that was a very seminal observation.
Booth: Could I just ask when was that done? 
Peters: I would have to refer to Tom Hastings Wilson’s book,21 but it was way before
the 1940s.22
P ro fessor Hermon Dow l i n g :2 3 Two brief points if I may. First, Chris, I enjoyed yo u r
opening re m a rks which provided a broad and helpful perspective. You mentioned
von Ta p p e i n e r’s publication in 1878,2 4 but, in fact, there was an earlier study eight
years before that which implied that there was selective absorption of bile acids.2 5
This was the prototypic substrate that was used to document segmental absorption
of specific substances. 
The second comment relates to the importance of passive diffusion, as opposed to
active transport, in glucose absorption. I shared your views about this until the late
1960s when I worked with Franz Ingelfinger in Boston. He had done a lot of work
using segmental perfusion techniques to study sugar absorption in humans26 and with
20 op. cit. notes 15 and 22. Professor Michael Gardner wrote: ‘I think it was Smyth’s group in Sheffield, rather than
Fisher and Parsons, who explored effects of metabolic inhibitors, though Holdsworth draws attention in footnote
22 to even earlier work. Though Fisher and Parsons did not use metabolic inhibitors, their observations of
Michaelis–Menten saturation kinetics (1953) and their findings of competition by phlorizin (1950), together with
transport of glucose against a concentration gradient (1950) led them to conclude that a carrier-binding process
was involved and also that active transport must be implicated (op. cit. notes 12 and 46). This predates Widdas’s
observations on carrier mediation in erythrocytes mentioned by Parsons (note 51), though it is after Shannon’s
work on kidney, mentioned on page 41, note 141.’ Letter to Dr Daphne Christie, 28 April 2000. See Parsons 
B J, Smyth D H, Taylor C B. (1958) The action of phlorrhizin on the intestinal transfer of glucose and water 
in vitro. Journal of Physiology 144: 387–402. 
21 Wilson T H. (1962) op. cit. note 13.
22 Dr Derek Holdsworth wrote: ‘They were used much earlier, for example, by Wilbrandt and Laszt in 1932
(quoted by Verzár op. cit. note 9, 130–134. [Wilbrandt W, Laszt L. (1933) Untersuchungen über die ursachen der
selektiven resorption der zucker aus dem darm. Biochemische Zeitschrift 259: 398–417]). Verzár quotes even earlier
work on the effect of metabolic inhibitors on glucose absorption, for example, fluoride by Cohnheim in 1899, and
Reid in 1900. Wilson and Wiseman used fluoride in their early everted sac in 1954 (op. cit. note 82).’ Note on
draft transcript, 25 October 1999. 
23 Professor Hermon Dowling MD FRCP (b. 1934) trained in medicine at the Queen’s University, Belfast,
graduating in 1959. In 1964 he moved to the Postgraduate School in London to work with Professor Sir
Christopher Booth and spent ten years at Hammersmith (which included two years in Boston) before moving to
Guy’s Hospital and Medical School to become Professor of Gastroenterology in 1974. He is a Past-President of the
European Society for Clinical Investigation and the British Society for Gastroenterology and was the Founding
Secretary of the United European Gastroenterology Federation.
24 op. cit. note 10.
25 Schiff M. (1870) Gallenbildung, abhängig von der aufsaugung der gallenstoffe. Archiv für die Gesamte Physiologie
3: 598. 
26 See, for example, Gray G M, Ingelfinger F J. (1966) Intestinal absorption of sucrose in man: interrelation of
hydrolysis and monosaccharide product absorption. Journal of Clinical Investigation 45: 388–398. Olsen W A,
Ingelfinger F J. (1968) The role of sodium in intestinal glucose absorption in man. ibid. 47: 1133–1142. 
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Ward Olsen, clearly showed that the bulk of glucose absorption in the human jejunum
took place by a passive process – rather than by active transport. As Roy Levin said,
for many sugars and amino acids it’s only when one gets down to low substrate
concentrations in the intestinal lumen that the active transport processes begin. For
the majority of ingested nutrients there is a huge concentration gradient from lumen
to plasma (mucosa to serosa) after meals. This favours passive diffusion and,
conceptually, active transport serves as an end-stage ‘mop-up’ function to transport
very low residual concentrations of substrate and to stop back-diffusion. Now that
may be a controversial idea which will be contested by many in this room but at least
it was the concept that emerged at that time. 
Turnberg: I think we will come to this controversy later on and I don’t think we
should open it now. Can I just comment on Dennis Parsons’s role in all this? It’s a
great pity he’s not here today because it does seem to me that he made a number of
the seminal observations upon which others have built. Is that a correct perception or
were there other leading figures then who had an equal or higher standing? 
Booth: You would have to include David Fisher,27 of course, with Parsons. 
Professor Richard Naftalin:28 I agree that Parsons did have a most important role; we
will come to that later this afternoon, but I think one shouldn’t forget Ussing’s role.
Although he wasn’t directly involved in the intestine, his experiments were seminal in
almost all the work of the 1950s, 1960s and 1970s in the intestine, and I think his
work can’t be underestimated.29
Turnberg: When did Jared Diamond and Peter Curran come in?30 It was a bit later.
27 See note 6.
28 Professor Richard Naftalin (b. 1939) has been Professor of Epithelial Physiology at King’s College, London, since
1991. He currently works on intestinal salt and water transport and glucose transport in red and white blood cells.
His main interest is in regulation of salt and water transport in the colon by growth factors relating to dietary salt
intake and to the effects of ionizing radiation on salt and water transport in the colon in relation to expression of
adhesion molecules by epithelial cells and myofibroblasts. 
29 Hans Henrikson Ussing (b. 1911) graduated in physiology from the University of Copenhagen in 1934, was
Research Professor and Head of the Isotope Division of the Department of Zoophysiology from 1951 to 1960,
Head of the Institute of Biological Chemistry from 1960 to 1980, and then Emeritus Research Professor. His many
experiments utilized a frog skin preparation mounted in a specially constructed apparatus, known as the ‘Ussing
chamber’, where each surface was bathed in a separate fluid. Chemical manipulation and analysis of the medium
on each side provided extensive information about transport processes across the skin. See, for example, Ussing 
H H, Zerahn K. (1951) Active transport of sodium as the source of electric current in the short-circuited isolated
frog skin. Acta Physiologica Scandinavica 23: 110–127. Ussing H H. (1989) Epithelial transport: Frog skin as a
model system. In Tosteson D C. (ed.) Membrane Transport. People and Ideas. Bethesda, MD: American
Physiological Society, 337–362. For short-circuit current in vitro measurements made on segments of rat and
rabbit terminal ileum, see, for example, Clarkson T W, Toole S R. (1964) Measurement of short-circuit and ion
transport across the ileum. American Journal of Physiology 206: 658–668. op. cit. note 99 and page 29.
3 0 See, for example, Curran P F, Solomon A K. (1957) Ion and water fluxes in the ileum of rats. Jo u rnal of Ge n e ra l
Ph y s i o l o gy 4 1: 143–168. Diamond J M. (1966) A rapid method for determining voltage-concentration relations acro s s
membranes. Jo u rnal of Ph y s i o l o gy 1 8 3: 83–100. i d e m (1971) Standing-gradient model of fluid transport in epithelia.
Fe d e ration Pro c e e d i n g s 3 0: 6–13. Curran P F. (1965) Ion transport in intestine and its coupling to other transport
p rocesses. ibid. 2 4: 993–999. i d e m (1968) Coupling between transport processes in intestine. Ph y s i o l o g i s t 1 1: 3–23.
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Booth: What was the date of the earliest work on the Ussing chamber?31
Naftalin: 1953. 
Dr Michael Hellier:32 The other people I feel we should pay credit to are Wilson and
Wiseman with their everted sac in the 1950s.33 I think they made a very major
contribution providing a technique to enable us to demonstrate active transfer.
B o o t h : I think we shall be coming to that because that’s a specific question we will addre s s .
Turnberg: I was just thinking whether before Parsons there were some important
advances on to which others latched? Ussing was certainly working on frog skin and
looking at ion transport largely in that tissue and only later was the technique taken
up by others to apply it to the intestine.34
L ev i n : In relation to Ussing, I think the importance of the technique was enormous, but
also it was the first model of an epithelial cell that you could actually see polarization at
the front and the back – the potassium and the sodium transport processes. I re m e m b e r
seeing it and it was burnt into my consciousness, and so that was the one that we all
f o l l owed. Re a l l y, it was t h e model of the epithelial cell and it has surv i ved for years. 
Turnberg: I think we should move on because a lot of this will come out as we move
to the next item on the agenda, which is sodium-linked glucose transport, amino acids
and peptides, and Richard Boyd is going to lead off.
Dr Richard Boyd:35 I have been in contact with Dennis Parsons36 this week and he has
given me something which he thought you might like to hear. He did make some
interesting contributions with David Fisher.37 This is dated 2 February 1999.
‘Dear Richard, here, as promised, are my recollections of how the work
on the intestine started in Oxford [Figure 2]. One of the things about
memory is that with experiments, for example, when they go well, the
31 op. cit. note 29. See also Ussing H H. (1954) Active transport of inorganic ions. Symposium of the Society for
Experimental Biology 8: 407–422.
32 Dr Michael Hellier MD MA FRCP (b. 1941) trained in medicine at Cambridge and St Thomas’ Hospital,
London. His MD thesis ‘A study of amino acid and dipeptide absorption with observations on their interactions
with water and electrolytes’ was written whilst a lecturer at St Bartholomew’s Hospital, London, in 1973. He
continued his research on absorption in Tropical Enteropathy in South India with Professor Selwyn Baker. He is
currently a gastroenterologist at Princess Margaret Hospital, Swindon. 
33 Wilson T H, Wiseman G. (1954) The use of sacs of everted small intestine for the study of the transference of
substances from the mucosal to the serosal surface. Journal of Physiology 123: 116–125.
34 op. cit. notes 29 and 31.
35 Dr Richard Boyd (b. 1945) is currently Medical Tutor at Brasenose College, Oxford, and works in the
De p a rtment of Human Anatomy and Genetics where he carries out re s e a rch on membrane transport in
epithelia. He trained in Dennis Pa r s o n s’s laboratory from 1971 to 1975, having been taught by him when he
was a medical student.
36 See note 4.
37 See, for example, notes 12 and 46.
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Figure 2. Dr Dennis Parsons (left) talking to Dr Neil Ian McNeil and Professor Leslie Turnberg (back to camera) at the 1983 Falk
Symposium on Intestinal Absorption and Secretion in Titisee, Black Forest. At the meeting, Parsons presented a valuable historical
account of some of the key aspects of intestinal absorption, including an autobiographical note about his own invo l vement. [Parsons D S.
(1984) Subsequence and consequence in studies on absorption in the intestine. In Skadhauge E, He i n t ze K. (eds) Intestinal Absorption and
Se c re t i o n. Lancaster: MTP Press, 1–17]. © Professor Michael Gardner, 2000.
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timescale is recalled as being short, but when they go badly the timescale
seems extended. I have not looked at my notebooks, so I don’t know
exactly when we started to use rats for example, nor do I remember when
we started to do kinetic studies of glucose absorption. I do remember
reading A N Richards’s micropuncture studies on glucose absorption in
the renal proximal tubule, where he had found saturation kinetics,38 and
I found this to be very stimulating and these certainly preceded and
probably catalysed some of our own work. I must mention Frank Caddick.
Frank was the technician who worked with R B Fisher and me and was a
m a rvellous assistant. You may remember that reducing sugars we re measure d
by the reduction method of Hagedorn and Je n s e n .3 9 This invo l ved analysis
of the total reducing sugar, the amount re m oved when you incubated the
analysate with yeast and then the residual reducing component. So eve ry
stage had to be calibrated; there was certainly a serious analytical pro b l e m
which Frank helped to solve. Who would go into all that now? 
With an MRC grant I started to work with R B Fisher in the
Biochemistry Department in Oxford. R A Peters was the Whitley
Professor, Fisher was a university lecturer; he had spent most of the war
on statistical problems, the bombing of strategic targets, and how to set
fire to cities from the air. This work had taken place in Princes
Risborough with J Bronowski40 and others. After the war was over and
having visited various bomb-targeted sites in Europe and Japan, Fisher
returned to the Biochemistry Department and prepared to start work on
intestinal absorption. His interest was stimulated by the work of E S
London from Leningrad who had used the cannula, the ‘London
cannula’, to study the composition of amino-nitrogen in the portal vein
of dogs. 41 London had reported the presence of peptides in portal blood
38 See, for example, Wearn J T, Richards A N. (1924) Observations on the composition of glomerular urine with
particular reference to the problem of reabsorption in the renal tubules. American Journal of Physiology 71:
209–227. See also Walker A M, Bott P A, Oliver J, MacDowell M C. (1941) The collection and analysis of fluid
from single nephrons of the mammalian kidney. ibid. 134: 580–595. Starr I. (1969) Alfred Newton Richards,
scientist and man. Annals of Internal Medicine 71: 1–89. 
39 Hagedorn H C, Jensen B N. (1923) Zur mikrobestimmung des blutzuckers mittels firricyanid. Biochemische
Zeitschrift 135: 46–58. 
40 Dr Jacob Bronowski (1908–1974) studied mathematics at Jesus College, Cambridge, obtaining his PhD in 1933
and becoming an Honorary Fellow in 1967. He was Senior Lecturer at University College, Hull, from 1934 to
1942, and carried out military research during the Second World War, remaining a government official until 1963.
From 1964 he was a senior fellow and Director of the Council for Biology in Human Affairs at the Salk Institute
for Biological Studies, San Diego, California. His many publications include The Poet’s Defence (1939), William
Blake, A Man without a Mask (1944) and The Ascent of Man (1973).
41 Dr Efim Semenovich London (1869–1939) and his school in Leningrad developed a technique for portal vein
sampling. The ‘London cannula’ was a metal cannula surgically fixed in close proximity to the portal vein or other
large vessel in such a way that a sharp needle could be introduced through the cannula into the vessel for sampling.
For a description, see London E S. (1929) Experimental fistulae of blood vessels. Harvey Lectures 23: 208–221. 
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during absorption of a meal. Fisher was attracted to this hypothesis, that
it was peptides, rather than amino acids, that formed the major form of
nitrogen traffic between the tissues in animals. London’s experiments
were done before the war and the methods of analysis of nitrogenous
substances were not very good. It was thought that the more recent
developments in chromatography, especially of paper chromatography
which had been developed by Martin and Synge,42 could be used in the
projected studies. Fisher’s views on peptide transport are expounded in his
excellent monograph on protein metabolism.43
Before the war Fisher had worked on a variety of aspects of cardiac
metabolism in vitro, using the rat heart in a Langendorff preparation. The
heart, in a water-jacketed organ chamber, was perfused via gravity from a
reservoir placed at a suitable height above it. The output from the
coronary veins was returned to the reservoir by a water-jacketed return
line at the bottom of which there was a glass nozzle through which gas
(95 per cent O2/5 per cent CO2) was injected to form an ascending
stream of bubbles in the returning fluid. This ‘gas lift’ was an excellent
way of maintaining the fluid circulation through and around tissues in
vitro. It seems to have been devised for heart perfusion experiments at
University College London. At the end of the nineteenth century, gas lifts
had been used by the London Metropolitan Water Board as pumps for
mixing in water treatment systems. Gas lifts are used to circulate the fluids
on both sides in the Ussing chamber.44 In any case, Fisher proposed to use
this system replacing the heart with a segment of small intestine. A key
notion was that the fluid in the lumen was to be isotonic extracellular
fluid, so that as in the case of the heart, the circulating fluid would be
Krebs bicarbonate Ringer and the tissue would thus be supplied with
oxygen from the mucosal surface. The length of the path of diffusion for
oxygen across the serosal surface and muscularis was much too long to
provide an adequate PO2 at the epithelium, even with serosal fluid
oxygenation with 100 per cent oxygen. All the glass vessels were water
42 Paper chromatography, a technique for separating the components of complex mixtures, was developed as a
research tool, for which Archer Martin shared the 1952 Nobel Prize for Chemistry with his coworker, Richard
Synge. See Martin A J P, Synge R L M. (1941) A new form of chromatography employing two liquid phases: 1. A
theory of chromatography, 2. Application to the micro-determination of the higher monoamino acids in proteins.
Biochemical Journal 35: 1358–1368. See also James L K. (ed.) (1993) Archer John Porter Martin. In Nobel
Laureates in Chemistry 1901–1992. Washington, DC: American Chemical Society and the Chemical Heritage
Foundation, 352–355. idem Richard Laurence Millington Synge. ibid. 356–358. Martin A J P. (1964) The
development of partition chromatography. In Nobel Lectures: Chemistry, 1942–1962. Amsterdam, the Netherlands:
Elsevier, 359–371. Synge R L M. (1964) Applications of partition chromatography. ibid. 347–387. See also
Gordon H. (1996) Richard Laurence Millington Synge FRS 1914–1994. Biographical Memoirs of Fellows of the
Royal Society 42: 455–479.
43 Fisher R B. (1954) Protein Metabolism. London: Methuen.
44 op. cit. note 29.
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jacketed and made in the glassblowers’ workshop and were rather fragile
and difficult to re p a i r. In my view the design was unnecessarily
complicated and I later made many modifications; for example, much to
Fisher’s disgust, I found that if you put a hypodermic needle through a
thick-walled rubber tube, you got exactly the same effect as that produced
by the glass nozzle. 
By the time I arrived in the department, Fisher had assembled at least one
set of circulation equipment but had not made serious use of it. He had
decided to use guinea-pigs, but first they had to be anaesthetized because
it was agreed that at no time was the mucosa to be anoxic, and that the
mesenteric circulation was to be maintained until the luminal circulation
was established. At the Nuffield Department of Anaesthetics at the
Radcliffe In f i r m a ry in Oxford, a physicist, Epstein, had produced a small
p o rtable anaesthetic machine for delive ry of volatile anaesthetics to patients
under field conditions. It was made of black plastic and was about 20 cm in
diameter by 12 cm deep. Ether was in a compartment provided from a water-
jacketed container. It was exactly the type of apparatus which appealed to
Fi s h e r. It was splendid looking, but proved to be quite useless and a lot of time
was wasted in trying to get it to work. I actually found that it was much easier
to use some ether on a piece of cotton wool gauze in a funnel. That work e d
well and we never looked back. But the guinea-pig experiments we re failure s .
This was because of the presence of ve ry significant peristalsis which
i n t e r rupted the luminal flow circulation to such an extent that the epithelium
became anoxic and the mucosa sloughed off. The peristalsis could not be
reduced by altering perfusion pre s s u re, so we tried the effect of adding pulses
of hyd rostatic pre s s u re to the lumen. 
At the end of the war there we re vast amounts of surplus equipment ava i l a b l e
for virtually nothing and being quite a gadgeteer myself I constructed a
pulsatile actuator which I called a pulsometer, electrically activated with a
pneumatic va l ve, to pump air as a way of trying to ove rcome peristalsis.
Although this equipment was most impre s s i ve, and indeed re d u c e d
peristalsis somewhat, it was not sufficient to provide a useful preparation. All
ve ry depressing. But guinea-pigs we re herbivo res, and so we started to use
rats, omnivo res, and right from the beginning the segments surv i ve d .
Peristalsis only caused problems if the luminal hyd rostatic pre s s u re was low.
In the Langendorff preparation the hearts we re given glucose as a fuel, so it
was provided for the rat intestine. 
As re g a rds the Kre b s – R i n g e r, it was made up each day from stock solutions,
the calcium always being added last, because it formed a precipitate, which
tended to dissolve when the solution was warmed up and gassed, but it neve r
went completely. Later on, A Ba i rd Hastings, the great clinical chemist, was
visiting the department and told us that Krebs had based the composition of
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his Ringer solution on the ionic content of whole mammalian plasma, but
because half the calcium ions of plasma are bound to proteins, the calcium
content in Krebs–Ringer is too high by a factor of two. He n c e f o rth, we cut
the calcium content by half and precipitation was never a problem. 
Just before the war an interesting book on intestinal absorption was
published. This was, of course, written by Ve rzár and Mc Do u g a l l .4 5 In that
they re p o rted that D-glucose, a hexose, was absorbed faster than the smaller
pentose, D-xylose; thus the process of absorption was more complicated
than merely simple diffusion. After the war there was great interest in ‘a c t i ve
t r a n s p o rt’, transport ‘u p h i l l’ against a concentration gradient, or, more
s t r i c t l y, an electrochemical gradient. Me rely as a test of the viability of our
intestinal segments, it was decided to see if they we re capable of sustaining
t r a n s p o rt of glucose from the bulk phase of the lumen into the serosal fluid,
the initial concentration in both sides being the same. We we re soon able
to show that such transport did occur, while at the same time the glucose
concentration in the lumen fell below, and that in the serosal fluid ro s e
a b ove, the initial value. These concentration changes we re observed in the
p resence of substantial fluid transport from the luminal to the serosal fluid.
Galactose produced similar findings, except that the fluid transport was
much less.4 6 The stimulatory effect of glucose on fluid transport was
examined later in experiments with Wi n g a t e .4 7 A finding of importance in
the glucose experiments was that the quantity that disappeared from the
lumen greatly exceeded the amount that appeared in the serosal fluid.
Me a s u rement of the glucose retained in the intestinal wall at the end of the
experiment did not account for this discre p a n c y. Later T H Wilson of
Ha rva rd, who had been working in Sheffield and had visited our lab in
O x f o rd, showed that lactate was a significant metabolic product of glucose
during its absorption from the intestine. This was of great importance in the
disposal of absorbed carbohydrate, lactate being an excellent substrate for
hepatic glyc o g e n e s i s .4 8 Nowadays, it is re c o g n i zed that extrusion of two moles
of lactate from one mole of absorbed glucose has consequences for entero c y t e
volume regulation. In experiments with galactose it was easy to show that the
quantity absorbed from the lumen could be accounted for by the amounts
appearing on the other side in the serosal fluid and by accumulation in the
intestinal wall. It was not metabolize d .
45 op. cit. note 9.
46 Fisher R B, Parsons D S. (1950) Glucose absorption from surviving rat small intestine. Journal of Physiology 110:
281–293. idem (1953) Glucose movements across the wall of the rat small intestine. ibid. 119: 210–223. idem
(1953) Galactose absorption from the surviving small intestine of the rat. ibid. 119: 224–232. 
47 Parsons D S, Wingate D L. (1961) The effect of osmotic gradients on fluid transfer across rat intestine in vitro.
Biochimica et Biophysica Acta 46: 170–183. idem Changes in the fluid content of rat intestine segments during
fluid absorption in vitro. ibid. 184–186. 
48 See note 66.
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A second test of the integrity of the circulated segment was to compare the
cellular stru c t u re before and after absorption had occurred. This was
s a t i s f a c t o ry, the absorbing segments being characterized by the presence of
dilated lymphatics in the villus cores, a sign indicative of raised tissue fluid
p re s s u re, as had been shown by Fl o rey and colleagues in the Sir Wi l l i a m
Dunn School of Pathology in Oxford .4 9 Another finding in both absorbing
and control tissue was that at the tips of the villi degenerating cells could
be seen, some in the process of desquamation. A search of the literature
re vealed that this was a natural phenomenon, the mucosal cell population
continually being re n ewed by cells migrating up the villi surface and
d i s c a rded at the tips. This was first described in the 1880s by Bi z zo ze ro and
must be one of the earliest accounts of what is now called apoptosis.5 0
About this time there was a great interest in understanding the nature of the
systems underlying sugar uptake in tissues. At the De p a rtment of Ph y s i o l o g y
at St Ma ry’s Hospital in London, glucose uptake into ery t h rocytes was being
m e a s u red by following the volume changes by nephelometry. W F Wi d d a s
was able to show that in this case the kinetics could be accounted for if the
glucose molecules we re transported by a small number of ‘c a r r i e r’ systems,
each with a re l a t i vely high turnover number.5 1 As with enzyme systems, the
reaction had a maximum transport rate (Vm a x) and an affinity for the glucose
m e a s u red as the concentration re q u i red to give half the Vm a x, which was
called Kt. These experiments we re going on at about the time that Fisher and
I examined the kinetics of glucose and galactose transport and of the
competition for transport between sugars. I cannot now remember the
d a t e s ,5 2 but we certainly became aware of Wi d d a s’s work .
The received wisdom of that time, at least as far as teaching was
concerned, was that the products of digestion of starch were glucose
molecules and of proteins, amino acids. But if we had read Starling and
Cohnheim, we would have known otherwise.53
49 Pullinger B D, Florey H W. (1935) Some observations on structure and functions of lymphatics: their behaviour
in local oedema. British Journal of Experimental Pathology 16: 49–61.
50 Bi z zo ze ro G. (1888) Über die regeneration der elemente der schlauchförmigen drüsen und des epithels des
magendarmkanals. Anatomischer An ze i g e r 3: 781–784. i d e m (1889) Über die schlauchförmigen drüsen des
magendarmkanals und die beziehungen ihres epithels zudem oberflächenepithel der schleimhaut. Erste Mi t t h e i l u n g .
Archiv für Mi k roskopische An a t o m i e 3 3: 216–246. Information provided by Dr Richard Boyd, 3 May 2000.
51 Widdas W F. (1954) Facilitated transfer of hexoses across the human erythrocyte membrane. Journal of Physiology
125: 163–180.
52 Professor Michael Gardner wrote: ‘Fisher and Parsons reported kinetics for glucose and galactose transport in
1953 (op. cit. note 46).’ Note on draft transcript, 28 April 2000.
53 See, for example, Starling E H. (1898) The mechanisms of the secretion of urine. In Schaefer E A. (ed.) Textbook
of Physiolog y. Edinburgh: Pentland, 639–661. idem (1899) The glomerular functions of the kidney. Journal of
Physiology 24: 317–330. op. cit. note 164.
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In spite of its limitations the recirculated intestinal segment was a very
useful and stable preparation. Provided that glucose in the lumen was
kept above 20 mmol/l, the preparation could surv i ve and for
demonstration purposes segments would continue to absorb for over
three hours. However, special apparatus was required, it took time to
learn the procedure, and most people took the easy way out by using, later
on, everted sacs. For these to work, the incubation flask had to be shaken
v i g o rously which can eventually cause damage if the experiment
continues too long. 
Fisher had lots of ideas, some very good, but he wasn’t a very good
experimentalist, and he loved complicated apparatus. I liked to simplify.
However, Fisher was a marvellous statistician. At the end of 1951, I left
Fisher and moved to my own lab, and started to work using recirculated
segments of rat intestine in vivo, looking at the effects of fluid transport
on absorption and on acid–base changes during fluid absorption.54 Later
my continuing interest in fluid transport produced more in vitro
experiments which, with David Wingate, showed that from a Ringer of
particular osmotic pressure in the lumen, fluid could be transported
across the intestinal wall into a fluid of lower osmotic pressure than that
in the lumen. But the presence of glucose in the system assisted this
transport greatly.’55
So that is Dennis Parsons’s view of experiments carried out some 50 years ago. Like
you, I think they were seminal experiments. It is interesting to see, running in 
parallel, the relevance of Richards’s work in the kidney and of Widdas’s work on 
the erythrocyte.56
To get the ball rolling I would like to move on and ask some questions. One obvious
one is, why wasn’t sodium-coupled glucose transport discovered in the UK and, more
specifically, why wasn’t it discovered either in Sheffield or in Oxford? Of course, the
seminal work that led to our key modern view of how sodium-coupled glucose
transport occurs was a model drawn by R K Crane and colleagues, published in an
extraordinarily interesting symposium which was held in Prague in 1960.57 It was put
together by A Kleinzeller and was held at the height of the Cold War. At that
symposium were a galaxy of young and later eminent scientists including two (Jens
Christian Skou and Peter Mitchell) who later received Nobel Prizes. From the
intestinal transport field Crane was the only participant, and he talked on the
54 See note 61. op. cit. note 129.
55 op. cit. note 47.
56 op. cit. notes 38 and 51.
57 Crane R K, Miller D, Bihler I. (1961) The restrictions on possible mechanisms of intestinal active transport of
sugars. op. cit. note 7, 439–464. See also Crane R K. (1962) Hypothesis for mechanism of intestinal active
transport of sugars. Federation Proceedings 21: 891–895.
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structural features of hexoses required for transport. As an addendum, added after the
meeting, he included the model, which for the first time shows the notion of flux
coupling, sodium moving through a transport molecule in the same direction as
glucose. There are a number of features of the model that nowadays are obviously
problematic (for example, where he put the sodium pump). But without doubt this
model, originally proposed at this obscure symposium in 1960, continues to dominate
thinking right through to 1999. I would like to ask the question, why wasn’t such a
model put forward by able people such as Dennis Parsons and his colleagues in the
1950s or David Smyth and his colleagues in Sheffield at a similar time?58
Another question relates to the coming together of the field of ‘bioenergetics’. This
was developing with mitochondrial studies, led, of course, by Peter Mitchell. (Mitchell
was also at the 1960 symposium in Prague, where he talked on transport in bacteria.)
Why was it that at that time people working on mitochondrial ATP synthesis and
chemiosmosis were so completely isolated from individuals working in the field of
intestinal transport? Intellectually, that has subsequently emerged as one of the major
syntheses in the last quarter of this century. I think it is interesting to examine the
issue of how much interaction there was between these two fields at different times.
My third comment is really a very straightforward one. Biology has benefited hugely
from interactions with chemists on the one side and physicists on the other. However,
it seems to me that people who come from a biochemical background failed to take
electricity sufficiently seriously and people who came from a biophysical (electrical)
b a c k g round failed to take biochemistry sufficiently seriously. When Richard
[Naftalin] talks about Ussing’s contribution in relation to this field, it becomes
obvious that indeed he is a key figure.59 I suspect, however, that the biochemical
community were both ignorant of, and a bit frightened by, people who talked about
electrical events; similarly I wonder if the biophysicists were not a bit baffled by the
chemistry of hexoses!
Turnberg: Thank you very much, Richard. You have thrown up some big questions.
Why wasn’t glucose–sodium linkage discovered earlier?
Naftalin: I think what Richard said is largely true. One of the things I noticed was that
he tended to telescope a certain amount of information [From the floor: Well he only
had a quarter of an hour]. One of the key pieces of information which he didn’t
mention was the linkage between not glucose and sodium, but water and sodium.
This was actually nailed by Curran in 1966. He showed, as I am sure we all know, that
there is a linear relationship between net sodium movement and water movement.60
58 Professor David Smyth FRS (1908–1979) was Professor of Physiology, Sheffield University, from 1946 to 1973,
and Emeritus Professor from 1973 to 1979. See Barcroft H, Matthews D M. (1981) David Henry Smyth.
Biographical Memoirs of Fellows of the Royal Society 27: 525–561.
59 op. cit. notes 29 and 31.
60 Curran P F. (1965) Ion transport in intestine and its coupling to other transport processes. Federation Proceedings
24: 993–999. 
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Now at that time I am almost sure that Parsons held the view that water transport was
active and that sodium, in part at least, was coupled to water movement and not the
other way round. And, in fact, if you look at Curran’s experiment where he showed a
linear relationship between water and sodium movement, as Parsons, I remember,
said, ‘Well, how do we know that it’s not sodium-coupled water.’ Of course, the
answer was that you could inhibit the sodium transport with ouabain and that showed
that water transport was directly related to sodium movement. From that comment
one can see that Parsons either didn’t want to recognize that connection or he actually
was thinking the wrong way round. There’s no great blame, because, in fact, water
transport was considered active by Fisher and his contemporaries right up until
1966.61 So I think that view should be considered and I would like to know what
Richard [Boyd] thinks Parsons thought about that? 62
Holdsworth: I remember visiting Parsons with Tony Dawson in 1962, because we had
found that both glucose and galactose stimulated water absorption in human jejunum
in vivo and we were anxious to have his comments. Parsons had shown that in vitro
glucose stimulated water absorption but galactose didn’t, and at that time he was very
keen on the explanation that this was entirely due to the metabolic action of glucose.63
In 1960 Curran had also demonstrated that active transport of sodium in vitro needed
glucose, and he too attributed this to the role of glucose in providing metabolic
61 Professor Michael Gardner wrote: ‘Note that Fisher’s early views on water transport in 1955 [Fisher R B. (1955)
The absorption of water and of some small solute molecules from the isolated small intestine of the rat. Journal of
Physiology 130: 655–664] included a solvent drag mechanism through a paracellular route which pre-empted the
current ideas of Pappenheimer and colleagues [Pappenheimer J R, Reiss K Z. (1987) Contribution of solvent drag
through intercellular junctions to absorption of nutrients by the small intestine of the rat. Journal of Membrane
Biology 100: 123–136. Pappenheimer J R. (1990) Paracellular intestinal absorption of glucose, creatinine, and
mannitol in normal animals: relation to body size. American Journal of Physiology 259: G290–G299].’ Letter to Dr
Daphne Christie, 5 November 1999. Dr Dennis Parsons wrote: ‘The late Paddy Fullerton (Mr leQuesne) and I
showed (c. 1953) that at least in vivo, there was evidence that solvent drag was involved in the “absorption” of both
glucose and xylose. If fluid absorption was zero, then glucose but not xylose was still absorbed. See Fullerton P M,
Parsons D S. (1956) The absorption of sugars and water from rat intestine in vivo. Quarterly Journal of
Experimental Physiology 41: 387–397.’ Letter to Dr Daphne Christie, 5 April 2000.
62 Professor Richard Naftalin wrote, in response to information requested by Dr Dennis Parsons and Dr Richard Boyd :
‘The question of the manner of coupling of water to Na+ and glucose flows is still very much an open one. Recently,
Zeuthen and collaborators have advanced the interesting view that isotonic water flow in epithelia results from
cotransport of water with Na+ and glucose via the Na+/glucose cotransporter [Loo D D F, Zeuthen T, Chandy G,
Wright E M. (1996) Cotransport of water by the Na+/glucose cotransporter. Proceedings of the National Academy
of Sciences of the United States of America 93: 13367–13370]. ...As the cotransporters have a high passive water
permeability, the process of sugar-driven water transport could be related to osmosis rather than cotransport. It
would seem important to test this possibility by observing bi-directional water flows in the cotransport condition,
as Meinild and colleagues (1998) have done with water flows to eliminate the possibility that sugar accumulation
in “hot spots” within the oocyte cortex is not a cause of water flow. Spring has recently expressed some reservations
about water cotransport [Spring K R. (1999) Epithelial fluid transport – a century of investigation. News in
Physiological Science 14: 92–98]. He bases his criticism on firstly the absence of pinocytic vesicles in transporting
epithelia – perhaps not surprising, as no claims were made for pinocytosis as the mechanism. Additionally,
cotransported water would have only a small effect on fluid absorption in the proximal tubule (< 2 per cent of
GFR) – this, of course, does not have much bearing on whether the process exists or not. Thirdly, he prefers the
Curran three-compartment model referred to earlier.’ Edited from a letter to Dr Daphne Christie, 14 April 2000.
63 op. cit. notes 12 and 46.
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substrate for the intestinal mucosa.64 Conversely, in 1958, Ricklis and Quastel had
shown, I think for the first time, that glucose transport in vitro was dependent on the
presence of sodium.65 Crane followed up this observation in the detailed study of the
kinetics of sugar absorption at different concentrations of sodium which led to his
hypothesis published in 1960.66
Pe t e r s : I am not sure that this is directly re l e vant, but I think we need to think of the
e n v i ronment in which Bob Crane was working in Missouri in the late 1940s. He was
w o rking for the two Coris who had just got the Nobel Pr i ze .6 7 In the lab at the same time
was Earl Sutherland, who you may remember got a Nobel Pr i ze for the discove ry of cyc l i c
adenosine monophosphate (cAMP), and Christian de Du ve, also a Nobel Laure a t e ,
whom I worked with, was working on glucose 6-phosphatase. He discove red the
lysosome because he was using acid phosphatase as a control for subcellular fractionation
studies. So in that lab there was a lot of work going on, on the bioenergetics, on the cell
b i o l o g y, physiology and biochemistry of carbohydrate metabolism. I think that was
p robably part of the reason for Cr a n e’s discove ry. The critical mass – not just one person
w o rking on his own, but several people looking at several aspects of carbohyd r a t e
metabolism from several different angles – provided a unique scientific enviro n m e n t .
Turnberg: Perhaps part of the reason was that he was working almost entirely in vivo,
so that it was very difficult to get down to low sodium concentrations to study the
effect of sodium on glucose transport. So the link may not have been very obvious.
Peters: It’s actually difficult in vivo to demonstrate sodium dependence of glucose
transport; you really have to have negligible levels of Na+ in the control perfusates.
Levin: I came to Sheffield in 1959. I remember that particular conference.68 The story
was that the model of sodium linked with glucose carrier was prepared on the
aeroplane going back, drawn on the back of an envelope, talking in the plane with
somebody, and that’s how it came about. Whether that’s true or not I don’t know, but
6 4 Curran P F. (1960) Na, Cl, and water transport in rat ileum in vitro. Jo u rnal of Ge n e ral Ph y s i o l o gy 4 3: 1137–1148.
65 Ricklis E, Quastel J H. (1958) Effects of cations on sugar absorption by isolated surviving guinea pig intestine.
Canadian Journal of Biochemistry and Physiolog y 36: 347–371.
6 6 Crane R K. (1960) Intestinal absorption of sugars. Physiological Re v i e w s 4 0: 789–825. i d e m (1960) Studies on the
mechanism of the intestinal absorption of sugars. III. Mutual inhibition in vitro, between some actively transport e d
sugars. Biochimica et Biophysica Ac t a 4 5: 477–482. i d e m (1962) op. cit. note 57. Dr De rek Ho l d s w o rth wrote: ‘A s
far as the production of lactate during glucose absorption is concerned, this is really an artifact of the in vitro
p reparations. We found that lactate levels in human subjects rose minimally or not at all in mesenteric blood
obtained at laparotomy when glucose was instilled into the jejunum, or when portal venous collaterals we re sampled
during glucose absorption [Ho l d s w o rth C D, Dawson A M. (1965) Fructose absorption in man. Proceedings of the
Society for Experimental Bi o l o gy and Me d i c i n e 1 1 8: 142–145].’ Note on draft transcript, 25 October 1999.
67 Professor Carl Cori (1896–1984) was Professor of Biochemistry, Washington University School of Medicine, St
Louis, MO, from 1931 to 1967. He shared (with Gerty Cori) the 1947 Nobel Prize in Physiology or Medicine,
for their discovery of the course of the catalytic conversion of glycogen. Professor Gerty Cori (1896–1957) was
Professor of Biochemistr y, Washington University Medical School, St Louis, MO, from 1947. See Houssay B A.
(1956) Carl F and Gerty T Cori. Biochimica et Biophysica Acta 20: 11–16. 
68 The Symposium held in Prague in 1960 discussed by Dr Richard Boyd on page 17. op. cit. note 57.
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it certainly wasn’t at the conference.
Turnberg: Richard, do you want to comment?
Boyd: I really haven’t got much to say except that I think Richard [Naftalin] has put
his finger on one really important thing about cause and effect. There is an editorial
in the Lancet in 1978 (which I suspect may have been written by somebody in this
room), which states that the discovery that water absorption was linked to sodium and
glucose absorption was one of the major medical advances of this century because it
opened the door to oral rehydration therapies. 69 I think Richard has put his finger on
a central problem (cause and effect) which is really not trivial. I don’t think that this
issue for the relationship between water and solute absorption was solved in the UK. 
With respect to the important comment on the environment that Crane was working
in at St Louis, I would disagree with the word ‘bioenergetics’. I think what people
knew about in the St Louis environment was excellent biochemistry; but I don’t think
they knew enough about membrane potential; and, with hindsight, I think that was
the important weakness of the ‘Crane hypothesis’ as originally presented.
P ro fessor Ramsey Bro n k :7 0 One point about the measurement of water movement and
the transport of glucose and sodium is again that people in the 1950s and the early
1960s did not recall the things that A N Richards had said in earlier decades about water
absorption in the kidney tubule.7 1 If they had re a l i zed that water transport was driven by
the osmolarity changes across the wall of the kidney tubule, they would have appre c i a t e d
the fact that changes in osmolarity we re also invo l ved in water transport in the intestine.
Turnberg: The work on the red cell. When was that? [From the floor: 1953].72
N a f t a l i n : Crane was able to look at the kinetics because he had a method to do it,
f o rt u n a t e l y. Looking at glucose transport in rats is incredibly laborious, as those of us
who have done it know, whereas looking at it with rings, which is what Crane did, is
re l a t i vely easy and you could, in fact, look at kinetic time dependence concentration of
methods with ease. It would take many, many rats to do that sort of thing. So one has
to look at the methodology, methodology is ve ry important, and I think you are right.
Tu r n b e r g : I think we must move on, but no doubt this will come back to the eve rted sacs
and the Ussing chambers, which we are going to hear a bit about now from Roy Levin.
69 Anonymous. (1978) Water with sugar and salt. Lancet ii: 300–301.
70 Professor J Ramsey Bronk (b. 1929), after graduating from Princeton University in 1952, went to Oriel College,
Oxford University, on a Rhodes Scholarship as a research student in Dr R B Fisher’s laboratory and completed his
DPhil in biochemistry in June 1955. He worked as a research scientist at the National Institutes of Health in
Bethesda, MD, until 1958 and was a member of the academic staff in the Department of Zoology at Columbia
University from 1958 to 1966, spending the 1964–1965 academic year in Dr D S Parsons’s laboratory in Oxford
as a Guggenheim Fellow. In 1966 Bronk became the first Professor of Biochemistry at the University of York and
continued to work on intestinal transport, becoming an Emeritus Professor in 1997.
7 1 o p. cit. note 38.R i c h a rds A N.(19 3 8)Processes of urine formation.Proceedings of the Royal Society of London 1 2 6: 398–432. 
72 op. cit. note 51.
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L ev i n : I came to Sheffield Un i ve r s i t y, as I said earlier, in 1959, and Gerald Wi s e m a n7 3
had been in the department for over ten years. He couldn’t manage to come down today
but I went and talked to him for a couple of hours and also re c o rded his comments
about how it all started. So I will say a little bit about the eve rted sac first of all.
Professor David Smyth74 advertised for a lecturer in 1948 and Gerald Wiseman, who
had done medicine in University College London, came up for an interview. Within
three days he got the letter saying, ‘Yes you are in, you are the Lecturer in Physiology’. 
He started to work with Smyth, and at the time, of course, Krebs was there, in the
Department of Biochemistry.75 They had a very active Biochemistry Department at
Sheffield. Physiology was about five or six strong, not particularly well known, but the
Biochemistry Department was extremely well known and everybody knew Krebs.
Everybody has forgotten now that Krebs worked and did the ‘cycle’ work in Sheffield,
not in Oxford.76 Wiseman worked with Smyth on trying to get information about the
citric acid cycle in the dog’s hind legs. It wasn’t very successful. 
As a medical student he had always thought that the idea that things were absorbed
across the intestine by passive diffusion was absolute rubbish, but he couldn’t prove it.
At Sheffield he was surrounded by people who were doing estimations of amino acids
with enzymes from bacteria, in the Department of Biochemistry which he said he was
in most of the time, and hardly in Physiology at all. At the time (you must realize this
was the late 1940s, or early 1950s), you couldn’t estimate D- and L-amino acids very
effectively. Moreover, you needed about a gram to do it! All of a sudden he came across
people who said, ‘Yes, I’ve got an enzyme, it will only take you six months to prepare
it, and you can then estimate the L- and the D-forms’. So he left working with the dog’s
hind legs and started to do absorption of amino acids. He prepared the powders,
which were enzymes of course, and estimated the amino acids by manometry. Gibson,
who was present in the department, had told him how to do manometry and estimate
the amino acids.77
7 3 Dr Gerald Wiseman (b. 1923) was at Un i versity College London and Un i versity College Hospital, London, from 1942
to 1947. He joined the staff of the Physiology De p a rtment, Sheffield, in 1948 and re t i red as a Reader in Physiology in 1989.
He is currently Ho n o r a ry Lecturer in Biomedical Science, Sheffield. His main re s e a rch was in intestinal absorption of amino
acids, sugars and peptides and he gave his first description of active absorption of amino acids in the early 1950s. With T h o m a s
Hastings Wilson, he introduced the sac of eve rted intestine technique. op. cit. notes 7, 33, 77 and 82. See also Fi g u re 3. Copies
of the tapes and transcript of an interv i ew with Dr Gerald Wiseman, conducted by Dr Roy Levin on 5 Fe b ru a ry 1999, will
be deposited with the re c o rds of this meeting in the Contemporary Medical Arc h i ves Centre of the Wellcome Library.
74 See note 58.
75 Sir Hans Adolf Krebs Kt FRS FRCP (1900–1981) was Lecturer in Pharmacology, University of Sheffield, from
1935 to 1938, Lecturer, Department of Biochemistry, University of Sheffield, from 1938 to 1945, and Professor
from 1945 to 1954. He was Whitley Professor of Biochemistry, and Fellow of Trinity College, Oxford, from 1954
to 1967. He shared (jointly with Fritz Lipmann) the 1953 Nobel Prize for Physiology or Medicine for the discovery
of the citric acid cycle (Krebs cycle). See Kornberg H, Williamson D H. (1984) Hans Adolf Krebs. Biographical
Memoirs of Fellows of the Royal Society 30: 351–385.
76 See note 75.
77 Gibson Q H, Wiseman G. (1951) Selective absorption of stereo-isomers of amino-acids from loops of the small
intestine of the rat. Biochemical Journal 48: 426–429.
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At the time David Smyth wasn’t involved in intestinal absorption and Gerald
[Wiseman] went to that particular Physiological Society Meeting.78 So he saw the
Fisher and Parsons apparatus and thought that he could make a much better
apparatus; that one was too complicated. So he made the Wiseman preparation which
used three pieces of intestine, and he started to estimate amino acids. He said that at
the time, because they were a small department, everybody talked with everybody else
and met at the bar. He was walking past a laboratory, which was actually that of Bob
Davies – a biochemist. He was looking at frogs’ stomachs in manometers and
incubating them and measuring acid secretion.79 What attracted Gerald’s attention
was the fact that the manometers were being gassed with rubber tubes and as he was
doing manometry, he thought, ‘What on earth is he doing?’ So he popped into the
laboratory and said to him, ‘Why are you gassing it?’ and Davies said, ‘Well, I have
got stomachs inside’. Gerald said, ‘Can you keep the stomachs alive?’ and he said, ‘Oh
yes! They go on for a long time’. And then he thought, ‘Well that’s a good idea, maybe
I should, in fact, take pieces of intestine and keep them alive outside of the body like
Fisher and Parsons did.’ The real problem was that he wanted to show that the amino
acids could be pumped against concentration gradients, so he thought at the time
(and it wasn’t to do with oxygenation), ‘If I turn the intestine inside out I will have a
small serosal fluid volume where I could pick up quite a large degree of change in the
concentration.’ So he had a method for estimating amino acids. He had a very good
glass blower, Mr Hadfield, in our department, who could make practically anything
in glass that you wanted. Wiseman was surrounded by biochemists who helped him
along. He had Krebs, who was a father figure to him. Krebs thought of him as a son
and as the ‘blue-eyed’ boy in the Department of Physiology.
At the time in America, Tom Hastings Wi l s o n8 0 had just finished medicine. He didn’t
like medicine ve ry much and decided, because his father, I think, was a Professor of
Bi o c h e m i s t ry, that he wanted to do purine absorption in the intestine and wanted to do
a PhD with Krebs. He wrote to Krebs, and Krebs replied, ‘Su re, come acro s s’. So To m
Hastings Wilson came across to Sheffield to work with Krebs. He said he wanted to do
purine absorption and Krebs said, ‘I know nothing about purines, I know nothing about
absorption, but there’s a bright young man in physiology who’s working on amino acids,
go across and see him’. So Tom Hastings Wilson went to Gerald [Wiseman] and Ge r a l d
said, ‘Well, I don’t know anything about purines and absorption either, but I do know
about amino acids and we are using this pre p a r a t i o n’. T h a t’s how Tom Hastings Wi l s o n
and Gerald got together and developed the ‘e ve rted sac’ (Fi g u re 3).8 1
They worked with all sorts of animals. Gerald told me they did pigeons, rats, mice and
hamsters, and in the end, because the sacs had to be shaken quite a lot to get good
78 Dr Gerald Wiseman wrote: ‘The meeting held in Oxford in 1949.’ Note on draft transcript, 31 March 2000.
See page 5, op. cit. note 12.
79 Davies R E. (1948) Hydrochloric acid production by isolated gastric mucosa. Biochemical Journal 42: 609–621.
80 See notes 14, 21 and 81. 
81 Some of the early work on intestinal absorption is given in Wilson T H. (1962) op. cit. note 13.
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oxygenation, they had the problem of cell shedding, knocking off the mucosa. T h e y
found out that the best sacs and the ones that got damaged the least, we re those
f rom the golden hamster.8 2 That was interesting in itself, because this hamster had
only begun to come into Britain as an experimental animal, because they we re
found in Syria originally under a stone. I think there we re about half a doze n
hamsters, and they we re brought across from what I shall call Israel, but what people
will probably still say is Palestine. It was Krebs who actually imported the hamsters
into England. These hamsters really we re a re l a t i vely new experimental animal 
in those days and only just begun to be used, and he actually bred his own 
colony of hamsters. So again, it was the ability of choosing the right animal for a 
p a rticular task. 
It all started, I suppose, by the conglomeration of the right people at the right time.
The amino acids were difficult to come by and were donated generously by a firm
called Lights which doesn’t exist now. It was a Sheffield-based firm and they gave
Wiseman £250 worth of amino acids, which probably represents a gift of about £5000
82 Dr Gerald Wiseman wrote: ‘Golden hamster (Mesocricetus auratus).’ Note on draft transcript, 31 March 2000.
See, for example, Wilson T H, Wiseman G. (1954) op. cit. note 33. idem Metabolic activity of the small intestine
of the rat and golden hamster (Mesocricetus auratus). Journal of Physiology 123: 126–130. Wilson T H, Vincent T
N. (1955) Absorption of sugars in vitro by the intestine of the golden hamster. Journal of Biological Chemistry 216:
851–866. For comment on the introduction of hamsters into laboratory research see note 93.
Fi g u re 3. Dr Ge rald Wiseman (left) and Dr Thomas Hastings Wilson (right) holding an enlarged photograph of a sac of eve rted small
intestine of the hamster. This photograph was taken in 1973 in Wi l s o n’s labora t o ry at Ha rva rd Medical School in Boston, Ma s s a c h u s e t t s ,
USA. © Dr Ge rald Wiseman, 2000.
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to £10 000 nowadays. There were few grants in those days; nobody bothered with the
Medical Research Council or the Science Research Council. Everybody funded
themselves from the meagre funds that the departments had. 
The key technique to begin with was the ability to estimate the D- and L-amino acids,
and that was, I suppose, the beginning of the everted sac which then obviously had
such a huge worldwide impact. The everted sac allowed you to show active transport
for the first time, it was relatively easy to prepare, it allowed you to demonstrate fluid
transfer and, of course, you could show transfer from the fluid outside to the fluid
inside. It also allowed you to study the metabolism; you incubated the sac with the
various compounds and then estimated how much was left, and it allowed you to
control the ionic concentration. 
To answer your [Richard Boyd] question.83 I don’t know why Sheffield didn’t actually
make that discovery of the link between Na+ and hexose transfer, because Sheffield
was the centre of intestinal absorption. For some reason people didn’t take sodium out
of the incubation fluid and link it together; I think they were too busy doing other
things at the time. They weren’t kinetic people at that particular time, although, to be
fair, David Smyth later turned to kinetics. 
After getting nowhere with the dog’s hind legs, David Smyth decided to pack it in.
Wiseman went to work in the States for a year, came back, and David Smyth said to
him, ‘Look, I’ve packed in the dog and I am going to work on the absorption of
glucose, is that all right? You’re doing amino acids and I’ll do hexoses.’ Gerald
Wiseman said, ‘Yes’. I think he couldn’t very well say anything else could he, he was
the Lecturer! So David Smyth started to work on the intestine and, of course, built up
a large school.84 I was one of the people that came in and worked with him on
hormones and intestinal absorption. In the end, of course, he got the FRS and Gerald
Wiseman didn’t. I suppose these things happen in science and in universities. 
I think the reason that the sac started to get supplanted by the sheet, was that it wasn’t
so easy to measure electrical activity across the sac. You could do it, but it wasn’t easy
to control, especially if you wanted to obtain the short-circuit current. You had to have
a silver coil around the sac, have a central silver electrode and it was far from easy to
set up. Silver seemed to poison the sac and it didn’t do too well. I think that was the
end of it. 
But there was a man, Shabtay Dikstein, a pharmacologist, who came over to visit the
[Sheffield] department from Israel. He was one of those incredible characters who had
a mind that could literally do anything in about one-and-a-half days. He said, ‘Let’s
83 See page 18.
84 Dr Roy Levin wrote: ‘Dr Brian Taylor worked on ions and fluid movement, Dr Roy Barry worked on fatty acid
transfer, Dr Leslie Jervis on amino acid absorption and Dr Harry Newey on peptide and amino acid absorption.
See, for example, Levin R J, Smyth D H. (1963) The effect of thyroid gland on intestinal absorption of hexoses.
Journal of Physiolog y 169: 755–769. Levin R J, Newey A, Smyth D H. (1965) The effects of adrenalectomy and
fasting on intestinal function in the rat. ibid. 177: 58–73.’ Note on draft transcript, 26 May 2000.
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measure the potential difference across the sac’. So he did just that! At the time there
was just one abstract on the subject, it was in Federation Proceedings.85 And this was in
the early 1960s. I think they had shown that when you add glucose to the mucosal
fluid bathing the sac you got an increase in the potential. What Dikstein did in about
three days was to add everything to the sac and measure potentials.86 I think that was
one of the early illustrations of the link between sodium and hexoses. Some of the
amino acids gave the potential as well. That was, I think, a really good demonstration
that ions were being transported across. We had no idea of the sodium–hexose carrier
model at the time because Crane hadn’t yet taken his aeroplane and drawn on the back
of his envelope!87 Gradually, of course, the glucose transfer potential or the hexose
transfer potential (as it was later called) became incredibly useful, because you could
do kinetic studies on the sacs and also on sheets very, very easily and they became the
dominant way, even, with Ernie Wright when he cloned the carrier. They used
electrical recording, now it is intracellular with microelectrodes, but they have been
using that to show how the hexose goes across the cell to this day.88
I just would add one thing about a man called Csáky. He used the hexose, 
3-O-methylglucose, which wasn’t metabolized but was actively transported.89 I think
that part of the reason that Crane was able to do things was by using sugars which
were actively transported but not metabolized. Glucose is very difficult to use, because
it is metabolized, galactose messes up the intestine, but by using things like 
3-O-methylglucose and D-xylose you could estimate them and do kinetics with them.90
So I think Csáky shouldn’t be forgotten, because I think he first utilized that 
3-O-methylglucose which is still used today.91
Turnberg: OK. Comments. Memories. Corrections.
85 Schachter D, Britten J S. (1961) Active transport of non-electrolytes and the potential gradients across intestinal
segments in vitro. Federation Proceedings 20: 137.
8 6 Ba r ry R J C, Dikstein S, Ma t t h ews J, Smyth D H. (1961) Electrical potentials in the isolated intestine. Jo u rnal of
Ph y s i o l o gy 1 5 5: 17–18P. i d e m (1964) Electrical potentials associated with intestinal sugar transfer. ibid. 1 7 1: 316–338.
87 See page 20.
88 Professor Michael Gardner wrote: ‘Wright’s early Sheffield work was on electrophysiology of intestinal transport
[see, for example, Wright E M. (1966) The origin of the glucose dependent increase in the potential difference
across the tortoise small intestine. Journal of Physiology 185: 486–500], work that became relevant in his
subsequent cloning studies of the sodium–glucose co-transporter when he was able to demonstrate that glucose
induced a similar potential difference in oocytes with inserted cloned carriers as had been observed in the original
whole intestinal tissue.’ Letter to Dr Daphne Christie, 5 November 1999.
89 See, for example, Csáky T Z, Glenn J E. (1957) Urinary recovery of 3-methylglucose administered to rats.
American Journal of Physiology 188: 159–162. Csáky T Z. (1958) Active intestinal transport of 3-O-methylglucose.
Proceedings of the Fourth International Congress of Biochemistry, 6–79. 
90 Fordtran J S, Clodi P H, Soergel K H, Ingelfinger F J. (1962) Sugar absorption tests, with special reference to
3-O-methyl-d-glucose and d-xylose. Annals of Internal Medicine 57: 883–891. Csáky T Z, Ho P M. (1965)
Intestinal transport of D-xylose. Proceedings of the Society for Experimental Biology and Medicine 120: 403–408. 
9 1 See, for example, Malo C. (1990) Separation of two distinct Na+/D-glucose cotransport systems in the human fetal
jejunum by means of their differential specificity for 3-O-methylglucose. Biochimica et Biophysica Ac t a 1 0 2 2 : 8–16. 
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Professor Oliver Wrong:92 I don’t want to impugn Hans Krebs in any way, but at my
boarding school in Edinburgh in 1938 or 1939, our Scottish housemaster’s daughter
had a golden hamster.93
Booth: I can remember going back in the 1960s to visit Gerald Wiseman to learn
about the everted sac. I hadn’t realized at that time that David Smyth had taken it over
and that Gerald was really running a rather private laboratory of his own in the
department. What I recollect most about it was the water bath that was on a sort of
dais in the middle of the laboratory and you had to go up two or three steps to get up
to the water bath to put your material inside, almost like approaching an altar. He was
tremendously helpful and encouraging. 
P ro fessor Michael Gard n e r:9 4 Can I ask if anyone knows why David Sm y t h
returned to the perfused preparation of Smyth and Ta y l o r, because this was, in a
sense, revisiting the Fisher and Parsons pre p a r a t i o n ?9 5 It was the first re m oval, I
think, of the serosal fluid which then led on to another generation of perf u s e d
p reparations, but it seemed to be acknowledging some of the shortcomings of
e ve rted sacs then.
Levin: I don’t know exactly why some of these things came around, but there was quite
an active feeling of trying to get new techniques all the time. There was the
92 Professor Oliver Wrong FRCP (b. 1925) graduated in 1947, trained in Oxford, Boston and Manchester, and
worked in clinical problems of salt and water metabolism, mainly in relation to kidney disease but also in
connection with the intestinal tract. In the 1960s, while on the staff at the Postgraduate Medical School, London,
he introduced the method of in vivo faecal dialysis for analysis of stool water. He was Chairman of the National
Kidney Research Fund from 1976 to 1980, and retired from the Chair of Medicine at University College London,
in 1990, now Professor Emeritus. He is currently working on the genetics of renal tubular disease. 
93 Professor Oliver Wrong wrote: ‘I have a vivid memory of this animal running over the carpet and tucking pieces
of biscuit into its cheek pads, and it cannot have been later than 1939 as the girl then went away to help with the
war effort. The point that I wanted to make is that hamsters had been introduced to the country many years before
the studies referred to by Dr Levin (see page 24). It is indeed possible that Krebs was the first to import the animals
into England (he came to England in 1933) but the dates don’t fit and I suspect the story has been elaborated in
the telling.’ Letter to Dr Daphne Christie, 29 March 2000. Dr Roy Levin wrote: ‘The hamsters of Krebs were
golden hamsters.’ Note on draft transcript, 26 May 2000. The Syrian hamster was introduced into laboratory
research by Dr Saul Adler of the Hebrew University of Jerusalem, in 1931. See Adler S. (1948) Origin of the
Golden Hamster, Cricetus auratus, as a laboratory animal. Nature 162: 256–257. For a review of this claim, and a
discussion of the relationship between Syrian and Chinese hamsters, see Yerganiam G. (1972) History and
cytogenetics of hamsters in pathology of the Syrian hamster. In Hornburger F. (ed.) Progress in Experimental Tumor
Research, vol. 16. Basel: S Karger AG, 2–42.’
94 Professor Michael Gardner DSc FIBiol (b. 1946) worked on intestinal absorption of sugars with R B Fisher in
the Department of Biochemistry, University of Edinburgh, from 1969 to 1975, and subsequently on a variety of
aspects of the physiological biochemistry of absorption, in Edinburgh and Bradford. These have included
investigations on absorption of intact peptides and proteins arising from Fisher’s early predictions, and
development of the Fisher and Gardner technique for intestinal perfusion [Fisher R B, Gardner M L G. (1974) 
A kinetic approach to the study of absorption of solutes by isolated perfused small intestine. Journal of Physiology
241: 211–234]. Professor Gardner has been Professor of Physiological Biochemistry in the Department of
Biomedical Sciences, University of Bradford, since 1996.
95 A preparation in which no serosal fluid is used, so that the fluid transported by the intestine can be collected,
and not diluted with serosal fluid. Smyth D H, Taylor C B. (1957) Transfer of water and solutes by an in vitro
intestinal preparation. Journal of Physiology 139: 632–648. op. cit. notes 12 and 46. 
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Sheff–Smyth technique where you circulated the fluid through the lumen of the
intestine by a gas lift;96 there was the Smyth and Taylor preparation;97 they were just
going on all at the time, I think, where people were thinking, ‘Let’s try this, let’s try
that’. There was a very good glass-blower, Mr Hadfield, and so they used to say, ‘See
if you can do that’. It was just an active department at the time, but I don’t really know
why that was the particular one at that particular time. I never really talked to David
Smyth about it; it’s funny really, because I worked with him for very many years, but
we never talked about the early history at all. 
Turnberg: The use of the Ussing chamber for the intestine overtook these everted sacs
a bit, because you could control the conditions across the intestine rather better, and
I think that’s what reduced the interest in everted sacs even though they were much
easier and quicker to use. I think they were useful for the purpose to which they were
put, but then the next technique came along and seemed to allow greater definition
of what was going on. 
Levin: I would agree that you can put drugs and inhibitors on the serosal surface, but
what you can’t do with the sheet is measure fluid transfer, especially absorption, very
easily. So you have to say, ‘Okay, I’m not interested in fluid transfer but only in the
electrogenic ion transfer’. I don’t understand to this day why you can’t obtain really
good fluid transfers in sheets as you can in sacs. Possibly the stretch on mounting the
sheets activates the intestine’s secretory mechanism?
Turnberg: I think Richard Naftalin tried, but it was with a very modified version of
Ussing chambers.
Naftalin: Yes. We did. Tripathi and I spent quite a long time looking at water transport
in Ussing chambers.98 In a way I am a bit hesitant to talk about Ussing chambers in
the presence of a major Ussing player. However, I was first introduced to Ussing
chambers in 1972 when I went to work with Peter Curran and, I have to say, I was
horrified. Most of you, I am sure, have worked with these things, but they are very
delicate and rather clumsy instruments, frankly, and certainly liable to breakage and
not particularly well designed for the rather simple thing that they had to do, which
was basically measure the containers for flux experiments. So anyway, I was bemused
by watching all these things going on and there was an even more horrific experiment:
Curran’s lab was looking at unidirectional fluxes. By this time they had understood
that looking at bidirectional fluxes of ions and sugars across the sheets wasn’t enough.
You had to look at uptake across the mucosal surface as well and so by this time
Curran’s lab was looking at unidirectional flux plus bidirectional fluxes. And to look
96 op. cit. note 13. See also Fullerton P M, Parsons D S. (1956) The absorption of sugars and water from rat
intestine in vivo. Quarterly Journal of Experimental Physiology 41: 387–397.
97 op. cit. note 95.
98 See, for example, Naftalin R J, Tripathi S. (1985) Passive water flows driven across the isolated rabbit ileum by
osmotic, hydrostatic and electrical gradients. Journal of Physiology 360: 27–50. idem (1986) The roles of
paracellular and transcellular pathways and submucosal space in isotonic water absorption by rabbit ileum. ibid.
370: 409–432.
Intestinal Absorption
29
at unidirectional flux they had a modified Ussing chamber where they had one side of the
tissue exposed to water va p o u r, and they had to do this in a fairly standard degree ro o m
which was highly saturated with water va p o u r. So it was quite a major effort to do this
experiment and it was all done ve ry rapidly over a period of two or three minutes. An
enormous amount of preparation went into getting the tissue right and it’s quite
understandable that this technique didn’t really catch on. But a number of people did do
it. What I want to say is that the Ussing chamber was adapted to the intestine and that
the primary exponent in the 1960s of this technique was certainly Stanley Schultz. 
His work, I think, more or less laid the foundations for our understanding of ion
t r a n s p o rt and nature of glucose–sodium coupling in the intestine. Schultz and Za l u s k y’s
w o rk in 1964 was without doubt the best quantitative work that there was and pro b a b l y
has been.9 9 That was really magnificent work. Fr i z zell and Schultz then used the Us s i n g
chamber to look at paracellular fluxes using modified short - c i rcuit current technique
w h e re the voltage is clamped at different vo l t a g e s .1 0 0 And they looked at the vo l t a g e -
independent flux and this technique was full of assumptions and difficulties. What I want
to say about the Ussing chamber is that it fulfilled a need in the 1960s. It was a marve l l o u s
system for getting quantitative data, net and unidirectional ion fluxes, and organic solute
f l u xes, but, as Roy has said, it didn’t really allow movement of water to be measure d
a c c u r a t e l y. In fact, it didn’t measure sodium movement ve ry accurately either, as Parsons and
Wade showed in their paper – that there was a large accumulation of water and electro l y t e
in the extracellular matrix.1 0 1 People had assumed that net flux across the mucosal surface is
equal to net flux across the serosal surface and, of course, the assumptions of the short - c i rc u i t
c u r rent are that that is exactly what happens. But Parsons had shown, and Tripathi and I
had shown as well, that water flux across the mucosal surface is about five times greater than
a c ross the serosal surface and during the time that one is actually measuring net flux, most
of the fluids and electrolytes are accumulating in the lamina propria, even in the strip
p re p a r a t i o n .1 0 2 So by that time I re a l i zed that one needed a perfused preparation to bring
one back to re a l i t y, I certainly didn’t want to chase artifacts for the rest of my scientific days,
which are numbered, but that didn’t pre vent a large number of people from going on. In
my view, the Ussing chamber of technology became a club, it was a rather exc l u s i ve club
and if you didn’t actually apply the techniques as prescribed, then you we re out. That was
ve ry much part of the reason why some of the British intestinal physiology was marginalize d
and why, in fact, America had such a hold over people like you [Turnberg]. So I think one
has to view the segmentation of science, the regionalizing of science, ve ry much in terms
of who was doing it and how exc l u s i ve it was. 
99 Schultz S G, Zalusky R. (1964) Ion transport in isolated rabbit ileum. I. Short-circuit current and Na fluxes.
Journal of General Physiology 47: 567–584. idem Ion transport in isolated rabbit ileum. II. The interaction between
active sodium and active sugar transport. ibid. 1043–1059.
1 0 0 See, for example, Fr i z zell R A, Schultz S G. (1972) Ionic conductances of extracellular shunt pathways in rabbit ileum.
Influence of shunt on transmural sodium transport and electrical potential differences. Jo u rnal of Ge n e ral Ph y s i o l o gy 5 9:
318–346. i d e m An ove rv i ew of intestinal absorptive and secre t o ry processes. Ga s t ro e n t e ro l o gy 6 3: 161–170.
101 Parsons D S, Wade S A. (1982) Influence of vascular and lumen flow on sodium movements across anuran
intestine in vitro. Quarterly Journal of Experimental Physiolog y 67: 323–324.
102 Naftalin R J, Tripathi S. (1986) op. cit. note 98.
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The other part, which I have n’t mentioned, is the secre t o ry story. That also raises lots and
lots of problems. For example, one of the major findings in secretion was the inhibition
of sodium chloride absorption.1 0 3 Yet nobody has ever been able to see inhibition of
sodium absorption in vesicles and nobody has ever been able to see inhibition of sodium
chloride absorption in isolated cells. So it is an artifact of unidirectional flux
m e a s u rement. T h a t’s just the fluxes re c ycled and it became obvious that this was the case
when one looked at accumulation. T h e re is a lot to be said against Ussing chambers. 
Turnberg: And you have said a lot of it. I think it is a very accurate summary.
However, Ussing chambers provided us with an enormous stimulus and a lot of
interest. It was only as time went on that it became obvious that as we became more
refined in our experimental ideas, it was recognized that we might be chasing artifacts
and very interesting artifacts. The technique created many publications during the
1960s and 1970s.104 And, of course, it was only when one tried to relate what was
being found in Ussing chambers to in vivo behaviour, that there seemed to be quite a
gap between what happened there and what seemed to happen in the Ussing chamber.
But they had their uses and they were a considerable boost even though, like all these
things in vitro, they introduced artifacts.
Dowling: I would like to take advantage of Roy Levin’s presence here to ask him about
two of the methods which the Sheffield team introduced to the world. First there was
the Wilson and Wiseman everted sac technique which contributed so much to our
understanding of gut physiology, but it did have problems when applied in certain
situations. For example, when I was working with Sir Christopher Booth 35 years ago,
we induced adaptive hyperplasia or hypoplasia in the small intestine, by a variety of
methods. And when one is studying absorption by everted sacs made from either very
thick (hyperplastic) or very thin (hypoplastic) segments of adapted intestine, you get
artifacts with Wilson and Wiseman’s in vitro system.105 That was one of the reasons
why we switched from their in vitro technique, to a second method pioneered in
Sheffield – Sheff–Smyth’s in vivo recirculation perfusion system, for our studies of
intestinal absorption in the adapting intestine.106
Roy, you referred briefly to the Sheff–Smyth technique but I wonder if you could tell
us a little more about it. It too was a wonderful system, but it could be fiendishly
difficult to apply – particularly if one is doing kinetic studies. You will recall that the
recirculation perfusion system includes a reservoir from which one takes samples at
regular intervals (every ten minutes for approximately one hour) during the perfusion.
103 Nellans H N, Frizzell R A, Schultz S G. (1973) Coupled sodium chloride influx brush-border of rabbit ileum.
American Journal of Physiology 225: 467–475. idem (1974) Brush-border processes and transepithelial Na+ and Cl-
transport. ibid. 226: 1131–1141. 
104 op. cit. notes 29 and 31.
105 Early work includes, Dowling R H, Riecken E O, Laws J W, Booth C C. (1967) The intestinal response to high
bulk feeding in the rat. Clinical Science 32: 1–9. Dowling R H, Booth C C. (1967) Structural and functional
changes following small intestinal resection in the rat. ibid. 139–149.
106 op. cit. note 13.
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This means that the total substrate load presented to the intestine diminishes
progressively with time as a result of sampling – as well as absorption. To make the
n e c e s s a ry calculations which correct for this is extraordinarily difficult. T h e
Sheff–Smyth technique was a wonderful method but it too had its limitations. 
Levin: With the Sheff–Smyth technique, I think that is absolutely true. I mean the
way we used to do it; we did it in chickens. I always had my favourite question,
whenever people used to come to the department, Professor Smyth used to hand out
little pieces of paper with a question, so that any foreign visitor that ever came and
talked always had a barrage of questions at the end. He was always very good about
that! And there used to be all these questions, and his one always, whatever it was, he
always used to say (he stuttered a little bit), ‘Ha...have you tried phlorizin?’ And no
matter what the system it was, phlorizin had to be tried in it. And my particular one
was, ‘That’s very interesting, have you tried it in chickens?’ because we were working
with chickens. And when we were doing it in chickens the people in the group got
their own back at me and said, ‘That’s very interesting, Roy, have you tried it in
hamsters?’! The Sheff–Smyth technique was the technique we used for the kinetics, it
took all day to do one kinetic experiment, one Km, one Vmax in one animal. That was
the problem with it, I think. We used to circulate the solution with the amino acid or
the sugar, and then estimate the whole lot after, but there was always the problem of
a decreasing concentration. I am not quite sure that it made that much difference to
the kinetics. The real weakness I thought of the Sheff–Smyth procedure was the high
intraluminal hydrostatic pressure that it imposed on the intestine. On the one hand it
made everything get in contact with the villi, but on the other hand it probably
inhibited venous return. So what you had with the Sheff–Smyth technique, was, I
think, an ‘in vitro preparation in vivo’. The blood flow to the intestine was probably
reduced but it was kept alive, because the circulatory fluids were oxygenated in the
Sheff–Smyth apparatus’s gas lift. It was very useful to do lots of things with it, but
there’s a time with these things, and all of a sudden you know that you can’t use the
Sheff–Smyth procedure any more. (I have two of them in my drawer in the lab and
my wife says they are not coming back into the house and I don’t know what to do
with these things. Perhaps give it to the Wellcome!) But I think you are absolutely
right, I mean some people did use the geometric concentration, if you remember, and
I did that and it didn’t make any difference if you used the initial concentration. I
think you can get too fussy. I always remember what someone once said of Bayliss’s
son, Leonard,107 who was in University College and had a most brilliant mind, that he
always had 15 reasons for not doing the experiment, brilliant ones, and so he never
did any experiments. You can always, I think, look back at these preparations and say,
‘Oh, it didn’t do this, and it didn’t do that’. But at the time, that’s how science
develops initially, by relatively crude methods. These are constantly refined.
107 Leonard Bayliss (1900–1964) was a physiologist at University College London and well known for his work on
the rheology of blood. He was the son of Sir William Bayliss Kt FRS (1860–1924) and nephew of Ernest Starling
(1866–1927), both Professors of Physiology at University College London. See Winton F R. (1964) Dr L E
Bayliss. Nature 204: 327–328.
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Dr Peter Williams:108 I just wondered if anybody knew what Ussing thought about his
technique being used for the intestine.109
Turnberg: Ussing was using the frog skin and the frog skin is very much thinner than
the intestine and doesn’t have all the problems that Richard was referring to.
Williams: So it was not his technique? 
Turnberg: It was his technique but others just adapted it for intestinal sheets. Then
they thought they could improve it by stripping off the serosal layers and finish up
with what might be presumed to act like a single layer of cells. Of course it doesn’t.
Richard Naftalin demonstrated that there are lots of things happening in the bit
between one side and the other side. So it had been adapted for another purpose, for
which Ussing hadn’t envisaged it.
We must move on now to brush-borders. Dr Richard Boyd is going to tell us
something about that. 
Boy d : Oddly enough, this comes back to the point I was making about how
mitochondrial bioenergetics met the field of intestinal absorption, because the key paper
in this field, published in 1974, came from Is s e l b a c h e r’s lab where both Mu rer and
Hopfer we re work i n g .1 1 0 It was this synthesis, of somebody interested in the
g a s t rointestinal tract and intestinal transport coming together with people who had seen
h ow mitochondrial particles could be used to study the chemiosmotic hypothesis of
Mitchell, that generated the ve ry first unambiguous data on flux coupling. I think,
t h e re f o re, that membrane vesicles, where you could control the composition of the media
on either side of a membrane (not of a cell, but of a membrane), and where you could
impose electrochemical gradients using ionophores (which we re really important as
experimental tools, again coming from the mitochondrial field) actually allowed pro p e r,
r i g o rous testing of this model and took it to a completely different level of analysis.1 1 1
Having said that I know there are people here who are aware of some of the inevitable
p roblems of membrane vesicle experiments. In my view, vesicles we re neve rtheless one of
108 Dr Peter Williams CBE FRCP (b. 1925) was Director of the Wellcome Trust from 1965 to 1991 and Honorary
Director, Wellcome Institute for the History of Medicine, from 1981 to 1983. He was President of the Royal
Society for Tropical Medicine and Hygiene from 1991 to 1993. 
109 Professor Oliver Wrong wrote: ‘Ussing applied his chamber with great success to frog skin, but it is unsuitable
for a complex multilayered membrane such as the intestine. Alexander Leaf in Boston used it extensively in his fine
studies of solute movement in toad bladder, working out the effects of vasopressin and aldosterone on transport of
sodium, water and urea. Leaf particularly made the point that that this membrane, both functionally and
morphologically, was only one cell thick. See Dibona D R, Civan M M, Leaf A. (1969) The anatomic site of the
transepithelial permeability barrier in toad urinary bladder. Journal of Cell Biology 40: 1–7. Leaf A, Sharp G W G.
(1971) The stimulation of sodium transport by aldosterone. Philosophical Transactions of the Royal Society of London
262: 323–332.’ Letter to Dr Daphne Christie, 29 March 2000. 
1 1 0 Mu rer H, Hopfer U. (1974) Demonstration of electrogenic Na+-dependent D-glucose transport in intestinal
b rush border membranes. Proceedings of the National Academy of Sciences of the United States of Am e r i c a 7 1: 484–488. 
111 See, for example, Murer H, Cassano G, Stieger B. (1983) Transport of sodium and chloride across the small
intestinal brush border membrane: studies with vesicles. In Turnberg L A. (ed.) Proceedings of the Third BSG.SK&F
International Workshop. Welwyn Garden City: Smith Kline & French Laboratories Limited, 8–12.
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the major advances over the last 30 years, allowing one experimentally to get from the cell
d own to membranes and there f o re directly on the path to molecules.
B ro n k : I would like to make a different point, if I could. By the time we reached the
1970s it was quite clear that the bru s h - b o rder apical membrane of the enterocytes was the
site of sodium-dependent glucose transport. Howe ve r, an important feature of intestinal
absorption is to re c o g n i ze that it is not just uptake across the apical membrane, but it is
also the exit across the basolateral membrane into the vascular system that is ve ry
i m p o rtant. One of the innovations that Dennis Parsons and Peter Hanson we re able to
d e velop was the vascular perfusion preparation for rat intestine.1 1 2 A colleague that I had
in Yo rk, Peter Ingham, and I used the Hanson and Parsons preparation to show the
sodium dependence of D-galactose uptake, and the fact that galactose was not
accumulated within the intestinal mucosa unless galactose was perfused through the
vascular side.1 1 3 The exit of galactose across the basolateral membrane of the entero c y t e s
was shown to be a passive process down a concentration gradient. With the va s c u l a r
p e rfusion preparation we we re able to show that although uptake across the apical
membrane was sodium dependent, the exit across the basolateral membrane was not; also
the uptake was phlorizin sensitive but the exit was not sensitive to phlorizin. In order to
consider the absorption of a solute in the small intestine from the lumen to the va s c u l a r
bed, it is necessary to investigate both uptake and exit of the solute from the entero c y t e s .
Dr Peter Hanson:1 1 4 I would like to make some general comments about pre p a r a t i o n s .
In the Pa r s o n s’s laboratory, the vascularly perfused frog preparation came before va s c u l a r l y
p e rfused rat intestine. Vascularly perfused frog intestine is a much superior preparation in
many respects. I think one lesson that perhaps wasn’t used was that often lower organisms
would have been a better bet than higher organisms to study basic transport mechanisms. 
The other comment I have is that a number of us tried to use isolated intestinal
epithelial cells to study transport mechanisms and to study metabolism and, with the
exception of an American called Kimmich who used chick cells,115 these were
uniformly ve ry unsatisfactory. I think we know now why they we re unsatisfactory; it is
that these cells we re undergoing apoptosis, because detachment of epithelial cells fro m
the basement membrane actually leads to apoptosis and this is quite a rapid process. 
112 Hanson P J, Parsons D S. (1976) The utilization of glucose and production of lactate by in vitro preparations
of rat small intestine: effects of vascular perfusion. Journal of Physiology 255: 775–795. idem (1977) Metabolism
and transport of glutamine and glucose in vascularly perfused small intestine rat. Biochemical Journal 166:
509–519.
113 Bronk J R, Ingham P A. (1976) Evidence for carrier-mediated uptake and efflux of sugars at the serosal side of
the rat intestinal mucosa in vitro. Journal of Physiology 255: 481–495. idem (1979) Sugar transfer from the lumen
of the rat small intestine to the vascular bed. ibid. 289: 99–113. 
114 Dr Peter Hanson (b. 1949) graduated from Oxford University in Biochemistry in 1971, and was a PhD student
and then MRC Research Assistant in Dr D S Parsons’s laboratory (1992–1997) where he worked on metabolism
in rat small intestine. From 1977 he has been at the Pharmaceutical Sciences Institute, Aston University,
Birmingham, working on signal transduction in gastric mucosa.
115 Kimmich G A. (1970) Preparation and properties of mucosal epithelial cells isolated from small intestine of the
chicken. Biochemistry 9: 3659–3668.
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Turnberg: Why did it work for the chicken?
Hanson: I really have no idea. 
Bronk: With respect to apoptosis, I had a research student in my laboratory who did
electron microscopy of isolated mucosal cells from the small intestine. One finding
that shocked us was the fact that these cells were filled with apoptopic vesicles. I have
no idea what triggered these changes.
Pe t e r s : Perhaps preceding these electrophysiological studies we re the experiments when
people we re trying to isolate bru s h - b o rder vesicles. I think the work of Miller and
Crane isolating bru s h - b o rders in the early 1960s, and of Alec Eichholz trying to isolate
b ru s h - b o rder subcomponents led to a greater understanding of their function.1 1 6 At the
same time George Hübscher in Birmingham was also developing methods for isolating
b ru s h - b o rd e r s .1 1 7 But I think the important step was when people moved from bru s h -
b o rders to the isolation of membrane vesicles and again that was done in Cr a n e’s lab in
Rutgers. The interesting observation was that if you made a microsomal pre p a r a t i o n
f rom enterocytes you got a mixture of bru s h - b o rder vesicles, basolateral membrane
vesicles, endoplasmic reticulum, etc., and the trick of adding Ca2 +, which pre c i p i t a t e d
all membranes, except bru s h - b o rder vesicles, allowed people to isolate fragments of the
b ru s h - b o rder that allowed the studies to be carried on that have been described. So I
think in parallel with electrophysiological and the in vivo studies, was subcellular
fractionation, and Ro b e rt Crane again made major contributions in that area. 
N a f t a l i n : I would like to ask two vesicle people whether they think that vesicle technology
actually contributed anything ve ry much to our knowledge of intestinal mechanisms?
B oy d : I think it has allowed us to test the Crane hypothesis and show that it was right.
Until then, I don’t think you could. Certainly there is that wonderful paper by Kimmich,
using the preparation that Peter [Hanson] has alluded to, disproving the Crane hypothesis
published in the Jo u rnal of Me m b rane Bi o l o gy in 1973.1 1 8 What these experimentalists had
forgotten is that if you impose a re versed sodium gradient (making the cells full of sodium),
you switch on the sodium pump, which is electrogenic; these cells probably had a
membrane potential of –120mV so they we re markedly hyperpolarized. It was a failure to
re a l i ze that electrochemical gradients are not synonymous with chemical gradients that led
to a conclusion that was spectacularly wrong. You couldn’t do that experiment
unambiguously with isolated cells but you could with membrane vesicles. 
116 Miller D, Crane R K. (1961) The digestive function of epithelium of the small intestine. 1. An intracellular
locus of disaccharide and sugar phosphate ester hydrolysis. Biochimica et Biophysica Acta 52: 293–298. Eichholz A,
Howell K E, Crane R K. (1969) Studies on the organization of the brush border in intestinal epithelial cells. VI.
Glucose binding to isolated intestinal brush borders and their subfractions. ibid. 14: 179–192. Eichholz A, Crane
R K. (1974) Isolation of plasma membranes from intestinal brush borders. Methods in Enzymology 31: 123–134.
117 See, for example, Hübscher G, West G R, Brindley D N. (1965) Studies on the fractionation of mucosal
homogenates from the small intestine. Biochemical Journal 97: 629–642.
118 Kimmich G A, Randles J. (1973) Interaction between Na+-dependent transport systems for sugars and amino
acids. Evidence against a role for the sodium gradient. Journal of Membrane Biology 12: 47–68. op. cit. note 66.
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I think they also had a role (and this is related to Ramsey Bronk’s comment) in
confirming directly that the input face and the output face, the apical membrane and
the basal membrane of the epithelium, had quite different transport properties. This
provided a direct test of the Ussing model of epithelial polarity in the small intestine.
Naftalin: These asymmetric properties had been recognized at least ten years before.
Crane had done all that work in sheets. So the recognition that this transport system
is different was quite extant in 1970.119
Turnberg: But not proven.
Naftalin: Well, what is proven?
Turnberg: You take the basolateral membrane and the apical membrane and show that
they behave in the ways you’ve predicted. 
Naftalin: Well, I agree that that’s an advance, but not an advance in knowledge.
Gardner: Another area in which vesicles I think were useful, albeit a bit later on, was
in proving proton-linked mechanisms for peptide transport.120
Tu r n b e r g : Any other comments? In which case we will move on. I have been asked
to introduce electrolyte transport. Because this is going to be a personal view, it will,
I ’m afraid, be somewhat biased. I am going to concentrate on the human in vivo
w o rk, because I want to bring in John Fo rdtran and the people who worked with him
as well as others who we re working at about the same time, with the whole human
gut. I think that he is a ve ry important figure in the field, because he used what is an
enormously crude technique of taking the whole human being and putting a tube
d own the gut, perfusing and making some observations which seemed to be of
i m p o rtance and, I think, that was an unusual thing to be able to do. He had been
w o rking with Ingelfinger in the 1950s and they had developed the ‘triple lumen
t u b e’. That tube allowed them to control the perfusate that was going down the
intestine. Up to that time, if you used a double lumen tube, you had fluid coming in
f rom the stomach and the pancreas and whatever else, to contaminate the fluid yo u
infused, so you had really little idea of what the content was of the fluid that was
going into your segment.1 2 1
119 See, for example, Bihler I, Cybulsky R. (1973) Sugar transport at the basal and lateral aspect of the small
intestinal cell. Biochimica et Biophysica Acta 298: 429–436. Naftalin R J, Curran P F. (1974) Galactose transport
in rabbit ileum. Journal of Membrane Biology 16: 257–278.
120 See, for example, Ganapathy V, Leibach F H. (1983) Role of pH gradient and membrane potential in dipeptide
transport in intestinal and renal brush-border membrane vesicles from the rabbit. Studies with L-carnosine and
glycyl-L-proline. Journal of Biological Chemistry 258: 14189–14192.
1 2 1 See, for example, Miller T G, Abbott W O. (1934) Intestinal intubation: a practical technique. American Jo u rnal of
the Medical Sciences 1 8 7: 595–599. Blankenhorn D H, Hirsch J, Ahreus E H. (1955) Transintestinal intubation:
technique for measurement of gut length and physiologic sampling at Ku rcon loci. Proceedings of the Society for
Experimental Bi o l o gy and Me d i c i n e 8 8: 356–362. Fo rdtran J S, Rector F C, Locklear T W. (1967) Water and soluble
m ovement in the small intestine of patients with sprue. Jo u rnal of Clinical In ve s t i g a t i o n 4 6: 287–298. op. cit. note 146.
Intubation methods for humans are also described in Wilson T H. (1962) (ed.) Methods, ch. 2. op. cit. note 13, 27–28.
Intestinal Absorption
36
Using the triple lumen tube, it became possible to sample fluid at the entry point to
the perfused segment of intestine. So that was the advance. Of course, that whole
system has been criticized and I think it was Bob Shields, who’s not here today, who
s h owed a picture of the human intestine at laparo t o m y, all ‘c o n c e rt i n a e d’ up. So, here
we we re thinking of a nice quiet 30-cm segment of intestine that was being perf u s e d ,
and what Shields did when he opened the abdomen was to show that the whole thing
was moving about and was really nothing like what eve ryone imagined.1 2 2 Ne ve rt h e l e s s ,
t h e re we re some interesting results that came out of this triple lumen tube.
There were others perfusing the intestine who were putting balloons in the intestine
and blowing them up and perfusing a segment between the balloons in order to isolate
it. But the problem with that system was it created some pain, it created peristalsis,
and the whole thing tended to move down the intestine. You were never sure which
region of the intestine you were perfusing. 
So, the triple lumen tube seemed to help sort out some of the problems, but clearly
left many others. The people who we re working at about the same time perf u s i n g
human intestine we re Syd Phillips at the Ma yo Clinic, Konrad Soergel in
Wisconsin, and in France, there was Be r n i e r’s group in Paris, with Rambaud and
Modigliani. Also in the States John Ba n well was perfusing the intestine. He was out
for a time in Dacca with the people studying cholera, Greenough and Carpenter.
They we re using the same technique to look at the intestine in patients with cholera.
And then in the UK, of course, there was Go rdon Sladen, Tony Dawson and Jo h n
Harries all perfusing the human intestine, and there are many others here who
joined forces with them. 
John Fordtran is still doing human gut perfusion experiments,123 in Texas where he was
born. He’s a farmer’s son and very much a man of the land. He was a Dallas graduate
and very keen on Dallas, and in fact when he went to Boston to work with Ingelfinger
that was a down point in his life, because it was the period between being in Dallas
and getting back to Dallas. He was born and bred in Dallas and doesn’t travel a great
deal outside the United States and not all that often outside Dallas. He is a very
affable, open man, as many of you will know.
He developed a very fruitful relationship with Floyd Rector, a renal physiologist, who
was doing a lot of the work with renal tubules.124 He was doing those shrinking drop
122 Shields R. Personal communication. Information provided by Lord Turnberg, 23 May 2000. See also Cook G C,
Carruthers R H. (1974) Reaction of human small intestine to an intraluminal tube and its importance in jejunal
perfusion studies. Gut 15: 545–548.
123 See, for example, Schiller L R, Santa Ann C A, Porter J, Fordtran J S. (1997) Glucose-stimulated sodium
transport by the human intestine during experimental cholera. Gastroenterology 112: 1529–1535. 
124 See, for example, Kunau R T, Frick A, Rector F C, Seldin D W. (1968) Micropuncture study of the proximal
tubular factors responsible for the maintenance of alkalosis during potassium deficiency in the rat. Clinical Science
34: 223–231. Andreucci V E, Herrera-Acosta J, Rector F C, Seldin D W. (1971) Measurement of single-nephron
glomerular filtration rate by micropuncture: analysis of error. American Journal of Physiology 221: 1551–1559.
Rector F C. (1983) Sodium, bicarbonate, and chloride absorption by the proximal tubule. ibid. 244: F461–F471.
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experiments, putting two drops of oil in a renal tubule with micropuncture techniques
and watching the shrinkage. Floyd Rector had a lot of basic information about
transport in the kidney and John Fordtran used this ideology to interpret what was
going on in the human intestine. 
The other thing that he had going in Dallas was an amazing team of volunteers who
we re willing to swallow the tube. He would pay them, of course. We would put the
tube down the night before and they would all turn up at the lab the next morning
at about 6.00 a.m. to screen the tube and to make sure it was in the right place. T h e n
we would start perfusing. We usually had two going at the same time so it was like a
p e rfusion factory. T h e re we re, I think, a number of valuable advances that we re being
made by John Fo rdtran about the behaviour of the human intestine. The first thing
that was of interest was how quickly the osmolality adjusted in the human jejunum
to iso-osmolar. That was a ve ry rapid process, and he proposed that the jejunum is
ve ry freely permeable to water. He showed that the volume of the meal goes up if yo u
eat a carbohydrate meal, as fluid rushes in to equalize the osmotic pre s s u re, and then
goes down as the fluid leaves with the absorbed solute. He then did some ve ry
i n t e resting things to try to calculate the re l a t i ve permeability of the human jejunum
c o m p a red with the human ileum and the colon. He used the Renkin re f l e c t i o n
coefficient idea that he had got from Fl oyd Rector and put a number of va r i a b l y
absorbed solutes, like urea, xylose and sodium into the intestine, and measured the
re l a t i ve osmotic pre s s u re gradients that they could cre a t e .1 2 5 Because they are of
d i f f e rent size and because they have a different ability to create an osmotic pre s s u re
he was able to calculate a reflection coefficient, and from those he made an
assumption about the size of the pores through which water and solutes we re
m oving. Now, all that from perfusing whole human intestine was quite a leap of
imagination and, of course, he presumed for the purposes of these calculations, that
the intestine was a single membrane with holes of a uniform size, which we re the
ones that he was determining the reflection coefficient for. He was saying that the
intestine behaved in that way, and surprisingly enough he was able to produce figure s
which, I suspect, are not too far off. He showed that the jejunum is roughly twice as
permeable as the ileum. That is, the presumed pores, through which water is flow i n g ,
a re about twice the diameter of those in the ileum. 
He then found himself face to face with Stanley Schultz, because Schultz, in the
1960s, was showing very clearly that glucose–sodium transport was an active process,
and that was that.126 What John Fordtran suggested from his experiments was that
when you put glucose in the lumen it was absorbed rapidly and created an osmotic
gradient down which water flowed across the mucosa. Furthermore, this water
movement dragged sodium and small ions through the pores with it; that is ‘solvent
drag’ sodium absorption. And he demonstrated this by influencing the movement of
125 Fordtran J S, Rector F C Jr, Ewton M F, Soter N, Kinney J. (1965) Permeability characteristics of the human
small intestine. Journal of Clinical Investigation 44: 1935–1944.
126 op. cit. note 99. 
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water, by other sorts of osmotic pressure gradients (unlinked to glucose), and showed
that sodium moved either way along with the flow of water. Furthermore, he showed
that the predicted electrical potential was created which you would expect from
moving ions with water.127 Stanley Schultz was dead against this, since it contravened
the glucose–sodium active transport hypothesis. Michael Field, who was in Boston,
was also dead against it, and John Fordtran felt very beleaguered because he was basing
all of this on whole human perfusion data, whilst Stanley Schultz was playing with
very much more sophisticated techniques. At the end of the day I think there was a
stand-off. I don’t know whether Stanley Schultz ever agreed that there may be such a
thing as solvent drag sodium absorption, but there was a lot of antagonism to the idea
in those days. 
When I got to Dallas and worked with John Fordtran he was interested in getting me
to look at why sodium transport was stimulated by bicarbonate. If you put isotonic
sodium chloride in the jejunum, it just sits there. But if you add sodium bicarbonate,
sodium absorption is stimulated.128 We eventually came up with the idea of a
sodium–hydrogen exchanger. The reasons behind that were that you generate a high
PCO2 in the lumen during sodium bicarbonate absorption and that is due to
h yd rogen being secreted, which generates the high luminal PCO2 and a
‘disequilibrium pH’. The demonstration of a ‘disequilibrium pH’ was the proof, as far
as Floyd Rector was concerned, and it was on this basis that the case was made. Of
course the whole idea was presaged by Dennis Parsons, who had shown the same thing
in 1956 in the rat intestine.129 So we had come a long way round to showing that
something similar happened in vivo in the human jejunum. 
And then we perfused the ileum, which was rather more difficult to do. You had to
wait longer for the tube to get down there, and therefore fewer people were perfusing
the ileum in those days. But we had this marvellous team of volunteers! 
On the basis of ileal perfusion experiments, we showed what we thought was a
double-ion exchange; that is sodium chloride was absorbed against the concentration
gradient compared with the jejunum. By analysing absorption rates at differe n t
concentrations of each ion we came up with a hypothesis that suggested that sodium
was absorbed in exchange for hyd rogen, and chloride was absorbed in exchange for
bicarbonate. So there was a coupled anion and cation exchange and that was the
‘double exc h a n g e’ .1 3 0
127 See, for example, Fordtran J S, Rector F C Jr, Carter N W. (1968) The mechanisms of sodium absorption in
the human small intestine. Journal of Clinical Investigation 47: 884–900.
128 Sladen G E, Parsons D S, Dupre J. (1968) Effects of bicarbonate on intestinal absorption. Gut 9: 731. Turnberg
L A, Fordtran J S, Carter N W, Rector F C Jr. (1970) Mechanism of bicarbonate absorption and its relationship
to sodium transport in the human jejunum. Journal of Clinical Investigation 49: 548–556. 
129 Parsons D S. (1956) The absorption of bicarbonate-saline solutions by the small intestine and colon of the white
rat. Quarterly Journal of Experimental Physiolog y 41: 410–420.
130 Turnberg L A, Bieberdorf F A, Morawski S G, Fordtran J S. (1970) Interrelationships of chloride, bicarbonate,
disodium, and hydrogen transport in the human ileum. Journal of Clinical Investigation 49: 557–567.
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That was a ve ry exciting time to be in Dallas, when those ideas we re emerging.
When we presented these findings in Atlantic City at the American Society for
Clinical In vestigation there was considerable scepticism. Michael Field got up and
said, ‘It doesn’t seem right’ and, of course, it was all derived from a crude system of
p e rfusing the human intestine. So proof of what we suggested took a long time in
coming. T h e re was no way we could determine at which cell membrane these
p resumed ion transport events we re happening nor, even, whether it was simply a
phenomenon due to perfusion, va s c u l a r i t y, or motility. All those compounding
factors we re in there and it was an enormous leap to interpret what we’d found in
terms of ion exchangers. But, quite a few years later, a number of people showe d
that if you take apical membrane vesicles from ileal mucosa you can demonstrate
anion and cation exc h a n g e r s .1 3 1 So it was re m a rkable that it was possible to deve l o p
those sorts of ideas from perfusing whole humans and I think John Fo rd t r a n
d e s e rves to be re c o g n i zed for doing this type of work and delivering import a n t
insights into epithelial function.
Boyd: I am really interested to hear about the input of Rector, because I have always
wondered about this play between the renal and the gastrointestinal. I can see how
Fordtran got a lot out of Rector; what did Rector get out of Fordtran?
Turnberg: His name on the papers. Certainly on the early papers, they worked very
closely together, on solvent drag, on reflection coefficients, and on our paper on the
double ion exchange.132
Naftalin: Were you influenced by the work of the red cell chloride shift,133 which is
very similar in many ways to the work which you describe of the anion exchange and
the movement of water?
Tu r n b e r g : Yes. You must remember that what we we re doing was simply putting saline
d own the intestine, aspirating fluid and measuring the ions, and to get anything out of that
which resembled anything that you could get in a single cell was, to me, re m a rkable. To
relate what was happening to a single cell, like a red cell, to what was happening with this
experimental technique was a leap which I found interesting. I still remain amazed that the
whole intestine behaves as if it is a single layer of cells. So although we knew about ion
exchangers in red cells it didn’t mean that we made the immediate connection.134
Dowling: You referred to Floyd Rector, but I wonder if you would comment on the
advances in renal transport which antedated those in gastrointestinal transport. It
seems to me that in the world of renal physiology, sophisticated micropuncture
131 Murer H, Sugrist-Nelson K, Hopfer U. (1975) On the mechanism of sugar and amino acid interaction in
intestinal transport. Journal of Biological Chemistry 250: 7392–7396. Hopfer U. (1977) Isolated membrane vesicles
as tools for analysis of epithelial transport. American Journal of Physiology 233: E445–E449.
132 op. cit. notes 125, 127, 128 and 130.
133 op. cit. note 51. 
134 See, for example, Hoffman J F. (1966) The red cell membrane and the transport of sodium and potassium.
American Journal of Medicine 41: 666–680.
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techniques had been developed by Berliner and others1 3 5 at a time when
gastrointestinal physiologists were using rather simple, crude techniques. Is that right? 
Turnberg: I suppose what Floyd Rector always said was that the intestine is one big
tubule. He thought of it in terms of a tubule and was happy that it was easier to
perfuse than the micropuncture techniques you need for the renal tubules. 
Booth: Can we just ask what date that was?
Turnberg: That would be about the late 1950s, early 1960s. 
Booth: If I can just comment on [Malcolm] Milne’s136 work, I think that might be
worth doing. The recognition that there was a renal transport defect in Hartnup
disease which was reflected in the intestine was made by the clinician Malcolm
Davenport Milne, first at the Hammersmith and later at the Westminster, after he had
been appointed Professor there.137 But the work on Hartnup disease was started at
Hammersmith in about 1959. Most people have been talking so far of physiologists
who come to the intestine through physiology. Malcolm Milne came to the intestine
through non-ionic diffusion. He was interested in the influence of pH on the
excretion of weak acids and bases in the kidney, and he’d worked particularly on the
drug mecamylamine.138 He then realized from Dent’s work139 that indoleacetic acid
was excreted in the urine of patients with Hartnup disease, a beautiful example of a
weak acid. So he invited Dent to send a patient of his with Hartnup disease to
Hammersmith to study the non-ionic diffusion of indoleacetic acid. He also knew
that indoleacetic acid was a bacterial breakdown product of the amino acid
tryptophan. He knew, too, that the defect in the renal tubule involved the
monoamino monocarboxylic amino acids, including tryptophan. He was sitting in his
bath in East Sheen one day and he suddenly leapt up and said, ‘My God, the reason
there’s indoleacetic acid in the urine is that there is malabsorption in the intestine’.
That’s how he came to the intestine and performed all that beautiful work. I
remember his first patient being shown on a grand round at Hammersmith. He had
135 See, for example, Sakai F, Jamison R L, Berliner R W. (1965) A method for exposing the rat renal medulla in
vivo: micropuncture of the collecting duct. American Journal of Physiology 209: 663–668. See also Windhager E E.
(1987) Micropuncture and microperfusion, ch. IV. In Gottschalk C W, Berliner R W, Giebisch G H. (eds) Renal
Physiology. People and Ideas. Bethesda, MD: American Physiological Society, 101–129. op. cit. notes 38 and 124.
136 Professor Malcolm Davenport Milne FRCP FRS (1915–1991) was Professor of Medicine, University of
London, at Westminster Medical School, from 1961 to 1980, then Emeritus. See Peart S. (1995) Malcolm Milne.
Biographical Memoirs of Fellows of the Royal Society 41: 299–307.
137 Milne M D. (1967) Hereditary abnormalities of intestinal absorption. British Medical Bulletin 23: 279–284.
idem (1969) Hartnup disease. Biochemical Journal 111: 3P–4P. See also Wilson T H. (ed.) (1962) Amino acids.
Comparison of amino acid transport in kidney and intestine. op. cit. note 13, 128–130.
138 Stone C A, Torchiana M L, Navarro A, Beyer K H. (1956) Ganglionic blocking properties of 3-methylamino-
isocamphane hydrochloride (mecamylamine): a secondary amine. Journal of Pharmacology and Experimental
Therapeutics 117: 169–183. Milne M D. (1965) Influence of acid-base balance on efficacy and toxicity of drugs.
Proceedings of the Royal Society of Medicine 58: 961–963. 
139 For example, Dent and Schilling’s studies on amino acid absorption. Dent C E, Schilling J A. (1949) Studies
on the absorption of protein: the amino-acid pattern in the portal blood. Biochemical Journal 44: 318–333. 
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done this work with a biochemist called Dalgliesh who had done the paper
c h romatography of all the bacterial bre a k d own products in the urine. He showed the
patient, with pieces of paper chromatography all over the place, sat down at the end of
the grand round presentations and got thunderous applause from about 300 people.
The Professor of Medicine at that time was a ve ry distinguished cardiologist, Sir Jo h n
Mc Mi c h a e l ,1 4 0 who wasn’t to be outdone. He stood up and looked at Milne, took out
his stethoscope and said, ‘Milne, I believe your patient has a systolic murmur’. 
Holdsworth: If I can continue with this theme of the relationship between renal and
intestinal transport, I am reminded that Wilbrandt said in 1959 that the membrane
carrier hypothesis for glucose transfer was introduced by Shannon in 1939,141 who
showed saturation kinetics for glucose absorption in the renal tubule, and suggested
‘reversible combination with some cellular element which is present in constant but
limited amounts’. But the concept was not transferred to intestinal absorption until
much later.142
Booth: Can I just ask one question? The two other people who always seem to be
forgotten in the field of human intubation studies are Harold Schedl and Jim Clifton
who was very active in Iowa City.143 Now what did they do?
Levin: I can tell you because I was in Iowa City on sabbatical in 1964–5. They actually
used prisoners in the University Hospital. They could come out of the prison and stay
on the wards and they would swallow the tubes and be perfused, and they got off some
of their sentence. It was actually the absorption of substances like methionine that
they were doing at that particular time, but I remember seeing them. They were in
pyjamas at the time so that they couldn’t escape! 
I want to go down a slightly different track, as we are off electrolyte transport and on
to glucose again, I want to bring it back. Just to say that you have got to have a bit of
luck in life because even if you do the right thing at the wrong time (viz too early) you
are often never recognized. There’s a very interesting early paper about intestinal
secretion. You talked about absorption, but this is secretion really, especially as you are
140 Sir John McMichael Kt FRCP FRS (1904–1993) was Professor and Director of the Department of Medicine
at the Postgraduate Medical School at Hammersmith between 1946 and 1966, Director of the British Postgraduate
Medical Federation from 1966 to 1971, and a Trustee of the Wellcome Trust from 1960 to 1977. His research
interests were predominantly in the field of cardiology and he was the first in Britain to apply the technique of
cardiac catheterization. See Dollery C. (1995) Sir John McMichael. Biographical Memoirs of Fellows of the Royal
Society 41: 283–296.
141 Shannon J A. (1939) Renal tubular excretion. Pysiological Reviews 19: 63–93. Wilbrandt W. (1959) In Geigy
Colloquium I, Kohlenhydratstoffwechsel im Kinderalter. Basel: S Karger. See also Kleinzeller A, Kotyk A. (eds)
(1961) Topic 3. Transport of sugars across cellular and biological membranes. In Membrane Transport and
Metabolism. London: Academic Press, 341–464. Professor Michael Gardner wrote: ‘According to D M Matthews
(1991) (see note 173), Dr Gerald Wiseman (Sheffield) said that his work on amino acid absorption in the 1950s
had been inspired by a paper by Shannon and Fisher (not R B Fisher) on renal reabsorption of glucose in the
1930s.’ Letter to Dr Daphne Christie, 28 April 2000. 
142 See note 20.
143 op. cit. notes 145 and 146.
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coming on to oral rehydration, I will just reactivate it. Charlie Tidball in Washington
University, way back in the early 1960s, had shown that it was chloride secretion that
was the ion that powered intestinal secretion (in dogs). He published that in the
American Journal of Physiology144 and also had an abstract in Federation Proceedings and
nobody picked it up for many years. Everybody said, ‘No, it doesn’t matter, it’s not
interesting’. It was the right thing to be done but at the wrong time, and nobody has
ever commented about Charlie Tidball at all, but I think he was one of the first, if not
the first, to show that it was chloride transport that was going on in the intestine. That
was the ion that powered diarrhoea. It’s funny if you are with the right thing, but at
the wrong time.
Dowling: You were asking about Schedl and Clifton. They were interested in diabetes
mellitus and its effects on intestinal transport. They also studied segmental intestinal
absorption in patients with proximally confined coeliac disease and showed that as one
goes down the gut, the profile of absorptive efficiency/unit length intestine was, as
expected, relatively low in the jejunum but unexpectedly high in the ileum.145 And
although they didn’t interpret their results as such, this was actually one of the first
demonstrations in humans that when there is damage to the proximal intestine, there
is compensatory or adaptive segmental hyperfunction in the ileum. 
Holdsworth: Schedl and Clifton also published in Nature in 1963,146 a paper that
demonstrated net stimulation of sodium transport by glucose in human jejunum in
vivo, and I think they should be given credit for that. 
Turnberg: Now we have a series of topics which we are going to try to pick up. The
first is oral rehydration which was, from the therapeutic point of view, a remarkable
advance. It was thought that this was based directly on the results of physiological
perfusion experiments. Whether it was or not is not so clear, but John Walker-Smith
will enlighten us. 
Professor John Walker-Smith:147 Thank you very much, Mr Chairman. I am speaking
as a clinician who has benefited from the development of oral rehydration therapy as
a powerful tool for treating children with acute diarrhoeal disease rather than as one
who has in any way contributed to its development. Through the centuries acute
diarrhoeal disease (cholera in particular), especially in infants and children, has been
144 Tidball C S. (1960) Active chloride transport during intestinal secretion. Federation Proceedings 19: 127. idem
(1961) Active chloride transport during intestinal secretion. American Journal of Physiology 200: 309–312. 
145 See, for example, Schedl H P, Clifton J A. (1961) Kinetics of intestinal absorption in man: Normal subjects and
patients with sprue. Journal of Clinical Investigation 40: 1079–1080.
146 Schedl H P, Clifton J A. (1963) Solute and water absorption by the human small intestine. Nature 199:
1265–1267.
147 Professor John Walker-Smith FRCP FRACP (b. 1936) graduated from the University of Sydney and began his
career in adult gastroenterology at the Hammersmith Hospital, London, and Royal Prince Alfred Hospital, Sydney,
before changing to paediatric gastroenterology. He held academic appointments at the Medical College of St
Bartholomew’s Hospital and Queen Elizabeth Hospital for Children from 1973 to 1995, and then transferred to
the Royal Free Hospital, London, as Professor of Paediatric Gastroenterology.
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a major cause of death – from dehydration in most cases. From the early part of the
century investigators have sought possible aetiological agents with varying success.
However, regardless of causation, it is, of course, dehydration which kills babies,
children and adults. From the 1960s the advent of the technique of oral rehydration
therapy has given a huge boost to the effective and practical management of
dehydration due to acute diarrhoea. Yet it is interesting that paediatricians, with one
notable exception, Dilip Mahalanabis,148 actually played very little part in this
development. There was, in fact, quite strong opposition against this treatment by the
paediatric establishment when it was first introduced.149
The development of oral rehydration therapy came from three directions. First, there
was the basic in vitro physiological work which has already been discussed. The work
of Schultz and Zalusky in their classic paper of 1964, that glucose stimulated sodium
transport across a piece of rabbit ileum, was of particular importance.150 Second, there
were the physiological studies in man such as those of John Fordtran in the classical
paper of Malawer and colleagues151 as well as Gordon Sladen and Tony Dawson in
their 1969 study amongst others.152 Third, in the field, practical work such as that of
Captain Phillips, who was the first to successfully use oral rehydration therapy in
clinical practice in two individuals and then in an uncontrolled trial.153 Unfortunately,
there were some deaths during this trial. Subsequently, there was general acceptance
of oral rehydration therapy based on controlled clinical trials in the field, particularly
in South-East Asia and particularly Dacca and Calcutta. The work of Nalin was
particularly important for oral rehydration therapy in children. Nalin was the first to
show in a paediatric cholera epidemic that oral rehydration therapy was effective.154
This was followed by the important work of Hirschhorn in gastroenteritis.155 However,
when we look at the historical perspective, the development of oral rehydration
therapy is like a patchwork quilt, with the in vitro observations, the perfusion studies
148 See page 44, op. cit. note 157.
149 Professor John Walker-Smith wrote: ‘This largely stemmed from the fear of hypernatraemia related to the
relatively high sodium content of the solution recommended by WHO and UNICEF.’ Letter to Dr Daphne
Christie, 4 October 1999.
150 op. cit. note 99.
151 Malawer S J, Ewton M, Fordtran J S, Ingelfinger F J. (1965) Interrelation between jejunal absorption of sodium,
glucose and water in man. Journal of Clinical Investigation 44: 1072. 
152 See, for example, Sladen G E, Dawson A M. (1969) Interrelationships between the absorptions of glucose,
sodium and water by the normal human jejunum. Clinical Science 36: 119–132. 
153 Phillips R A. (1964) Water and electrolyte losses in cholera. Federation Proceedings 23: 705–712. See also idem
(1967) Twenty years of cholera research. Journal of the American Medical Association 202: 610–614. Ruxin J N.
(1994) Magic bullet: the history of oral rehydration therapy. Medical History 38: 363–397.
154 Nalin D R, Cash R A, Islam R, Molla M, Phillips R A. (1968) Oral maintenance therapy for cholera in adults.
Lancet ii: 370–373. Nalin D R, Cash R A. (1971) Oral or nasogastric maintenance therapy in pediatric cholera
patients. Journal of Pediatrics 78: 355–358.
155 Hirschhorn N, McCarthy B J, Ranney B, Hirschhorn M A, Woodward S T, Lacapa A, Cash R A, Woodward
W E. (1973) Ad libitum oral glucose-electrolyte therapy for acute diarrhoea in Apache children. Journal of
Pediatrics 83: 562–571.
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and the clinical studies occurring independently and then being linked together some
time after the event. Indeed, those working with patients were not always well
informed concerning, or did not accept, the work of the physiologists. Ruxin in 1994
published a very interesting paper in Medical History which reviewed these issues.156 In
fact, although scientists and re s e a rch clinicians we re convinced that oral re h yd r a t i o n
therapy worked, based on elegant trials, it was not until the Bangladesh war of
independence, when Dilip Mahalanabis and his colleagues actually used oral
re h ydration therapy ve ry effectively in refugee camps in an emergency situation, that
oral re h ydration therapy became widely used in practice.1 5 7 Mahalanabis applied it in a
disaster situation for the first time, whereas others had applied it under more contro l l e d
re s e a rch situations. It was this practical application which persuaded UNICEF and the
World Health Organization to appreciate the clinical value of oral re h ydration therapy. 
Here in Britain we had a very different situation from the developing world. By the
time oral rehydration therapy was developed children were no longer dying on a large
scale from acute diarrhoeal disease. Infant diarrhoea mortality had fallen very greatly.
At the Queen Elizabeth Hospital in the 1970s we were horrified that a few children
were still dying in our wards from gastroenteritis with hypernatraemic dehydration;
indeed, we had deaths in hospital up until 1979 in our gastroenteritis unit. So,
because of this continuing low mortality associated with hypernatraemia we were at
first cautious about the high sodium content of oral rehydration solution. Possibly we
were wrong, because when this solution is given properly it is safe, but as observations
from Egypt made clear, uncontrolled use of oral rehydration solution based on a
powdered solution given incorrectly as an over-concentrated solution could lead to
hypernatraemic dehydration. There was indeed reasonable cause for concern at that
time, but retrospectively we were a bit unwise, I think, in slowing introduction of oral
rehydration therapy to the UK. Now oral rehydration therapy has been shown to be
an extremely effective therapy in many studies. Indeed, we paediatricians are greatly
in debt to the variety of investigators that led to the development of oral rehydration
therapy. One can now weave together a comprehensive logical story, from in vitro
observations, to field work, to clinical use, but the actual events were not quite so
logical as it might seem when we view events retrospectively.
I am a little bit too young to have been personally involved in the early work on oral
rehydration therapy but I would be interested to hear from other people here how they
feel that the physiological work, for example, contributed directly to the development
of oral rehydration therapy.
Turnberg: Thank you very much. There’s this nice logical progression of ideas; that
glucose stimulates sodium and water absorption, deduced from the physiological
156 Ruxin J N. (1994), op. cit. note 153. 
157 Mahalanabis D, Choudhuri A B, Bagchi N G, Bhattacharya A K, Simpson T W. (1973) Oral fluid therapy of
cholera among Bangladesh refugees. Johns Hopkins Medical Journal 132: 197–205. Rahaman M M, Aziz K M,
Patwari Y, Munshi M H. (1979) Diarrhoeal mortality in two Bangladeshi villages with and without community-
based oral rehydration therapy. Lancet ii: 809–812.
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experiments we have been talking about. Although the intestine is secreting away at a
great rate in the presence of cholera, it is still capable of absorbing salt and water, if
you give the right substrates into the lumen; hence why not try this in humans with
cholera, and give them glucose and other solutes to stimulate the sodium and water
absorption. It all sounds very logical, except I am not sure that it did happen quite like
that. It would be very nice if it had, but it does seem that people were already feeding
infants rice water and, I think, Carpenter and others in Dacca and Bangladesh were
putting in fluids with different solutes before the physiological basis for what was
being done was recognized. I think the idea of giving rice water as a stimulus to try
and help to rehydrate people was already going on to a significant extent before the
physiological knowledge came along. Is that correct? 
Walker-Smith: There was quite a body of experience at the Queen Elizabeth Hospital
for Children from 1952, using an oral glucose electrolyte solution as recommended
by the Medical Research Council. Winifred Young used such a glucose electrolyte
solution for treatment of mild cases of gastroenteritis. The glucose content was
thought to be an important calorie source and there was no appreciation whatever of
the notion of oral rehydration therapy. A glucose electrolyte solution was used for
inpatients and a sucrose electrolyte solution for outpatients with gastroenteritis. I
inherited that approach. It was a breakthrough when the work of the physiologists
gave a rational basis for a correctly formulated oral rehydration solution. In fact, the
solution introduced by Winifred Young had a glucose content which was too high.
Indeed, when this solution has been used in animal models it has a powerful osmotic
effect. So when that solution was used in severe cases, particularly rotavirus
gastroenteritis, osmotic diarrhoea would have resulted. 
One of the issues for paediatricians was, it is all ve ry well for oral re h ydration therapy to
w o rk in cholera but what about ro t a v i rus gastroenteritis, where it was known from the
w o rk of Barnes at the Royal Childre n’s Hospital in Melbourne that there could be an
almost flat small intestinal mucosa.1 5 8 In actual fact, oral re h ydration therapy is effective
in most such cases. It may be that the extent of the small gut damage is most import a n t .
Hellier: I think you are right, there was a change of attitude regarding treatment of
people dying of diarrhoea. From our experience in South India, where 30 000 people
died of dehydration from what we termed ‘tropical sprue’ in the early 1960s, the
change of attitude was that up until that time if you had diarrhoea you didn’t drink,
because that seemed the best way to stop the diarrhoea. The last thing you wanted to
do was to pour fluid in if you had diarrhoea. It was when the change of attitude came
about that people actually should drink, irrespective of what they drank, that
mortality started to fall. 
Turnberg: And what was the attitude change due to?
158 See, for example, Walker-Smith J. (1978) Rotavirus gastroenteritis. Archives of Disease in Childhood 53:
355–362. Davidson G P, Barnes G L. (1979) Structural and functional abnormalities of the small intestine in
infants and young children with rotavirus enteritis. Acta Paediatrica Scandinavica 68: 181–186.
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Hellier: I think it may well have stemmed from the realization that water and electro l y t e
absorption could be stimulated by nonelectrolytes. It came about in the mid-to-late 1960s. 
D ow l i n g : To continue the theme that the renal physicians and physiologists had
something to teach gastrointestinal physiologists: in my early postgraduate days, I trained
in Belfast with Graham Bu l l .1 5 9 He visited the cholera re s e a rch unit in Dacca, and there
he met, and became friendly with, an American called Bob Phillips who was studying
fluid and electrolyte balance in cholera patients. Bull always claimed that Phillips was one
of the first to show the importance of adding glucose to re h ydration solutions, to enhance
sodium and water absorption in cholera.1 6 0 Now is that correct or not?
Booth: My knowledge of this field is derived from the excellent book by Seal and van
Heyningen on the history of cholera and particularly the history of the Dacca unit.161
I think the story of the American involvement with cholera is an example of an
advantage which derived from a military alliance, the South-East Asia Treaty
Organization. It was they who funded Bob Phillips and his work. Phillips was working
in the Philippines and then went to Taiwan and from Taiwan went to head the unit
in Dacca, which was where he built up the cholera research unit. The story there goes
that Phillips tried a couple of cases of oral rehydration, I think in Taiwan, before he
went to Dacca, but I may be wrong about that. Certainly the people in Dacca were
told by Bob Phillips under no circumstances were they to indulge in oral rehydration
therapy because it had proved to be wrong. Now Phillips was a very commanding
character with certain personal problems of his own; that made him a somewhat
difficult director of the Institute in Dacca. They really didn’t get ahead with it until he
had gone. I think the people in Dacca following Phillips were the ones who deserve
credit for having introduced the oral treatment, remembering, of course, that it wasn’t
they who said it was the oral treatment of diarrhoea, it was the oral treatment of
cholera they were concerned with. Others said, ‘Right let’s try this for infantile
diarrhoea throughout the world’. 
Professor Roy Pounder:162 Adding to that, speaking as an adult gastroenterologist,
these solutions not only liberated travellers around the world, but, importantly, made
1 5 9 Sir Graham Bull Kt FRCP (1918–1987) was Lecturer in Medicine at the Postgraduate Medical School in
Hammersmith, London, from 1947 to 1952, Professor of Medicine, The Queen’s University, Belfast, from 1952
to 1966, and Director of the MRC Clinical Research Centre, from 1966 to 1978. He was Chairman of the Ciba
Foundation Executive Committee from 1977 to 1983 and second Vice-President of the Royal College of
Physicians, from 1978 to 1979. 
160 See, for example, Taylor J, Hirschhorn N, Phillips R A. (1967) Enhancement by intestinal glucose lavage of net
sodium and water absorption in acute cholera patients. Federation Proceedings 26: 384.
161 Seal J R, van Heyningen W E. (1983) The SEATO cholera research program and the Pakistan-SEATO cholera
research laboratory in Dacca. In Cholera. The American Scientific Experience 1947–1980. Boulder, CO: Westview
Press, Inc, 95–118. See also Phillips R A. (1967) Twenty years of cholera research. Journal of the American Medical
Association 202: 610–614.
162 Professor Roy Pounder MA, MD, DSc(Med), FRCP (b. 1944) qualified in medicine at Cambridge and Guy’s
in 1969. He trained under Sir Christopher Booth, Sir Francis Avery Jones, George Misiewicz and Brian Creamer.
Appointed to the Royal Free by Dame Sheila Sherlock in 1980, he is now Professor of Medicine and Director of
the Centre of Gastroenterology at the Royal Free and University College Medical School, London. 
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possible the management of the short bowel in people with Cro h n’s disease. Wo rk at St
Ma rk’s Hospital defined how you can get the last bit of life out of the small intestine in
people with a ve ry short bowel, by forcing salt in, rather than losing it out of the stoma. 
Walker-Smith: A further comment on Captain Phillips.163 He was actually working on
the wrong premise. He thought that in cholera there was a ‘poisoning’ of the intestinal
sodium pump and that this was the functional disturbance in cholera. He was trying
to ‘unpoison’ the pump. So pathophysiologically, he was completely wrong. However,
the worst thing that happened to him was that owing to his success with his first two
patients he planned another ad hoc study. He then went on holiday leaving others to
do the study. When he came back after holidaying, five of the patients in the new
study had died. He was very shocked by that outcome and thereafter rather lost heart.
He certainly was not an heir of the physiologists, he was working independently, and
he seemed to be indifferent to the precise amount of glucose that was present in the
solutions that were given. 
Turnberg: I think it is quite interesting that Michael Field, doyen of the Ussing
chamber and in vitro techniques, and John Fordtran, the whole-human gut perfusion
man, jointly were given the King Faisal Prize for developing the scientific basis for
treatment of diarrhoeal disease. 
Now, peptide absorption is the next topic. Mike Hellier might lead the discussion. 
Hellier: Up until the end of the last century it was very much assumed that protein
was absorbed in the form of peptides. But Cohnheim in 1901 discovered ‘erepsin’ and
showed it could digest peptones (peptides) down to free amino acids.164 Really, from
this time onwards right through to the end of the late 1960s it was taken for granted
that protein was absorbed in its free amino acid form, and any suggestion that peptide
absorption might be of significance in protein absorption was rather overlooked. 
But I think the credit for raising the profile of peptides again goes to the Westminster
group where Craft, Milne, Matthews, Asatoor and Navab started to look at peptides
in the late 1960s.165 They looked at absorption in animal studies and showed that
amino acids could be absorbed faster when presented as a dipeptide solution than as
free amino acids which favoured intact peptide absorption. They took advantage of a
patient with Hartnup disease, and did oral absorption studies which showed that the
patient seemed to absorb neutral amino acids when given in the form of peptides.
163 op. cit. notes 153 and 161.
164 Otto Cohnheim (1873–1913) looking for the synthesis of protein in the intestinal mucosa during absorption
in the dog found that the mucosa could break down ‘peptones’ (peptides) to free amino acids. He called the
chemical responsible for the hydrolysis ‘erepsin’. See Cohnheim O. (1901) Die umwandlung des eiweiss durch die
darmwand. Zeitschrift für Physikalische Chemie 33: 451–455. idem (1902) Trypsin und Erepsin. ibid. 36: 13–19.
165 See, for example, Craft I L, Geddes D, Hyde C W, Wise I J, Matthews D M. (1968) Absorption and
malabsorption of glycine and glycine peptides in man. Gut 9: 425–437. Asatoor A M, Bandoh J K, Lant A F,
Milne M D, Navab F. (1969) Absorption of amino acids and the dipeptide, carnosine, from the gut in normal
subjects and a case of Hartnup disease. Clinical Science 37: 568. 
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Well, it was about this stage that I came on the scene. In 1969 I had succeeded in
passing my membership examination [for the Royal College of Physicians] and
thought that from then onwards it would be downhill and easy, but my supervisor
quickly corrected me of this idea and said, ‘Now the difficult times are just starting,
you must do some research and get an MD’. So I thumbed through the back of the
British Medical Journal and saw a job advertised at St Bartholomew’s Hospital. The job
was to look at cystinuric patients, because there was a unique collection of cystinuric
patients at St Bartholomew’s, thanks to Dr Dickie Watts. He had more cystinuric
patients than anyone else in the country and I was to devise an oral-load test to try
and look for subgroups of cystinuric patients and perhaps use it for looking for partial
defects. There was also a chap called Derek Holdsworth at Bart’s at the time and I was
told he was a rising star in British gastroenterology and that I could do worse than to
go and work with him. So I ended up working for Derek on Richard Watts’s cystinuric
patients at St Bartholomew’s. However, three months later I was no further on. It was
quite clear that an oral absorption test in cystinuria was going to be of no use, unlike
in Hartnup disease. My fluorometric assay for arginine wasn’t working and wouldn’t
work and was never likely to work. So I went through the phase that I think a lot of
researchers go through, of utter gloom, and decided that I might cut my losses, get
out, and get back into clinical medicine. And then, fortuitously, as so often happens,
a bright idea came along, I am not quite sure whose bright idea it was, probably
Derek’s, aware of Milne’s and Matthews’s work.166 Here we had a unique collection of
cystinuric patients, we knew they couldn’t absorb the dibasic amino acids and
therefore if we were to use dibasic amino acids in peptide form this really should
provide the chance to demonstrate fairly clearly whether peptides could be absorbed
intact. This involved initially assessing the kinetics of dibasic amino acid absorption
which had not been done in man before, and we had no idea what the Kt and Vmax
figures might be. Initially we thought they might be comparable to those of the
neutral amino acids. 
At Ba rt’s, we had refined a perfusion technique which meant that we could look in a
rather more detailed way at absorption. The first thing to do was to look at arginine.
De rek vo l u n t e e red to swallow this terrible tube and I seem to remember we met
about four o’clock in the morning on the medical unit at Ba rt’s. It took about six
hours to get the tube into position and then we started to perfuse concentrations of
arginine from 10 to 300 millimolar which we thought was the range needed to be
c ove red. De rek started to vomit and develop abdominal pain and had terrible
diarrhoea. I then followed this a week later and had exactly the same experience and
finally we re a l i zed that, in fact, the absorption kinetics of the dibasic amino acids
we re quite different from those of the neutral amino acids and the Vm a x f i g u res we re
p robably a tenth of those for the dibasic amino acids. Well, at last we managed to
establish the absorption characteristics of the dibasic amino acids. We managed to
166 See, for example, Milne M D, Asatoor A M, Edwards K D G, Loughridge L W. (1961) The intestinal absorption
defect in cystinuria. Gut 2: 323–337. Matthews D M, Lis M T, Cheng B, Crampton R F. (1969) Observations on
the intestinal absorption of some oligopeptides of methionine and glycine in the rat. Clinical Science 37: 751–764.
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find a cystinuric patient pre p a red to undergo a perfusion study and sure enough the
patient could not absorb the free dibasic amino acids, but to our delight, absorbed
arginine and lysine quite normally in the form of dipeptides. This, we felt, was
convincing evidence in favour of intact peptide absorption. We presented this work
at the Medical Re s e a rch Society in 1970.1 6 7
We went on to look at other peptides to see if we could discover more about their
mechanism of transport. We were looking at glycyl-lysine and wondered whether in
fact the dipeptide was being absorbed using the glycine transport mechanism. So we
then looked at lysyl-lysine, because that obviously wouldn’t be able to use a neutral
amino acid transport mechanism. Lysyl-lysine was absorbed normally as well, so that
really suggested that the absorption mechanism was different. We looked at the rates
of the absorption of amino acid and peptide solutions and demonstrated what
Matthews and Milne showed, that the amino acids actually got in faster when given
as peptides than as free amino acids.168 Ultimately we went on to look at electrolyte
and water absorption in association with amino acid and peptide absorption, and
from then on the work moved into the area of nutrition and the relevance of peptide
absorption in nutritional solutions, but that is another story.
Turnberg: Thank you very much indeed. The use of a couple of basic defects in
transport proved very valuable in illuminating the physiological basis.
Gardner: It’s perhaps worth looking a bit earlier than this at the ideas of David Fisher,
because by 1954 when he published his monograph on protein metabolism,169 he had
become convinced, more on theoretical grounds170 than anything else, that peptide
absorption must have been a reality. I suspect that when he started to work with
Dennis Parsons171 the intention always was to investigate peptide absorption rather
than glucose absorption but, of course, because of their obsession with getting the
preparation to work in vitro, that was why they stuck to glucose for so long. So
certainly Fisher had set the scene and I think that subsequently some of the interest
perhaps fell away because of the Sheffield group’s very effective concentration on
amino acid transport, which then, of course, set the scene for stereospecific active
transport of amino acids, and so peptide absorption and metabolism was lost sight of.
167 Hellier M D, Perrett D, Holdsworth C D. (1970) Dipeptide absorption in cystinurea. British Medical Journal
iv: 782–783. 
168 Hellier M D, Holdsworth C D, Perrett D, Thirumalai C. (1972) Intestinal dipeptide transport in normal and
cystinuric subjects. Clinical Science 43: 659–668.
169 op. cit. note 43.
170 Professor Michael Gardner wrote: ‘Fisher repeatedly drew attention to the fact that the known activities of
gastric and pancreatic proteases and peptidases were seriously inadequate to account for the speed of protein
digestion if absorption were to be wholly in the form of free amino acids.’ Letter to Dr Daphne Christie, 5
November 1999.
171 Professor Michael Gardner wrote: ‘This was confirmed by Parsons in a historical lecture at a Falk Symposium
(see Parsons D S. (1984) Subsequence and consequence in studies on absorption in the intestine. In Skadhauge E,
Heintze K. (eds) Intestinal Absorption and Secretion. Lancaster: MTP Press, 1–17).’ Letter to Dr Daphne Christie,
5 November 1999. See also Figure 2.
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I think also that Fisher’s original view was of a considerable resynthesis in the gut
during protein simulation and I am not sure, but I suspect, he was concerned with the
product precursor relationships of protein digestion, and I also suspect that he was
then realising the role of amino acids in lipoprotein synthesis in whole body
assimilation of a meal. I think, though, there is no doubt that it was the inborn errors
of amino acid absorption which then made it possible to make the biggest advances
in peptide absorption. It is worth, I think, perhaps cross-referring to the work of
David Matthews who had been in Sheffield before and so he had cut his teeth in
David Smyth’s lab,172 and, of course, Matthews was a key figure in promoting work on
peptide transport in a variety of organs, but I think there are several cross-working
networks there which were very influential.173
H o l d swo rt h : I well remember David Ma t t h ew s’s initial invo l vement in the field of
peptide absorption. In 1962 we both worked at the Royal Free Hospital, London,
David in Chemical Pa t h o l o g y, myself in the De p a rtment of Medicine. He
a p p roached me one day with an idea for a possible absorption test for the diagnosis
of idiopathic steatorrhoea, as we then called adult coeliac disease, which was to
administer oral glyc y l - g l ycine, and measure glycine in venous blood. David was not
the sort of person to normally show excitement, but even he was obviously exc i t e d
when the blood levels he measured in normal volunteers that I carried out for him in
pilot studies we re higher after diglycine than after equimolar glycine. Howe ve r, he
did not publish this until 1968.1 7 4
Hellier: Newey and Smyth had actually demonstrated glycyl-glycine intact in the
172 Matthews D M, Smyth D H. (1954) The intestinal absorption of amino acid enantiomorphs. Journal of
Physiology 126: 96–100.
1 7 3 Professor Michael Gardner wrote: ‘The history of ideas on protein and peptide absorption has been
comprehensively reviewed in the monograph by the late David Matthews (Matthews D M. (1991) Protein
Absorption: Development and present state of the subject. New York: Wiley-Liss) and in his earlier works, for example,
Matthews D M. (1975) Intestinal absorption of peptides. Physiological Reviews 55: 537–608. Matthews D M,
Payne J W. (eds) (1975) Peptide Transport in Protein Nutrition. Amsterdam: North Holland. Matthews D M.
(1977) Memorial lecture: protein absorption – then and now. Gastroenterology 73: 1267–1279.’ Letter to Dr
Daphne Christie, 5 November 1999. See also Smyth D H. (1961) Studies on the transport of amino acids and
glucose by the intestine. op. cit. note 7, 488–510.
1 7 4 See, for example, Ma t t h ews D M, Crampton R F, Lis M T. (1968) Intestinal absorption of peptides. L a n c e t i i:
639–640. Ma t t h ews D M, Craft I L, Geddes D M, Wise I J, Hyde C W. (1968) Absorption of glycine and glyc i n e
peptides from the small intestine of the rat. Clinical Science 3 5: 415–424. See also note 173. Dr De rek Ho l d s w o rt h
w rote: ‘By this time Ma t t h ews was working in the Chemical Pathology De p a rtment at the Westminster Ho s p i t a l ,
w h e re, by coincidence, Milne was Professor of Medicine, and was carrying out studies on Ha rtnup disease that led to
him publishing in 1970 his conclusion that intact peptide absorption could occur in man and be of nutritional
significance. Ma t t h ews was, of course, alert to the possibility of intact peptide absorption from his contact with the
w o rk on dipeptide absorption in the De p a rtment of Physiology at Sheffield when he worked there (see Asatoor A M,
Cheng B, Ed w a rds K D, Lant A F, Ma t t h ews D M, Milne M D, Na vab F, Richards A J. (1970) Intestinal absorption
of two dipeptides in Ha rtnup disease. Gu t 1 1: 380–387). These we re the “c ro s s - w o rking network s” that Ga rd n e r
mentions, as I remember them. The other being that after leaving the Royal Free to work for a year with Tom Wi l s o n
in the USA, I moved to St Ba rt h o l o m ew’s Hospital where there was a unique opportunity to study patients with
cystinuria, which Michael Hellier did so effective l y. All those whose names I have mentioned used to meet in a
London pub from time to time in an informal “Tr a n s p o rt Club”, which I am sure both Sir Christopher Booth and
Professor Timothy Peters will remember (see page 65).’ Note on draft transcript, 25 October 1999.
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blood, but this was criticized because it was felt at that time that glycyl-glycine was an
atypical peptide and not reflective of peptides as a whole.175
Turnberg: Where does the work of Adibi in the States fit in with all that; was he ahead
or behind?
Gardner: Almost simultaneous, in 1968.176
Hanson: Who was the first user of non-hydrolysable dipeptides at that time? That, I
think, would have been quite an important development. 
G a rd n e r: I think the answer to that is that Ma t t h ews, in anticipating the wide occurre n c e
of peptide transport mechanisms, struck up relationships with the microbial transport
people, especially John Payne, then in Durham. I think they then hit on the idea of using
g l yc y l - s a rcosine as the non-hyd rolysable peptide, because it was re c o g n i zed that peptides
we re a valuable nutrient and must be taken up by bacteria. That was the raison d’ ê t re f o r
the first of the two Ciba Foundation Symposia, ‘Peptide Tr a n s p o rt in Bacteria and
Mammalian Gu t’ ,1 7 7 and then I would say that Ma t t h ews and Payne we re co-partners in
plugging the similarity of intestinal and microbial transport mechanisms.1 7 8
Hellier: You referred to Adibi. We were aware of Adibi’s work. He had the advantage
that has been alluded to earlier, that he had local prisoners ‘volunteering’ to be
perfused. We had to try and persuade recalcitrant medical students and medical
colleagues. I was having to get the dipeptides made by Fox Chemicals in Los Angeles
when they were hit by an earthquake, and back home we had a postal strike in the
United Kingdom, so my paper was put back by four months and I had envisaged
Adibi getting all the answers first, but we just beat him to it. 
Pe t e r s :The first absorption studies with a non-hyd rolysable peptide utilized carnosine by
Malcolm Milne. I was working on peptidases at that time and one of the import a n t
o b s e rvations that Malcolm made was to ask, ‘Why don’t patients with Ha rtnup disease
or cystinuria show protein malnutrition? If they couldn’t absorb essential amino acids like
t ryptophan and lysine, why we re they not grossly malnourished?’ I think the question
c i rculated in his mind, and he then said, ‘Well, there must be a way of bypassing it.’ 
I would like to think that perhaps the work we were doing on dipeptidases was
relevant. At that time people were thinking that proteins were absorbed like
175 Newey H, Smyth D H. (1959) The intestinal absorption of some dipeptides. Journal of Physiology 145: 48–56.
idem (1967) Absorption of nutrients from the intestine. Assessment of absorptive capacity. Proceedings of the
Nutrition Society 26: 5–12.
176 Adibi S, Phillips E. (1968) Evidence for greater absorption of amino acids from peptide than from free form in
human intestine. Clinical Research 16: 446.
177 Elliott K, O’Connor M. (eds) (1972) Peptide Transport in Bacteria and Mammalian Gut. Ciba Foundation
Symposium. Amsterdam: Elsevier.
178 Professor Michael Gardner wrote: ‘The second Ciba Foundation Symposium was on peptide transport and
hydrolysis. See Elliott K, O’Connor M. (eds) (1977) Peptide Transport and Hydrolysis. Ciba Foundation
Symposium. Amsterdam: Elsevier.’ Letter to Dr Daphne Christie, 5 November 1999.
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carbohydrates, and there would be a brush-border dipeptidase. Histochemically
people had demonstrated a leucine amino-peptidase. At that time in 1967 I had just
started my PhD at the Hammersmith, Adrian Douglas was working on peptidases in
coeliac disease,179 and I was asked to look at the physiology of peptide absorption. We
looked at where in the cell dipeptidases were localized and to our surprise they weren’t
in the brush-border, they were all inside the cell.180 Certainly in my mind, that
observation, linked with Malcolm Milne’s findings, brought it all together. It was the
inherited defects that really nailed the conclusions. 
Booth: Is it worth just asking what is the biggest size of peptide that can get across the
mucosal membrane? Four or five, six or seven? Anybody know? Is it guess work?181
Dr Derek Bangham:1 8 2 I refer to the interesting pro p e rty of gut mucosal cells of some
species to transfer certain intact whole proteins selectively across a cell barrier. In the 
m i d -1950s at the National Institute for Medical Re s e a rch an American showed with
histological methods that homologous gamma globulin was transported through gut
columnar cells in suckling mice and rats.1 8 3 R JJe r ry and I showed the selective transmission
and surv i val of orally fed I1 3 1 gamma globulin, but not albumin, into rats younger than
t h ree we e k s .1 8 4 Newborn calves, howe ve r, absorbed I1 3 1 s e rum proteins unselective l y.1 8 5
Later we showed in Rhesus monkeys there was almost no absorption from the amniotic
fluid swallowed by the fetus, but there was selective transmission of gamma globulins into
the fetal circulation across the placenta; ve ry little albumin and no transferrin crossed the
placenta (in the monkey the placental stru c t u re is closely similar to that of humans).1 8 6
179 Douglas A P, Booth C C. (1970) Digestion of gluten peptides by normal human jejunal mucosa and by mucosa
from patients with adult coeliac disease. Clinical Science 38: 11–25.
180 Booth C C, Peters T J, Doe W F. (1977) Immunopathology of coeliac disease. Ciba Foundation Symposium 46:
329–346. 
181 Professor Michael Gardner wrote: ‘Absorption of synthetic octapeptides via the paracellular pathway has been
studied by Pappenheimer [see, for example, Pappenheimer J R, Dahl C E, Karnovsky M L, Maggio J E. (1994)
Intestinal absorption and excretion of octapeptides composed of D amino acids. Proceedings of the National
Academy of Sciences of the United States of America 91: 1942–1945]. It is now also clear that biologically significant
amounts of intact protein can be absorbed, especially via the M-cell route [see, for example, Gardner M L G.
(1988) Gastointestinal absorption of intact proteins. Annual Review of Nutrition 8: 329–350. idem (1994)
Absorption of intact proteins and peptides. In Johnson L R. (ed.) The Physiology of the Gastrointestinal Tract. New
York: Raven Press, 1795–1820].’ Letter to Dr Daphne Christie, 5 November 1999.
182 Dr Derek Bangham FRCP (b. 1924) was Head of the Division of Biological Standards at the National Institute
for Medical Research (NIMR) from 1961 to 1972. He was later Head of the Hormones Division of the National
Institute for Biological Standards and Control (NIBSC), from 1972 to 1987.
183 Clark S L. (1959) The ingestion of proteins and colloidal materials by columnar absorptive cells of the small
intestine in suckling rats and mice. Journal of Biochemical and Biophysical Cytolog y 5: 41–50.
184 Bangham D R, Terry R J. (1957) Absorption of 131I-labelled homologous and heterologous serum proteins fed
orally to young rats. Biochemical Journal 66: 579–583, 584–587.
185 Bangham D R, Ingram P L, Roy J H, Shillam K W G, Terry R J. (1958) Absorption of 131I-labelled serum and
colostral proteins from the gut of the young calf. Proceedings of the Royal Society 148: 184–191.
186 Bangham D R. (1960) Transmission of homologous serum proteins to the foetus and to the amniotic fluid in
the Rhesus monkey. Journal of Physiology 153: 265–289.
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Turnberg: Thank you very much. We must move on. Now, Chris Booth will tell us
about the exciting work on B12 absorption localization.
Booth: I think we mentioned earlier that entrance to gut work came in different ways.
Physicists, physiologists and others can take an interest in the gut, and renal physicians
like Malcolm Milne can come round to the gut. In the case of Sheila Callender and
myself, we were both introduced to gut transport through the field of haematology. I
should perhaps stress that I started my research career as a registrar in haematology in
Sir John Dacie’s department with David Mollin and it was there that I started work
on vitamin B12. At that stage, the B12 which was available was labelled as cobalt60 and
it had a very low specific activity, but we had a friend called J E Bradley who had a
colleague in the Birmingham cyclotron who was able to produce some cobalt56. The
cobalt56 was of very much higher specific activity than cobalt60, which was being used
in the American studies at that time. We gave this radioactive cobalt to Lester Smith
at Glaxo. I think Lester Smith is one of the great unsung heroes of the modern world.
He was a wonderful scientist, a most generous man, and I owe him much, because he
produced this very highly radioactive B12. My mentor, David Mollin, wanted to inject
this into the blood to study the clearance of vitamin B12 from the blood. In vitamin
deficiencies, if you inject a vitamin which is lacking, it disappears from the blood very
quickly as it is taken up by the tissues. However, if you inject a tracer dose of B12 into
a patient with severe deficiency of B12, then the clearance from the blood is very slow.
The reason for this is that there is a binding protein in the blood, which binds the B12
and traps it there. I wasn’t terribly interested in that, but it seemed to me that we
might for the first time be able to measure vitamin B12 in the blood after an oral dose,
the object of the exercise being to distinguish normal people from those with
Addisonian pernicious anaemia who had intrinsic factor deficiency and therefore
could not absorb B12. We fed our radioactive B12 to some normal people to see what
happened. Normally if you do a glucose tolerance test, you take blood at half-hourly
intervals for two hours after giving oral glucose and that covers the absorption phase
of glucose. So I did that and to my surprise absolutely nothing appeared in the blood
at all and we were puzzled by this. So we decided we’d extend the experiment to six
hours and then found that at three hours we began to get an increase of radioactivity
in the blood and there was a significant amount there at six hours. We went on to feed
radioactive B12, measure the radioactivity in the blood up to 24 hours, and found this
fascinating phenomenon that nothing appeared in the blood for three hours after you
fed the radiolabelled B12, then it went up and came down as the B12 was cleared from
the body into the lumen.187 The question, of course, was why the delay happened, and
clearly there were two options. One was that the B12 went into the intestinal mucosa,
was held up there, and only later released, or secondly it could be that the B12 was
absorbed lower down in the intestine than we had thought. 
187 Booth C C, Mollin D L. (1956) Plasma, tissue and urinary radioactivity after oral administration of 56Co-
labelled vitamin B12. British Journal of Haematology 2: 223–236. Booth C C, Chanarin I, Anderson B B, Mollin
D L. (1957) The site of absorption and tissue distribution of orally administered 56Co-labelled vitamin B12 in the
rat. ibid. 3: 253–261.
Intestinal Absorption
54
At that time there was considerable doubt about the site of absorption of B12. W B
Castle, who had discovered the intrinsic factor in Boston in the 1920s, had published
an article claiming that absorption must occur high up in the intestine.188 His reason
for stating that was from studies of infection in Finland of people with the fish
tapeworm, Diphyllobotrium latum. He pointed out that intubation studies had been
done in Finland which had shown that anaemia only occurred when the parasite was
in the upper intestine, not when it was in the lower. Of course, the reason for that was
that until the patient was sick the tapeworm didn’t really get up the intestine.
But there were other views. Frank Gardner, a physician in Boston, had seen patients
who had abnormalities of the intestine which involved the distal intestine and who
became B12 deficient. 
We went on to do studies in the rat and we showed that when you fed radiolabelled
B12 to a rat in a physiological dose, you got no radioactivity in the blood for one hour
and during that one hour, all the B12 was locked up in intestine. To discover its site of
absorption we had to chop the intestine up into lengths to find out where the B12 was.
With a very small oral dose the radioactive B12 was in the mid-intestine. As you
increased the dose, it went down into the distal intestine too, which was in keeping
with the idea of increasing saturation of a receptor in the intestine. We went on to do
a similar experiment in man in which we fed radiolabelled B12 to patients who were
going to have part of their stomachs taken out by a surgeon for peptic ulcer. We
deliberately measured the blood and showed the expected feature of the blood levels
going up at three hours and we were able to show that at three hours if you took a
Geiger counter and ran it round the intestine, all the B12 was in the distal intestine. 
The point about Frank Ga rd n e r’s studies on patients with gut abnormalities who
d i d n’t absorb B1 2 was that many of them had bacterial ove r g rowth in the intestine,
and it was this that inhibited B1 2 absorption. So the crucial question was not just
that they didn’t absorb B1 2, but whether, if you gave them an antibiotic and then
m e a s u red B1 2 absorption, you could then show normal absorption. This had been
s h own by Sheila Callender’s group in Oxford in patients with jejunal
d i ve rt i c u l o s i s .1 8 9 When they fed antibiotics the B1 2 absorption went up. But we
found in some dozen patients that the only ones in whom the absorption got better
after antibiotics, we re those who had an ileum. We went on to study patients with
gut resection, and showed what we expected, that there was malabsorption of B1 2 i f
the ileum had been re m oved. I was then Malcolm Mi l n e’s re g i s t r a r, and we had a
patient with Cro h n’s disease of the distal ileum. She was quite unable to absorb B1 2
and I remember Malcolm Milne looking at this patient and he said, ‘Just like yo u r
rats, Christopher, just like your rats’ and I said, ‘Ye s’. We published that paper in t h e
188 Castle W B. (1953) De velopment of knowledge concerning the gastric intrinsic factor and its relation to
pernicious anaemia. New England Jo u rnal of Me d i c i n e 2 4 9: 603–614. Wiseman G. (1964) op. cit. note 7, 299–324.
189 See, for example, Badenoch J, Bedford P D, Evans J R. (1955) Massive diverticulosis of the small intestine with
steatorrhoea and megaloblastic anaemia. Quarterly Journal of Medicine 24: 321–333. See also Anonymous. (1967)
Jejunal diverticulosis and B 12 deficiency. The London Clinical Medical Journal 8: 10–11.
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L a n c e t in 1959.1 9 0 In the following year the Year Book of Me d i c i n e came out. The editor
of the gastrointestinal section was the great American physiologist, Franz J In g e l f i n g e r, and
he chose to launch an attack upon this paper which lasted for two whole pages of that fine
print that they used in the Year Book of Me d i c i n e, saying that he didn’t believe a word of it
and that it couldn’t have been proved and it wasn’t tru e .1 9 1 I wrote to him to object. But it
soon became quite clear from other studies that B1 2 is normally absorbed in the ileum. I
h a ve a suspicion that I must have been in some way influenced at that time by Mi l n e’s
concept of the gut as a renal tubule, because that was the way that he was thinking. 
The work was followed up by Bob Donaldson in the United States, using isolated
brush-borders from experimental animals and showing that the intrinsic factor bound
radiolabelled B12 would only be taken up by the brush-borders of the ileum and not
by the jejunum.192 Subsequently a considerable amount of work has been done
isolating the receptors in the ileum that take up B12.
Now one other point about B1 2. The re q u i rement of B1 2 in man is something betwe e n
1 and 4 micrograms per day, and if you don’t get that you get pernicious anaemia, which
is what happens to people who have no intrinsic factor. In fact, the B1 2 absorption is the
only one which demonstrates the concept of mucosal block, that is the idea that you can
i n c rease the dose of what you are feeding, and then you reach a stage where no more will
go in. It is not like glucose, where when you give increasing doses of glucose the re c e p t o r
becomes saturated as you increase it and you get a curvilinear re l a t i o n s h i p. With B1 2 a n d
intrinsic factor you don’t. You get a linear relationship up to a certain point and in most
people the limit is about 2 micrograms, something like that. So that is your maximum
capacity to absorb B1 2 and it’s restricted to your ileum. 
Turnberg: Thank you very much. Any comments on B12?
Boyd: Two questions. One, I would like to hear about the origin of the Schilling test.
Two, were the structural studies on B12 and the work of Dorothy Hodgkin completely
unrelated to your interest in epithelial transport of this vitamin?
Booth: Well, Dorothy Hodgkin193 first. She was working entirely on crystallography
looking at the molecular structure, but she was interested in all that was going on. We
190 Booth C C, Mollin D L. (1959) The site of absorption of vitamin B12 in man. Lancet i: 18–21.
191 Ingelfinger F J. (1960) The digestive system. Site of absorption of vitamin B12 in man. In Beeson P B,
Muschenheim C, Castle W B, Harrison T R, Ingelfinger F J, Bondy P K. (eds) Year Book of Me d i c i n e . Chicago, IL:
The Year Book Publishers, 506–507.
192 See, for example, Donaldson R M, Jr Mackenzie I L, Trier J S. (1967) Intrinsic factor-mediated attachment of
vitamin B12 to brush borders and microvillous membranes of hamster intestine. Journal of Clinical Investigation 46:
1215–1228. Mackenzie I L, Donaldson R M. Jr (1972) Effect of divalent cations and pH on intrinsic factor-
mediated attachment of vitamin B12 to intestinal microvillous membranes. ibid. 51: 2465–2471.
1 9 3 Do rothy Ma ry Hodgkin FRS (1910–1994) was Re s e a rch Fe l l ow at So m e rville College, Oxford, from 1936 to
1977 and Wolfson Re s e a rch Professor at the Royal Society from 1960 to 1977. A crystallographer of distinction, she
was awarded the Nobel Pr i ze for Chemistry in 1964 for discoveries, by use of X-ray techniques, of the stru c t u re of
molecules, including penicillin, vitamin B12 and insulin. She was made a member of the Order of Merit in 1965 and
was awarded the Lenin Peace Pr i ze in 1987. See Fe r ry G. (1998) Do rothy Hodgkin. A Li f e. London: Granta Books.
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had a meeting in 1956 in Hamburg. Dorothy Hodgkin came to that meeting with
Lester Smith and we were all there together, clinicians and various people from Europe
and America. It was at that meeting that Dorothy Hodgkin got agreement to the
nomenclature for the new molecule and the different bits of it. She was a bright,
breezy, lovely young lady in those days. I knew her in later years when she had become
very crippled by rheumatoid arthritis, but she was tremendously excited by everything
that was happening and was always very interested in everything. 
The first question was about the Schilling test, named after Robert F Schilling, who
was a research worker in Boston.194 The point about B12 is that if you feed it by mouth
and then look at the urine, you don’t get any radiolabelled B12 coming out in the urine
at all. It all gets locked up in the body in some way or another. So that if you want to
do a test of absorption using oral doses of B12, you can’t do it just by feeding B12. On
the other hand, if you inject B12 as a large, subcutaneous intramuscular injection at
the same time, then much of it will flood out into the urine immediately. Schilling
took advantage of this and said that if you fed a physiological dose of B12, say 1–2
micrograms, and then gave an injection of, say, 1000 micrograms, then it would wash
around 30 per cent of radiolabelled B12 out into the urine.
195
Dr Sheila Callender:196 We abandoned the Schilling test quite quickly because we
then had the whole-body counter, which made life very much easier.197
B o o t h : Well, I suppose you could say that the Schilling test was the poor man’s
absorption test, if you didn’t have a whole-body counter. But it was ve ry 
useful clinically.
Pounder: I’d not heard about the B12 absorption levelling off. It makes you wonder
whether there would be an overload disease – yet we see plenty of patients who get
194 See page 72.
195 Silberstein E B. (1969) The Schilling test. Journal of the American Medical Association 208: 2325–2326.
Anonymous. (1969) Schilling test of vitamin B12 absorption. British Medical Journal i: 300–301. Rinsler M G,
Booth C C. (1985) Intestinal function tests. In Booth C C, Neale G. (eds) Disorders of the Small Intestine. Oxford:
Blackwell Scientific Publications, 28.
196 Dr Sheila Callender MD FRCP (b. 1914) qualified in medicine in 1938 at St Andrews. She spent three years
in pathology in Dundee and developed a special interest in haematology. In 1942 she joined Professor L J Witts
in the Nuffield Department of Medicine in Oxford, and in 1946 joined Dr Carl Moore and his department in St
Louis, Missouri, USA, who were studying iron metabolism using radioactive iron as a tracer. On returning to
Oxford she introduced the technique especially for studies of iron absorption from foods. 
197 The whole-body counter offered a convenient and reliable method of measuring retention or loss of radioactivity i n
v i vo. Dr Sheila Callender wrote: ‘The Schilling test was certainly useful but it was a re l a t i vely crude measurement. It
re q u i red the cooperation of the subject to ensure an accurate collection of urine as indeed did the collection of faeces
for the measurement of unabsorbed radioactive B1 2 for the estimation of absorption [Callender S, Turnbull A, Wa k i s a k a
G. (1954) Estimation of intrinsic factor of Castle by use of radioactive vitamin B1 2. British Medical Jo u rn a l i: 10–13].
We abandoned both these methods when, in 1966, Warner and Ol i ver in Oxford designed a simple whole-body
c o u n t e r, using the shadow shield technique, which enabled direct measurement of absorption [Warner G T, Ol i ver R.
(1966) A whole-body counter for clinical measurements using the ‘s h a d ow shield’ technique. Physics in Medicine and
Bi o l o gy 1 6: 83–94. Callender S, Witts L J, Warner G T, Ol i ver R. (1966) The use of a simple body counter for
haematological investigations. British Jo u rnal of Ha e m a t o l o gy 1 2: 276–282].’ Note on draft transcript, 25 April 2000. 
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addicted to little red injections, who donÕ t seem to come to any harm from being
awash with vitamin B12.
Booth: No, I think the advantage of B12 is that it is entirely water soluble, so it just
gets excreted in the urine. ThatÕ s why water-soluble vitamins have never caused an
overload problem. The only vitamins that cause overload problems are the fat-soluble
vitamins D and A. 
Wrong: ItÕ s a very minor point, but, of course, B12 clearance was used for a time for
measurement of glomerular filtration.198 It was entirely in accord with what Chris has
just said.
Tu r n b e r g :L e tÕs discuss bile acids now. Who else but Hermon Dowling to talk about these?
Dowling:Thank you. Well it seems appropriate I should be talking about bile acid
absorption immediately after Sir ChristopherÕ s contribution, because my story forms
a logical sequence to his. And although he might imply that vitamin B12 absorption is
complicated, itÕ s nothing compared to bile acids! We arenÕ t talking about the
absorption of just one substrate, but about the absorption of perhaps ten or more
different bile acids. 
As you know, the liver synthesizes two primary bile acids — cholic acid and
chenodeoxycholic acid — from cholesterol. After conjugation (or amidation) to glycine
or taurine, the four resultant bile acids are then secreted into bile and pass into the
intestine where colonic bacteria biotransform them into the two secondary bile acids
— deoxycholic acid and lithocholic acid. Some of these secondary bile acids are then
absorbed and return to the liver where they, in turn, are conjugated with glycine or
taurine before they join their ÔparentsÕ in the enterohepatic circulation. Intestinal
bacteria can also oxidize and/or reduce the primary and secondary bile acids to form
keto bile acids and b-epimers. So altogether, there are at least ten to 15 different bile
acids, all of which can be absorbed from the stomach, duodenum, jejunum, ileum and
the colon — albeit with very different efficiencies. So it takes somebody either very
naive or very ignorant to start studying bile acid absorption — and I was both of these. 
I too would like just to give a rather personal account. When Tilli Tansey approached
me, if I could paraphrase what she said, it was something like, ÔTel  us how it was for
youÕ and thatÕs exactly what I would like to do.
Forty years ago Chris Booth and colleagues published a paper in theBrit sh Journal of
Surgery199 showing that if one resects the jejunum, the residual ileum became quite
hypertrophic, whereas if one resects the ileum, the remaining jejunum does not show
198 Nelp W B, Wagner H N, Reba R. (1964) Renal excretion of vitamin B12 and its use in measurement of
glomerular filtration in man. Journal of Laboratory and Clinical Measurement 63: 480—491. Breckenridge A,
Metcalfe-Gibson A. (1965) Methods of measuring glomerular filtration rate. A comparison of inulin, vitamin B12
and creatinine clearances. Lancet ii: 265—267.
199 Booth C C, Evans K T, Menzies T, Street D F. (1958—9) Intestinal hypertrophy following partial resection of
the small bowel in the rat. British Journal of Surgery 46: 403—410.
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the same degree of adaptive growth. Chris, maybe you can confirm this, but I think
that that particular study was one of a series in which you looked at the sites of
absorption of different substrates – including intrinsic factor-bound vitamin B12. And
to prove that B12 was absorbed in the terminal ileum, you showed that if one removes
the ileum, one gets B12 malabsorption whereas if one performs a jejunectomy (as a
control), one does not [Booth: That’s correct].200
Well, having performed these surgical procedures and measured B12 absorption, when
the rats were subsequently opened up, they showed these very striking adaptive
changes in the gut. At that point I joined Chris as a very junior research fellow and
my task was to study these adaptive phenomena. 
At that time, the registrars and research fellows working with Sir Christopher set up a
journal club and once a month we would organize a working supper in each other’s
homes (with people like Soad Tabaqchali, Graham Neale and several others). At one
of these evening journal clubs, I had to review a paper by a young Australian called
Marc Playoust. He had gone to work, I think, with Kurt Isselbacher at the
Massachusetts General Hospital (although the publication in question was with Leon
Lack and Weiner).201 His study was based on Lack and Weiner’s observations, which
extended the very old studies by Schiff and Tappeiner, that the ileum was the active
transport site for conjugated bile acids.202
Chris had done much to popularize the idea that the Schilling test of vitamin B1 2
absorption could be used as a test of ileal function. Gi ven Pl a yo u s t’s findings it was a logical
extension of Chris’s ideas to suggest that it should be possible to devise a clinical test of ileal
function using bile acids, rather than vitamin B1 2. Indeed, this was the basis of pro p o s e d
studies in Boston with Franz Ingelfinger and Donald Small (one of In g e l f i n g e r’s protégés). 
At that time, Donald Small’s interest was not so much in the physiology of bile acid
absorption, but rather in the pathogenesis of gallstones. But today we are not talking
about bile acids in the liver: nor are we talking about the absorption of a nutrient –
but rather about the absorption of endogenous detergents which facilitate the
digestion and absorption of dietary fats, sterols and fat-soluble vitamins. Moreover as
clinicians know, abnormal bile acid metabolism can cause many problems.203 For
200 Booth C C. (1961) The metabolic effects of small intestinal resection in man. Postgraduate Medical Journal 37:
725–739. 
201 Playoust M R, Lack L, Weiner I M. (1965) Effect of intestinal resection on bile salt absorption in dogs.
American Journal of Physiology 208: 363–369. op. cit. note 212.
202 Professor Dowling wrote: ‘Playoust showed that in the dog, ileal resection markedly impaired the enterohepatic
circulation of bile acids while jejunal resection did not.’ Note on draft transcript, 12 June 2000. See Baker R D,
Searle G W. (1960) Bile salt absorption at various levels of rat small intestine. Proceedings of the Society for
Experimental Biology 105: 521–523. op. cit. notes 10, 25 and 212. 
203 See, for example, Dowling R H. (1972) The enterohepatic circulation. Gastroenterology 62: 122–140. Small D
M, Dowling R H, Redinger R N. (1972) The enterohepatic circulation of bile salts. Archives of Internal Medicine
130: 552–573. Hofmann A. (1978) The enterohepatic circulation of bile acids. In Sleisenger M, Fordtran J T. (eds)
Gastrointestinal Disease. London: W B Saunders, 418–429. idem (1989) Enterohepatic circulation of bile acids. In
Schultz S G, Forte J G, Rauner B B. (eds) Handbook of Physiology. New York: Oxford University Press, 567–596.
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example, jejunal bile acid deficiency can impair the absorption of dietary lipids. And
when excess bile acids spill into the colon they can cause diarrhoea, inhibit water and
electrolyte transport, influence motility, regulate peptide hormone release, promote
oxalate absorption, and so on. They may even play a role in the development of
colorectal cancer. So for all these reasons, it seemed important to study further the
effects of ileal resection on bile acid metabolism. 
At that time, several investigators had shown that patients with ileal resection often
had severe diarrhoea, steatorrhoea and malabsorption of cholesterol and fat-soluble
vitamins whereas those with jejunal resection did not. On this basis, they reached the
logical, but erroneous, conclusion that the ileum must be the site of absorption of
dietary fat, sterols and fat-soluble vitamins. We now know, of course, that these
phenomena are largely a consequence of bile acid malabsorption. 
To study the effects of ileal resection on the enterohepatic circulation of bile acids, we
had to adopt indirect approaches – rather than measuring bile acid absorption directly.
One such approach is to study bile fistula models but, as you know, once you
cannulate the bile duct and drain the bile acid pool to the exterior, there are all sorts
of artifacts and you are no longer studying normal physiology. To overcome this
problem, Donald Small proposed that we should study Rhesus monkeys and apply a
technique first developed in humans by Isaksson and Thureborn.204 This involved a
chronic biliary fistula and the use of an extra-corporeal stream-splitting device,
coupled to a drop counter. Drops of fistula bile passed through the drop counter and
the stream-splitter was programmed to divert every twentieth drop of bile into a
sampling system and to return the other 19 drops to the upper intestine (through a
return cannula in the distal common bile duct).205 In other words, the 5 per cent bile
diversion provided a representative sample of bile for analysis, but ensured that the
enterohepatic circulation remained virtually intact. It enabled us to sample bile
without significantly distorting the normal physiology.206
One related question which we addressed was as follows: if you haven’t got an ileum
(as a result of resection or bypass), does the rest of the gut take over bile acid
2 0 4 See T h u reborn E. (1962) Human hepatic bile: composition changes due to altered enterohepatic circ u l a t i o n . Ac t a
C h i rurgica Scandinavica 3 0 3: 1–63. Isaksson B, T h u reborn E. (1963) A method for continuous collection of hepatic
bile at ‘intact’ entero-hepatic circulation in man. Second Wo rld Congress of Ga s t ro e n t e ro l o gy, Munich, 1962. 3: 3. 
205 See, for example, Dowling R H, Mack E, Picott J, Berger J, Small D M. (1968) Experimental model for the
study of the enterohepatic circulation of bile in rhesus monkeys. Journal of Laboratory and Clinical Medicine 72:
169–176. Dowling R H, Mack E, Small D M. (1970) Effects of controlled interruption of the enterohepatic
circulation of bile salts by biliary diversion and by ileal resection on bile salt secretion, synthesis and pool size in
the rhesus monkey. Journal of Clinical Investigation 49: 232–242. idem (1971) Biliary lipid secretion and bile
composition after acute and chronic interruption of the enterohepatic circulation in the Rhesus monkey. IV.
Primate biliary physiology. ibid. 50: 1917–1926.
206 Professor Hermon Dowling wrote: ‘We then used this model in Rhesus monkeys to study graded interruption
of the enterohepatic circulation either with the stream splitter (10, 20, 33, 66 or 100 per cent bile diversion) or as
a result of resecting the distal one-third or two-thirds of the small intestine.’ Note on draft transcript, 7 June 2000.
op. cit. note 205.
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transport?207 This, of course, was the theme of the work that Chris Booth had started
me on when I was working on adaptation. And we used just this technique – not just
perfusing the gut and measuring luminal disappearance with all the artifacts that this
involves – such as non-specific binding to surface mucus, bidirectional transport, etc.
Instead we used bile fistula ileectomized rats, and perfused the residual jejunum or
colon with isotopically labelled bile acids. Once absorbed, bile acids go to the liver and
pass out in the bile, so the appearance of labelled bile acids in bile is proof positive
that they have been absorbed.208
One other comment about bile acids. As many of you know, for several years we we re
t rying to dissolve cholesterol gall stones with oral bile acid tre a t m e n t2 0 9 and at that time,
it became important to understand something about the pharmacokinetics and
b i o a vailability of the ingested bile acids. To do this, we had to modify an appro a c h
f requently used by clinical pharmacologists – that is, looking at the area under the seru m
bile acid concentration–time curves after the oral ingestion of different bile acid doses.
With this approach one normally needs a ‘gold standard’ as a re f e rence point. That gold
s t a n d a rd is usually obtained by giving the same dose of the drug intrave n o u s l y, and
looking at the serum concentration–time curve. Howe ve r, one cannot use this appro a c h
to study bile acid absorption in humans, because intravenous bile acids are toxic. 
E a r l i e r, Les [Turnberg] was talking about John Fo rdtran. On one occasion, he visited us at
Gu y’s Hospital when we discussed the problem. He proposed that we should intubate the
gut and infuse different bolus doses of bile acids (plus markers) down the proximal lumen
of a double-lumen tube. Provided we confirmed that no bile acids remained in the luminal
fluid aspirated from the district port of the double lumen tube, we could use re s u l t a n t
concentration–time curves as bona fide re f e rence standards to study the pharmacokinetics
and bioavailability of both chenodeoxycholic acid and ursodeoxycholic acids.210
The final thing that I would say is that although my hope was to follow in Chris’s
footsteps by developing a bile acid absorption test as a measure of ileal function
(analogous to the Schilling test), I never accomplished that aim. Instead, this goal was
achieved simultaneously by two separate groups – Alan Hofmann and Hans Fromm,
207 Dowling R H, White J, Perry P M. (1973) Conservation of intestinal bile acid concentration after ileal
resection. Helvetica Medica Acta 37: 103–111. Mok H Y, Perry P M, Dowling R H. (1974) The control of bile
acid pool size: effect of jejunal resection and phenobarbitone on bile acid metabolism in the rat. Gut 15: 247–253.
208 Professor Hermon Dowling wrote: ‘Mike Perry, a surgical fellow at the that time, showed that after ileal
resection, there was an adaptive increase in jejunal, but not in colonic, bile acid absorption.’ Note on draft
transcript, 12 June 2000.
209 Bell G D, Whitney B, Dowling R H. (1972) Gallstone dissolution in man using chenodeoxycholic acid. Lancet
ii: 1213–1216. Iser J H, Dowling R H, Mok H Y I, Bell G D. (1975) Chenodeoxycholic acid treatment of
gallstones: a follow-up report and analysis of factors influencing response to therapy. New England Journal of
Medicine 293: 378–383. Maton P N, Murphy G M, Dowling R H. (1977) Ursodeoxycholic acid treatment of
gallstones: dose–response study and possible mechanisms of action. Lancet ii: 1297–1301.
210 See Ponz de Leon M, Loria P, Carulli N, Murphy G M, Dowling R H. (1980) Intestinal solubilization,
absorption, pharmacokinetics and bioavailability of chenodeox ycholic acid. Eu ropean Jo u rnal of Clinical
Investigation 10: 262–271.
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(his then young German research fellow) at the Mayo Clinic, and Sherr and colleagues
at the Johns Hopkins Hospital in Baltimore. This was, of course, the 14C-glycine-
labelled glycocholate bile acid breath test which is still used in some centres today.211
Chris may remember that when Alan Hofmann synthesized this isotopic bile acid he
g e n e rously sent some of it for us to try out in one of our patients with ileal re s e c t i o n .
This extremely valuable sample had been flown across the Atlantic. But when we fed it
to our poor patient, she promptly vomited it all over the floor. Chris tried to persuade
me that we should follow Malcolm Mi l n e’s example because he had scooped up some
vomit containing ingested isotopes and reused it, but we didn’t follow that example! 
So with these few reminiscences, I would welcome your comments and questions.
Turnberg: Thank you very much, very nice to hear it. Any comments on bile acids?
Booth: Can you show any form of saturation kinetics of bile acid transport either in
in vitro systems or in man?
Dowling: As noted earlier at this meeting, the kinetics of bile acid transport in
different segments of the gut were worked out in the early 1960s, by Lack and
Weiner.212 However, the topic was revisited subsequently by others, including John
Dietschy, who worked with Jared Diamond on the importance of unstirred layers in
bile acid transport.213 They redefined this in considerable detail, as did Henrik
Westergaard, and Eugene Schiff, both of whom worked with John Dietschy in this
field214 More recently the kinetics of bile acid absorption from the intestine was re-
examined by Hofmann and colleagues, in San Diego.
The concept that the active transport site in the terminal ileum is responsible for all
bile acid absorption, is potentially misleading. Of course, the ileum is the site for
active bile acid transport and it is very important for the trihydroxy bile acid, cholic
acid. But passive diffusion is also important215 and in the jejunum and colon, this is
211 A test that is used both as a measure of ileal function and as a screen for bacterial overgrowth in the small
intestine. See Fromm H, Hofmann A F. (1971) Breath test for altered bile acid metabolism. Lancet ii: 621–625.
Sherr H P, Sasaki Y, Newman A, Banwell J G, Wagner H N Jr, Hendrix T R. (1971) Detection of bacterial
deconjugation of bile salts by a convenient breath-analysis technic. New England Journal of Medicine 285:
656–661. See also page 70.
212 Lack L, Weiner I M. (1961) In vitro absorption of bile salts by small intestine of rats and guinea pigs. American
Journal of Physiology 200: 313–317. idem (1966) Intestinal bile salt transport: structure-activity relationships and
other properties. ibid. 210: 1142–1152. idem (1973) Bile salt transport systems. In Nair P P, Kritchevsky D. (eds)
The Bile Acids, Physiology and Metabolism. New York: Plenum Press, 33–54.
213 See, for example, Dietschy J M. (1968) Mechanisms for the intestinal absorption of bile acids. Journal of Lipid
Research 9: 297–309. op. cit. note 214.
214 See, for example, Schiff E R, Dietschy M. (1969) Current concepts of bile acid absorption. American Journal of
Clinical Nutrition 22: 272–278. Dietschy J M. (1973) Mechanism of bile acid and fatty acid absorption across the
unstirred water layer and brush border of the intestine. Helvetica Medica Acta 37: 89–102. Westergaard H,
Dietschy J M. (1974) Delineation of the dimensions and permeability characteristics of the two major diffusion
barriers to passive mucosal uptake in the rabbit intestine. Journal of Clinical Investigation 54: 718–732.
215 op. cit. notes 205 and 207.
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the principal transport mechanism for glycine conjugated, and unconjugated bile acids.
In the absence of an ileum, hepatic supplies of taurine for bile acid conjugation rapidly
become exhausted as a result of which, most of the bile acids become conjugated with
g l yc i n e .2 1 6 Fo rt u i t o u s l y, this acts as conservation mechanism where by, even in the
absence of an active bile acid transport system in the ileum, at least some of the glyc i n e
conjugated bile acids can still be absorbed from extra-ileal sites, by diffusion.2 1 7
I might add that molecular medicine arrived fairly late in the bile acid field, but about
five years ago, Paul Dawson from North Carolina identified and cloned the ileal bile
acid transporter gene, and this sodium-linked bile acid transporter gene has now been
defined in some detail.218
Turnberg: We will move on now to iron absorption. This is an interesting area for me,
because I started out my research by measuring iron absorption in patients in a rather
crude way and I always remember thinking that the doyenne of iron absorption was
Sheila Callender. I used to quote her work all the time, and I’m delighted that here
she is going to talk about iron absorption.
C a l l e n d e r: It seems almost incredible that when I was a student in the 1930s, iro n
deficiency when not clearly related to blood loss was re f e r red to as ‘idiopathic iro n
d e f i c i e n c y’. Howe ve r, Stanley Davidson and colleagues had shown the ve ry high
f requency of iron deficiency in the poorer parts of places like Ab e rdeen and Ed i n b u r g h ,
and had suggested that this was nutritional in origin.2 1 9 Also, Witts had shown that a high
p ro p o rtion of patients with iron deficiency had achlorhyd r i a .2 2 0 He thought this might be
an aetiological factor and suggested the name ‘simple achlorhydric anaemia’. A significant
b re a k t h rough came with McCance and Wi d d ow s o n’s meticulous iron balance studies of
1937, which showed that there was negligible exc retion of iron from the gut.2 2 1 This posed
the problem of how the absorption of iron was controlled to pre vent the development of
i ron overload. Little pro g ress was made until the development of radioisotopes as tracers
in the early 1940s. Then there was an explosion of investigations, notably in the USA, in
St Louis in Carl Mo o re’s laboratory, where I went to work in 1946. This group had show n
that ferrous iron was much better absorbed than the ferric form, and we soon also showe d
216 Chadwick V S, Modha K, Dowling R H. (1973) Mechanism for hyperoxaluria in patients with ileal
dysfunction. New England Journal of Medicine 289: 172–176.
217 Professor Hermon Dowling wrote: ‘Indeed, we found that after distal small bowel resection in the Rhesus
monkey, approximately 50 per cent of the circulating bile acids could still be reabsorbed from the non-ileal sites
(op. cit. note 205).’ Note on draft transcript, 12 June 2000.
218 Wong M H, Oelkers P, Craddock A L, Dawson P A. (1994) Expression cloning and characterization of the
hamster ileal sodium-dependent bile acid transport e r. Jo u rnal of Biological Chemistry 2 6 9: 1340–1347. Dawson P A,
Oelkers P. (1995) Bile acid transporters. Current Opinion in Lipidology 6: 109–114.
219 Davidson L S P, Fullerton H W, Campbell R M. (1935) Nutritional iron-deficiency anaemia, with special
reference to prevalence and age and sex incidence. British Medical Journal ii: 195–198.
220 Witts L J. (1930) Simple achlorhydric anaemia. Guy’s Hospital Reports 80: 253–296. idem Achlorhydria and
anaemia. Practitioner 124: 348–357.
221 McCance R A, Widdowson E M. (1937) Absorption and excretion of iron. Lancet ii: 680–684.
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that iron was much better absorbed in iron-deficient patients than in normal subjects.2 2 2
This was using inorganic ferrous iron salts, clearly not completely applicable to
absorption of iron from foods. Now, a number of people began to devise ways of labelling
foods with radioactive iron, for example by growing vegetables and cereals in hyd ro p o n i c
tanks. When I came back to Oxford we continued this work and confirmed that the iro n
in cereals labelled with radioactive iron was ve ry poorly absorbed in contrast to that fro m
inorganic iron salts. We also labelled eggs by injecting birds with 5 9Fe and showed a ve ry
poor absorption from this sourc e .2 2 3 It appeared that absorption of inorganic iron in food
was greatly influenced by the composition of the diet. Acid in the stomach increased the
absorption of inorganic iron, and, notably, ascorbic acid – for example in orange juice –
which kept the iron in the ferrous form and also formed small molecular we i g h t
c o m p l e xes, enhanced absorption. We went on to show that there we re other factors which
would depress absorption, such as phytates and phosphates in cereals and the
p h o s p h o p rotein in eggs. 
We then turned our attention to haem iron absorption. For a long time iron in haem
had been thought not to be available for absorption. In fact, Douglas Black and Joan
Powell,224 when I arrived in Oxford, were carrying out a study on iron-deficient
patients and I was rather surprised to see these patients in the ward with blood
dripping into their stomachs from bottles of blood. Black and Powell were able, by
careful iron-balance studies, to show that a proportion of the iron was absorbed from
the blood, and, in fact, three out of four patients showed a slight reticulocytosis and
a small response to the treatment with the haem iron.225 Much later we went on to
study haem iron absorption using rabbit blood labelled biologically with 59Fe. We
injected rabbits with radioactive iron and took samples of their blood. When it had
reached a peak of activity, we gave haemolysates of the blood to various volunteers,
both iron deficient and normal, using the amount of blood containing 5-milligram
iron, i.e. the amount we had been using with the inorganic iron studies. We were able
to show that the haem iron absorption was unaffected by substances like phytates,
phosphates, and ascorbic acid, quite unlike absorption from inorganic iron. Also, the
peak of plasma iron absorption of the radioactive iron following the dose was delayed.
Instead of appearing quite early, it was delayed up to 100–200 minutes after the dose,
so we assumed that the iron was being absorbed further down the intestine. 
I went on with John Badenoch to look at patients with steatorrhoea and coeliac disease.
These conditions are characterized by sensitivity to gluten in wheat. This results in
222 Moore C V, Dubach R, Minnich V, Roberts H K. (1944) Absorption of ferrous and ferric radioactive iron by
human subjects and by dogs. Journal of Clinical Investigation 23: 755–767. Badenoch J, Callender S. (1954) Use
of radioactive iron in investigation of anaemia. British Journal of Radiology 27: 381–386.
223 Callender S T, Marney S R, Warner G T. (1970) Eggs and iron absorption. British Journal of Haematology 19:
657–665.
224 Black D A K, Powell J F. (1942) Absorption of haemoglobin iron. Biochemical Journal 36: 110–112.
225 Callender S T, Mallett B J, Smith M D. (1957) Absorption of haemoglobin iron. British Journal of Haematology
3: 186–192. Anand B S, Callender S T, Warner G T. (1977) Absorption of inorganic and haemoglobin iron in
coeliac disease. British Journal of Haematology 37: 409–414.
Intestinal Absorption
64
damage to the villi in the upper part of the small intestine leaving a flat mucosal surf a c e .
We found that inorganic iron was ve ry poorly absorbed; in fact this absorption could
be used as a pointer to a diagnosis of malabsorption syndro m e .2 2 6 In contrast, the haem
i ron absorption was normal in these patients. This again suggested that the haem iro n
was absorbed much further down the intestine where there was no mucosal damage.2 2 7
It no longer seems surprising to look back on the very high frequency of iron
deficiency in women in the 1930s during the depression, because I know from my
own experience of ‘district deliveries’ in Dundee, many women had multiple
pregnancies increasing iron requirement and also they were existing mainly on diets
of bread and tea. Tea has been shown by Disler and colleagues to be another factor
which exerts an inhibitory effect on iron absorption.228 So gradually, the whole picture
has emerged. There isn’t anything ‘idiopathic’ about iron deficiency, but there are
multiple factors in the absorption of iron, which determine the cause of anaemia. 
B o o t h : Can I just chip in an additional point. Sheila Callender re f e r red to the ladies in
Dundee living on tea and bread. When I was in Dundee we used to call it ‘whippet disease’ .
C e rtainly when the miners in Fife kept whippets in food-rationing time, the meat was
g i ven to the whippet and nobody else got it, so we used to call it ‘whippet disease’ .
Callender: In my time before the war they were existing on the dole of 30 shillings a
week, and if ever there was a scrap of meat, it was given to the men in the family,
because they had to keep their strength up!
Turnberg: What about the mechanisms for haem iron absorption? Has there been any
further progress on how it gets in?
Callender: For inorganic iron the first idea was Granick’s – who suggested that
apoferritin was formed in response to iron in the mucosal cell and this was converted
to ferritin and from that there was passage on to the serosal surface and into the
blood.229 Where the apoferritin was saturated it was referred to as a mucosal block; it’s
not as simple as that, certainly. We now think that the ferritin is really a mechanism
for bypassing the absorption and that most of the ferritin iron is shed from the gut.
226 Badenoch J, Callender S T. (1960) Effect of corticosteroids and gluten-free diet on absorption of iron in
idiopathic steatorrhoea and coeliac disease. British Journal of Haematology 23: 135–146.
2 2 7 Dr Sheila Callender wrote: ‘All these studies indicate that absorption of iron occurs largely in the upper part of the
small intestine, and depends on the iron being present in a soluble form. Any other substance which conve rts it into
an insoluble state will inhibit absorption. Conve r s e l y, anything which increases solubility will enhance absorption.
Potentially iron can be absorbed from any level of the intestine but the more alkaline medium lower down pre ve n t s
this, except in the case of haem iron with is not dependent on such factors.’ Note on draft transcript, 25 April 2000.
228 Disler P B, Lynch S R, Charlton R W, Torrance J D, Bothwell T H, Walker R B, Mayet F. (1975) The effect of
tea on iron absorption. Gut 16: 193–200.
2 2 9 See, for example, Granick S. (1946) In c rease of the protein apoferritin in the gastrointestinal mucosa as a dire c t
response to iron feeding. The function of ferritin in the regulation of iron absorption. Jo u rnal of Biological Chemistry
1 6 4: 737–746. See also Drysdale J W, Shafritz D A. (1975) In vitro stimulation of apoferritin synthesis by iro n .
Biochimica et Biophysica Ac t a 3 8 3: 97–105. Zahringer J, Konijn A M, Baliga B S, Mu n ro H N. (1975) Me c h a n i s m
of iron induction of ferritin synthesis. Biochemical and Biophysical Re s e a rch Communications 6 5: 583–590.
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The rate of erythropoiesis, and the state of the iron stores, are both important factors
in regulating absorption through the cell.230
Turnberg: And haem. Is haem split before the iron gets into the cell? In some 
way digested?
Callender: Probably most of the haem is split in the cell and is absorbed after it has
been liberated there. Hence the lack of effect on absorption of other factors in the diet.
Booth: We know a lot in terms of in vitro systems for glucose, galactose, dibasic and
amino acids and so on. Do we have comparable data for iron in respect to kinetics of
absorption and so on?
Peters: Iron absorption is enormously complicated. Tim Cox and I worked very much
in this area. Tim did his MD thesis with me and determined the kinetic constants for
iron absorption in humans.231 There is evidence that haem–iron can also be broken
down within the lumen of the gut in the presence of ascorbate. A chap with the
splendid Irish name of Poroc O’Cora from Galway showed that chemically iron could
be released from haem within the lumen of the gut. The remaining haem can be taken
into the cell and the iron released by haem oxygenase. 
Tansey: It strikes me that during the course of this meeting, the scientists and
clinicians have been singing from different hymn sheets. Was there much interaction
between the two groups?
D ow l i n g : I think Tilli is right to draw attention to this. On the other hand, I think the
a p p a rent split is not quite as great as it might seem. For many years we had a ‘Tr a n s p o rt
C l u b’ where basic scientists and clinicians worked together on all aspects of transport .
Mo re ove r, when I started working with Chris Booth, one of the first things he did was
to send me off to David Sm y t h’s lab in Sheffield (where I met Roy Levin for the first
time) to learn some basic methods of studying intestinal transport. Later, when I arrive d
in Boston, I spent three months working exc l u s i vely on the physical chemistry of bile
acids – titration curves in a test tube from which we derived the pH of precipitation, and
the pKas of the bile acids, and the ratio of ionized versus non-ionized bile acid species
(which we have just been talking about).2 3 2 I think that such approaches are vital.
Turnberg: But you had to go to America to do it!
Dowling: I did and that’s 35 years ago. Today our work is on bile acid absorption from
the colon as a function of transit-induced changes in intracolonic pH (probably as a
230 Dr Sheila Callender wrote: ‘It is possible that some of the iron is released within the lumen of the gut but
findings of the in vivo studies strongly suggest that the great part of the iron is liberated within the mucosal cell
and is therefore unaffected by intraluminary factors.’ Letter to Dr Daphne Christie, 25 October 1999. 
231 See, for example, Cox T M, Peters T J. (1979) The kinetics of iron uptake in vitro by human duodenal mucosa:
studies in normal subjects. Journal of Physiology 289: 469–478.
232 Dowling R H, Small D M. (1968) The effect of pH on the solubility of varying mixtures of free and conjugated
bile salts in solution. Gastroenterology 54: 1291. Roda A, Hofmann A F, Mysels K J. (1983) The influence of bile
salt structure on self-association in aqueous solutions. Journal of Biological Chemistry 258: 6362–6370.
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result of changes in short-chain fatty acid absorption).233 It’s a question we have been
addressing because bile acids (particularly deoxycholic acid) have been implicated in
the pathogenesis of gallstone disease and colorectal cancer. Slow transit constipation
influences colonic luminal pH, and the solubility and bio-availability of the nascent
deoxycholic acid. In this situation, the physical chemistry of the secondary bile acids
becomes vitally important – lessons first learnt 35 years ago.
Booth: I wonder whether I might just put in a plug for the Medical Research Council.
When I was working at Hammersmith, I think I was made a Professor for the first
time in 1966 and I remember just then applying to the MRC for a research grant. In
those days there was a thing called Group Structure. You could apply for an MRC
Group and this would support perhaps a lecturer, a couple of technicians, some
equipment, and the rest of it, and that lasted for five years. At the end of the five years,
in those halcyon days, the university had to take over your funding. That was a rule
and had been negotiated by that great supporter of medical research in this country,
Sir Harold Himsworth.234 I remember applying for one of his groups in 1967. We got
our group. But the point about it was the agreement that the other group that they
supported was an intestinal absorption group. That was in Sheffield and under David
Smyth. We were expected to get together and, as Hermon has said, we did.235
Walker-Smith: In relation to Dennis Parsons, it is interesting how one can have a
long-term influence. A young medical student was inspired by him whilst doing his
BSc to take up gastroenterology, in fact paediatric gastroenterology. He was Ian
Sanderson, who has recently been appointed Professor of Paediatric Gastroenterology
at Bart’s. His inspiration was through Dennis Parsons, which led him to work with Dr
Tony Dawson, and to be where he is now.
Turnberg: I think the whole issue of how clinicians and basic scientists work together
is an enormously tricky one. You ought to have a meeting on that, because it clearly
is one of the difficulties of UK medical research and it’s not one that can be overcome
immediately. There is undoubtedly a problem but there is a lot of effort going on to
try and get over it, and I think it is being successfully overcome in some but not all
places around the UK. In the past we were riddled with antagonisms between basic
2 3 3 See, for example, Veysey M J, Thomas L A, Mallet A I, Jenkins P J, Besser G M, Wass J A, Murphy G M, Dow l i n g
R H. (1999) Prolonged bowel transit increases serum deox ycholic acid: a risk factor for octreotide induced gallstones.
Gu t 4 4: 675–681. Dowling R H, Veysey M J, Pe reira S P, Hussaini S H, Thomas L A, Wass J A, Murphy G M. (1977)
Role of intestinal transit in the pathogenesis of gallbladder stones. Canadian Jo u rnal of Ga s t ro e n t e ro l o gy 1 1: 57–64.
234 Sir Harold Himsworth KCB FRCP FRS (1905–1993), a distinguished clinical scientist, was Secretary of the
Medical Research Council from 1949 to 1968. He was appointed Professor of Medicine and Director of the
Medical Unit at University College Hospital, London, in 1939. His major project, the Clinical Research Centre,
was described as a dream inspired by Sir Thomas Lewis. See Gray J, Booth C. (1994) Sir Harold Himsworth.
Munk’s Roll 9: 238–241. See also Reynolds L A, Tansey E M. (eds) (2000) Clinical Research in Britain,
1950–1980. Wellcome Witnesses to Twentieth Century Medicine, vol. 7. London: The Wellcome Trust, 74pp.
235 Professor Timothy Peters wrote: ‘I think we should also record the contributions of the Wellcome Trust in
supporting training and research in intestinal transport through Prize Studentships, Fellowships and Senior
Fellowships over the past three decades.’ Note on draft transcript, 8 October 1999.
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and clinical scientists. I think there were some exceptions. The Hammersmith group,
Chris Booth’s group, a group here and there, but overall in gastroenterology there was
first of all a suspicion that the basic scientists were working in fields which were not
relevant – relevance was the key – and on the basic science side a sort of snootiness
that the clinicians really were very amateurish and not to be trusted. Those were not
the attitudes which encouraged collaboration and it’s taken a long time to get through
that. My own impression is that things are improving.
Booth: Can I just make a point about America and Britain, because there is a very real
distinction that can be drawn here. The Association of American Physicians was
founded in 1886 and when it was founded it was a group that was to bring in all
American physicians, a term which includes scientists as well as physicians, so that
men like Van Slyke (a biochemist) and Oswald Avery (a microbiologist) and William
Welch, who was a pathologist, were members. William Welch was president of that
group in 1901 when he made a classical speech on the importance of the full-time
system in medicine. The British Association wasn’t founded until 20 years later by
William Osler in 1907 and it was restricted predominantly to people doing internal
medicine in university departments in Britain. It’s only been the last three or four
years that we have had any basic scientists in that group. A fundamental distinction.
Bangham: Could I just add that during the 1950s at the National Institute for Medical
Research, for about ten years or more, half the staff were medically qualified and in
one of the Divisions, Virology, that of Sir Christopher Andrewes, 17 of the scientists
were medically qualified. The proportion has gradually diminished since, but in those
days it was very firmly a good mixture of medical and basic scientists. 
D ow l i n g : I am reminded of one occasion when the British Society of Ga s t ro e n t e ro l o g y
o r g a n i zed annual satellite meetings in conjunction with a pharmaceutical company.
Our chairman (Les Turnberg) organized one of these sessions on Intestinal Ab s o r p t i o n
and Se c retion. At that meeting, one of the most fascinating talks was given by Mi k e
Berridge about the insect saliva ry gland and the IP-3 second messenger system. T h e re
was also a talk, by Don Powell of Chapel Hill, No rth Carolina, about
mesenchymal–epithelial interactions in transport – a talk given by a clinical
i n ve s t i g a t o r.2 3 6 So that’s a good example of how you can have basic scientific and clinical
interaction. I do think that’s the sort of model we ought to be working on.
Turnberg: So there’s hope for the future even if the history isn’t as good as we’d like. 
I think we have had quite a long session and we have covered an enormous amount
of ground. I am intrigued that we did cover the whole of this agenda, because I suspect
we could have done just half of it, and filled the time, but we have kept going, and I
have found it absolutely fascinating. I am very grateful to everyone for giving their all
and telling us about their own historical recollections, and I am very grateful to Tilli
236 Berridge M J. (1982) Phosphatidylinositol hydrolysis: a general transducing mechanism for calcium-mobilising
receptors. op. cit. note 111, 28–34. Powell D W. (1982) Neurohumoral control of intestinal secretion. ibid. 42–45.
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Tansey and Chris Booth and the Wellcome Trust for putting up with us, and putting
it on. Thank you.
Ta n s ey : Can I also add the thanks of the Wellcome Trust to all of you for coming to this
day and also particularly to Sir Leslie Turnberg for chairing the meeting. It’s really been
a splendid occasion and there have been many issues to the interest of historians that
h a ve emerged today. When Chris Booth and I first proposed this topic some of our
colleagues we re ve ry dismissive, they saw this as a ve ry esoteric part of contemporary
medicine and thought that we would only get people to talk for ten minutes. The fact
that we have kept going for four hours and could keep going for much longer, show s
that we we re right to pursue this. Thank you all ve ry much for coming.
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Achlorhydria
The absence of hydrochloric acid from 
gastric secretion.
Addisonian anaemia
See Pernicious anaemia .
Affinity constant [Kt (or Km)]
A measure obtained in kinetic studies of the 
affinity of a substance for a carrier or enzyme 
site (Km is half Vmax).
Apoptosis
Programmed cell death which in the intestinal
mucosa leads to shedding of the cells.
Bile
A golden yellow fluid that is secreted by the liver.
It is stored and concentrated in the gallbladder
which contracts in response to food and expels 
the concentrated bile into the duodenum, via the
common bile duct . Bile is a complex aqueous
medium, greater than 90 per cent water, which
contains lipids (bile acids , phospholipids and
c h o l e s t e rol), bile pigments (mainly conjugated
b i l i rubin), electrolytes and small amounts of proteins. 
Bile acids
Bile acids are amphilic (‘loving’ both water and
fats/lipids), 24-carbon, steroid-ring, detergent
molecules, which are synthesized in liver from
cholesterol. Their principal functions in the liver 
are to stimulate blood flow and solubilize biliary
cholesterol, and in the intestine to promote the
digestion and absorption of dietary triglycerides,
sterols and fat-soluble vitamins. In biological fluids,
most bile acids are present as their sodium salts, and
occasionally as their calcium or potassium salts.
Bile acid breath test
A test utilizing a 14C-labelled conjugated bile acid
which is given by mouth; the amount of 14CO2
appearing in the breath provides a measure of
bacterial deconjugation and metabolism of the
labelled bile acid (op. cit. note 211).
Bile duct
Any of the ducts that convey bile from the liver.
Bile salts
The salts (usually sodium) of bile acids such as
cholic and chenodeoxycholic acids (for example,
sodium glycocholate and sodium taurocholate);
necessary for the emulsification of fats.
Biliary fistula
An abnormal communication between the biliary tre e
and either the surface of the body or an internal organ.
Bi l i a ry fistulae occur spontaneously in disease but can
also be created surgically – usually by inserting a tube
or cannula into the common bile duct .
Brush-border
Microvilli on the free surfaces of certain epithelial
cells, particularly the absorptive surface of the small
intestine and the proximal convoluted tubules of
the kidney.
Citric acid cycle 
See Krebs cycle .
Cobalt56
A radioisotope of cobalt having a half-life of only
72 days, used in diagnostic tests for the evaluation
of vitamin B12 absorption (see page 53).
Cobalt60
A radioisotope of cobalt having a half-life of 5.25
years, used in diagnostic tests for the evaluation of
vitamin B12 absorption (see page 53). 
Coeliac disease (idiopathic steatorrhoea)
A cause of malabsorption, genetically determined
but associated with dietary gluten intake; there are
significant changes in the small-intestinal mucosa. 
Crohn’s disease
One of the two types of inflammatory bowel
disease. It may affect the small and large intestines,
the pathological changes being marked as severe.
Cystinuria
An abnormal presence of the amino acid cystine in
the urine. The disorder is caused by an autosomal
recessive trait that impairs cystine reabsorption by
the kidney tubules. In high concentration cystine
tends to cause kidney or bladder stones.
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Enterohepatic circulation
Substances which are secreted by the liver into bile,
pass down the intestine, are reabsorbed, return to
the liver (usually in the portal vein) and are then
resecreted into bile, are said to undergo an
enterohepatic circulation. The best known example
is the enterohepatic of the naturally occurring bile
acids (op. cit. notes 203 and 205 and page 69).
Enteropathy
A disease or other disorder of the small intestine.
Erepsin
A mixture of protein-digesting enzymes secreted 
by the intestinal glands. 
Erythrocyte (red blood cell)
In mammals erythrocytes lack a nucleus;
haemoglobin is a major constituent.
Erythropoiesis
The process of red blood cell (erythrocyte )
production, which normally occurs in the 
blood-forming tissue of the bone marrow.
Hartnup disease
A genetically determined (autosomal re c e s s i ve) defect
in renal and intestinal transport of certain neutral
amino acids – including methionine and try p t o p h a n .
Hypernatraemic dehydration
Dehydration associated with an excessive
concentration of sodium in circulating blood. This
condition is virtually confined to infants who are
usually sodium- and water-depleted (‘dehydrated’)
from diarrhoea, but have lost more water than salt
(because of insensible water losses from their large
surface area in relation to body mass) so their serum
sodium concentration actually rises.
Hypertonic solution
A solution in which the concentration of solutes
exceeds that of an isotonic solution. 
Intrinsic factor
A glycoprotein secreted by the parietal cells of the
gastric mucosa as a component of gastric juice and
essential for the absorption of vitamin B12.
Its absence leads to pernicious anaemia .
Ionophore
An antibiotic that carries specific ions across a
membrane, such as the plasma membrane of
bacterial or animal cells or the mitochondrial
membrane, e.g. valinomycin.
Jejunal diverticulosis
A clinical condition in which diverticuli of varying
sizes develop along the mesenteric border of the
small intestine. It is often associated with stagnation
of luminal contents, bacterial overgrowth and
malabsorption of fat and vitamin B12.
Krebs bicarbonate Ringer
See Krebs–Ringer solution .
Krebs cycle (citric acid cycle)
A sequence of enzymatic reactions involving the
metabolism of carbon chains of monosaccharides,
fatty acids and amino acids to yield carbon diox i d e ,
water and high energy phosphate bonds (see note 75).
Krebs–Ringer solution
Ringer’s solution modified with sodium
bicarbonate, magnesium sulphate and 
phosphate buffer.
Kt (or Km)
See Affinity constant .
Lacteals 
Lymph vessels containing chyle draining the small
intestine; these are termed lacteals because of their
milky white appearance conferred on them by the
presence of chylomicrons. Digested fats are
absorbed into the lacteals.
Langendorff preparation
A preparation of an isolated mammalian heart in
which the aorta is cannulated and perfused, thus
supplying blood flow to the coronary circulation.
Mecamylamine 
A non-depolarizing ganglionic blocking agent
causing a decrease in the volume and acidity of
gastric secretion, and a reduction in the tone and
motility of the gastrointestinal tract in humans.
3-O-methylglucose
A non-metabolizable monosaccharide (hexose).
Pepsin
An enzyme secreted by the stomach that breaks
peptide bonds and thus initiates the process of
breaking the proteins in food into their constituent
amino acids.
Peptone
A large protein fragment produced by the action of
enzymes on proteins in the first stages of protein
digestion.
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Pernicious anaemia (Addisonian anaemia)
The defective production of red blood cells caused
by a lack of vitamin B12.
Phlorizin
A plant glycoside which inhibits intestinal (and 
renal tubular) absorption of glucose and galactose.
[ See Newey H, Parsons B J, Smyth D H. (1959) 
The site of action of phlorrhizin in inhibiting
intestinal absorption of glucose. Jo u rnal 
of Ph y s i o l o gy 1 4 8: 83–92. op. cit. note 20.]
PO2
Partial pressure (P) of oxygen (O2) measured 
in mmHg.
Reticulocyte
An immature red blood cell (erythrocyte ); they
normally comprise about 1 per cent of the total red
cells and are increased (reticulocytosis ) whenever
the rate of red cell production increases.
Reticulocytosis
An increase in the proportion of immature red
blood cells (reticulocytes ) in the bloodstream.
Ringer’s solution
An artificial physiological salt solution containing
sodium chloride, potassium chloride, calcium
chloride and distilled water. It is used for
maintaining organs or tissues alive outside the
animal or human body for limited periods. This
was introduced by Sydney Ringer (1835–1910)
from University College London.
Schilling test
Developed by the American haematologist 
Robert F Schilling (b. 1919) as a test for measuring
vitamin B12 absorption. Vitamin B12 tagged with
radioactive cobalt is administered orally, and a 
large intramuscular injection of nonradioactive
B12 is given to ‘flush’ the orally administered 
B12 into the urine. Gastrointestinal absorption 
is measured by determining the radioactivity of 
urine samples collected over a 24-hour period 
(op. cit. notes 195 and 197). 
Sheet
An epithelium removed from animals or humans
and mounted as a membrane between two
chambers. In the case of the intestine (large, small
or rectum) it can be mounted with or without their
smooth muscle coats.
Short circuit current
A measure of net ion electrogenic transport.
Solvent drag
The passive movement of solute secondary to
movement of fluid across a membrane.
Steatorrhoea 
Excess faecal fat excretion – usually due to
malabsorption and/or maldigestion of dietary fat. 
It is a feature of coeliac disease and tropical sprue .
Tropical sprue
A clinical syndrome usually occurring in tropical
countries, typified by chronic diarrhoea, weight loss
and malabsorption; there may be an association
with vitamin deficiencies.
Vmax
The maximum rate at which the enzyme or carrier
transfers or breaks down a substance (see K m).
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achlorhydria, 62, 70
acid–base changes, 17
acids, weak, 40
active transport, 4–5, 6–9, 10, 15
adaptive hypertrophy/hyperfunction, 30, 42, 57–58
adenosine triphosphate (ATP), 8, 18
Addisonian (pernicious) anaemia, 53, 54, 55, 72
affinity constant (Kt or Km), 16, 48, 70
American Journal of Physiology, 42
American Society for Clinical Investigation, 39
amino acids
absorption, 47, 48–50
estimation, 22–23, 25
inborn errors of absorption, 40–41, 48, 50
see also cystinuria; Hartnup disease
as products of digestion, 16, 47
purified, 24–25
transport, 9, 22–23, 25, 49–50
anaemia
iron deficiency, 62
pernicious (Addisonian), 53, 54, 55, 72
simple achlorhydric, 62
anaesthesia, 14
animals, experimental, 4–5, 14, 23–24
see also specific animals
antibiotics, 54
apical membrane, 33, 35, 39
apoferritin, 64
apoptosis, 16, 33–34, 70
arginine, 48, 49
artifacts, 29, 30
ascorbic acid (ascorbate), 63, 65
Asia, South-East, 43, 46
Association of American Physicians, 67
ATP, see adenosine triphosphate 
bacteria
bile acid metabolism, 57
intestinal overgrowth, 54
peptide transport, 51
balloons, intestinal, 36
basolateral membrane, 33, 35
bicarbonate, 38
bile, 59, 60, 70
bile acid breath test, 61, 70
bile acids, 70
abnormal metabolism, 58–59
absorption, 8, 57–62, 65–66
conjugation, 57, 62
gallstone treatment, 60
ileal function test, 58, 60–61
passive diffusion, 61–62
pharmacokinetics and bioavailability, 60, 61
physical chemistry, 65
radiolabelled, 60, 61, 70
secondary, 57
site of absorption, 5, 58, 61–62
see also cholic, chenodeoxycholic, deoxycholic 
and lithocholic acids, enterohepatic circulation
bile acid transporter gene, ileal sodium-dependent, 62
bile duct, 59, 70
bile salts, 70, see also bile acids
biliary fistula, 59, 60, 70
biochemistry, 18
bioenergetics, 18, 20, 32
biophysics, 18
Boston, MA, 8, 36, 38, 54, 56, 65
breath test, see bile acid breath test
British Association for the Ad vancement of Science, 67
British Journal of Surgery, 57
British Medical Journal, 48
British Society of Gastroenterology, 67
brush-border, 5, 32–33, 34–35, 52, 55, 70
calcium (Ca2+), 14–15, 34
cAMP, see cyclic adenosine monophosphate
carbohydrates, 15, 20
carnosine, 47, 51
carrier system, glucose transport, 8, 16, 41
cereals, iron absorption and, 63
chemiosmosis, 18, 32
chenodeoxycholic acid, 57, 60
chickens, 31, 33–34
children, acute diarrhoea in, 42–44, 45, 46
chloride, 38
secretion, 42
shift, 39
cholera, 42–44, 45, 46, 47
human gut perfusion studies, 36
research unit, Dacca, 36, 43, 45, 46
cholesterol, 57, 59
cholic acid, 57, 61
chromatography, paper, 13, 41
Ciba Foundation Symposia, 51
citric acid (Krebs) cycle, 22, 71
clinical trials, oral rehydration therapy, 43, 44
clinicians, interactions with scientists, 65–67
cobalt-56 (56Co), 53, 70
cobalt-60 (60Co), 53, 70
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coeliac disease (idiopathic steatorrhoea), 42, 70
iron absorption, 63–64
peptide absorption, 50, 52
colon, 69
bile acid absorption, 61–62, 65–66
colorectal cancer, 59, 66
concentration gradient, 6, 9, 15, 33
constipation, slow-transit, 66
Crane’s hypothesis, see sodium-coupled glucose
transport
Cricetus auratus, 27
Crohn’s disease, 47, 54, 70
crystallography, 55–56
cyclic adenosine monophosphate (cAMP), 20
cystinuria, 70
oral absorption test, 48
peptide absorption, 48, 49, 50, 51
Dacca, 36, 43, 45, 46
Dallas, Texas, 36–37, 38–39
dehydration, 43, 44, 45
hypernatraemic, 44, 71
deoxycholic acid, 57, 66
diabetes mellitus, 42
diarrhoea
bile acids and, 59
oral rehydration therapy, 42–44, 45, 46–47
osmotic, 45
diffusion, 4–5, 6–9, 22
bile acids, 61–62
digestive tract, 69
diglycine (glycyl-glycine), 50–51
dipeptidase, 51–52
dipeptides, 47, 50–51
non-hydrolysable, 51
Diphyllobotrium latum, 54
diverticulosis, jejunal, 54, 71
dog, 4–5, 12, 22, 25, 42
double ion exchange, 38, 39
double lumen tube, 35, 60
duodenum, 69
eggs, iron absorption and, 63
Egypt, 44
electrical potential, 26, 38
electrochemical gradient, 15, 34
electrogenic ion transfer, 28
electrolyte transport, 9, 10, 28–29, 35–39, 41–42
electrophysiology, 25–26, 34
enterocytes, 15, 33
enterohepatic circulation, 57, 58, 59, 69, 71
enteropathy, 71
erepsin, 47, 71
erythrocytes, 8, 9, 16, 17, 71
chloride shift, 39
glucose transport, 8, 9, 16, 17
erythropoiesis, 65, 71
ether anaesthesia, 14
European Intestinal Transport Group meeting,
Southampton (1980), 7
everted sac preparation, 5, 22–26, 27, 30
contribution made by, 10, 25
development, 22–25
limitations, 17, 25–26, 27, 28, 30
experiments
early, 4–5
see also in vitro studies, in vivo studies
Falk Symposium on Intestinal Absorption and
Secretion (1983), 11, 49
fat absorption, 59
Federation Proceedings, 26, 42
ferritin, 64
fetus, gamma globulin uptake, 52
Fisher and Parsons’s recirculated intestinal segment
technique, 5, 7, 13–17, 23, 27
fish tapeworm, 54
fluid transport, see water transport
fluoride, 8
fluxes
bidirectional, 28–29
unidirectional, 28–29, 30
food, iron absorption from, 63
Fox Chemicals, Los Angeles, CA, 51
fractionation, subcellular, 34
frog
intestine, 33
skin, 9, 10, 32, see also Ussing chamber
stomach, 23
fructose, 6
galactose, 6, 26
kinetics of uptake, 5, 16
sodium dependence of uptake, 33
water absorption and, 15, 19
gallstones, 58, 60, 66
gamma globulin, 52
gas lifts, 13, 28, 31, see also Langendorff
preparation, Sheff–Smyth technique, Ussing 
chamber
gastroenteritis, 43, 44
Glaxo, 53
glomerular filtration rate, 57
glucose
electrolyte solution, oral, 45
as metabolic substrate, 14, 17, 19–20
in oral rehydration solution, 44–45, 47
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transfer potential, 26
transport, 5, 6, 15, 25
carrier system, 8, 16, 41
kinetics, 12, 16, 26, 41
passive diffusion, 8–9
renal tubules, 12
sodium-linked, see sodium-coupled glucose 
transport
water absorption and, 7, 15, 17, 19, 21
glucose 6-phosphatase, 20
gluten, 63–64
glycine, 47, 49, 50
bile acid conjugation, 57, 62
glycogenolysis, hepatic, 15
glycyl-glycine (diglycine), 50–51
glycyl-lysine, 49
glycyl-sarcosine, 51
guinea-pigs, experiments with, 14
Guy’s Hospital, London, 60
haem iron, absorption, 63, 64–65
haem oxygenase, 65
hamsters, 23–24, 31
everted sac preparations, 24
golden, 24, 27
introduction to England, 24, 27
Handbook of Physiology (1968), 3–4
Hanson and Parsons’s preparation, 33
Hartnup disease, 40–41, 48, 71
peptide absorption, 47, 50, 51
heart perfusion studies, 13, 14, see also Langendorff
preparation
hereditary disorders, see cystinuria; Hartnup disease
hexoses, 15, 18, 25, 26
hexose transfer potential, 26
human gut perfusion studies, 35–39, 41, 47
bile acid absorption, 60
ion transport, 37–39
peptide transport, 48–49
hydrostatic pressure, luminal, 14, 31
hypernatraemia, 43, 44, 71
hypertonic solution, 71
ideopathic steatorrhoea, see coeliac disease
ileum, 69
bile acid absorption, 5, 58, 61–62
clinical tests of function, 58, 60–61
c o m p e n s a t o ry hyperf u n c t i o n / h y p e rt ro p h y, 42, 57–58
human perfusion studies, 37, 38, 42
resection, 54, 57–58, 59–60, 61, 62
vitamin B12 absorption, 54–55
India, 10, 43, 45
indoleacetic acid, 40
infantile diarrhoea, 42–44, 45, 46
inhibitors, metabolic, 6, 8
intestinal epithelial cells, isolated, 33–34
intrinsic factor, 54, 55, 58, 71
deficiency, 53, 55
in vitro studies, 4, 5, 7
brush-border membranes, 5, 32–33, 34–35
heart, 13, 14
isolated intestinal epithelial cells, 33–34
oral rehydration therapy and, 43–44, 47
sodium-coupled glucose transport, 19–20
vascularly perfused intestine, 33
see also Fisher and Parsons’s recirculated intestinal 
segment technique; Ussing chamber
in vivo studies
recirculated intestinal segments, 17
sodium-coupled glucose transport, 19–20
see also Sheff–Smyth technique, human gut 
p e rfusion studies, water transport intubation studies
iodine-131 (131I)-labelled proteins, 52
ion exchangers, 38, 39
ionophore, 32, 71
ion transport, see electrolyte transport
Iowa City, 41
IP-3 (inositol triphosphate), 67
iron
absorption, 56, 62–65
balance studies, 62, 63
deficiency, 62–63, 64
anaemia, 62
‘idiopathic’, 62, 64
ferrous/ferric, 62–63
haem, 63, 64–65
radiolabelled, 62, 63
iron-59 (59Fe), 63
jejunum, 69
bile acid absorption, 5, 61–62
diverticulosis, 54, 71
glucose absorption, 9, 19
human perfusion studies, 37, 38, 42
resection, 57–58, 59
journal clubs, 50, 58, 65
Journal of Membrane Biology, 34
kinetics, 5, 8, 26
amino acid absorption, 48–49
bile acid absorption, 60, 61
glucose absorption, 12, 16, 26, 41
iron absorption, 65
Sheff–Smyth technique, 30–31
King Faisal prize, 47
Km (Kt), 16, 48, 70
Krebs cycle, 22, 71
Intestinal Absorption – Index
76
Krebs–Ringer (Krebs bicarbonate Ringer) solution,
13, 14–15, 71
Kt (or Km), 16, 48, 70
lactate, 15, 20, 33
lacteals, 4, 71
Lancet, 21, 55
Langendorff preparation, 13, 14, 71
laparotomy, 36
Leningrad, 12
Lights, Sheffield, 24–25
lipid absorption, 59
lithocholic acid, 57
London cannula, 12–13
London Metropolitan Water Board, 13
lysine, 49, 51
lysosome, 20
lysyl-lysine, 49
malabsorption, 40, 59, 64
manometry, 22–23
Massachusetts General Hospital, MA, 58
mecylamine, 40, 71
Medical History, 44
Medical Re s e a rch Council (MRC), 12, 25, 45, 46, 66
Medical Research Society, 49
membrane vesicles, 32–33, 34–35, 39
mesenchymal–epithelial interactions, 67
Mesocricetus auratus, 24, 27
metabolic inhibitors, 6, 8
methionine, 41
methodology, see techniques, investigational
3-O-methylglucose, 26, 71
micropuncture studies, 12, 37, 40
military research, 12
mitochondria, 18, 32
MRC, see Medical Research Council
mucosal block, 55, 64
National Institute for Medical Research, 
London, 52, 67
Nature, 42
nephelometry, 16
Nobel laureates, 13, 17, 20, 55
oral rehydration therapy, 21, 42–47
ad hoc study, 47
clinical trials, 43, 44
physiological basis, 43–45
osmosis, 4–5, 6
osmotic pressure gradients, 17, 21, 37–38
ouabain, 19
Oxford, 16, 17, 23, 54
Fisher and Parsons’s work, 10–12, 14, 15
iron absorption studies, 63
oxygen, 7
partial pressure (PO2), 13, 72
paper chromatography, 13, 41
paracellular transport, 19, 52
passive transport, 4–5, 6–9, 15, 22, 33
pentose sugars, 15
pepsin, 71
peptic ulcer surgery, 54
peptidases, 49, 51–52
peptides, 10
absorption, 13, 35, 47–52
in portal blood, 12–13
peptone, 47, 71
peristalsis, intestinal, 14
pernicious anaemia, 53, 54, 55, 72
pH
bile acid absorption and, 65–66
‘disequilibrium’, 38
renal excretion and, 40
phenol red, 7
Philippines, 46
phlorizin, 8, 31, 33, 72
Physiological Society, 5, 23
phytates, 63
pigeons, experiments with, 23
placental transport, 52
PO2, 13, 72
portal vein cannulation, 12–13
Postgraduate Medical School, Hammersmith
Hospital, London (also known as Royal 
Postgraduate Medical School, British 
Postgraduate Medical School), 40–41, 66, 67
Prague symposium (1960), 17–18, 20–21
prisoners, experiments with, 41, 51
proteins
131I-labelled serum, 52
digestion, 16, 47, 50
metabolism, 13, 49
transport of whole, 52
see also amino acids; peptides
pulsometer, 14
purine absorption, 23
Queen Elizabeth Hospital for Children, 
London, 42, 44, 45
rabbits, experiments with, 63
rats, 5, 14, 21, 23
bile acid studies, 60
vitamin B12 studies, 54
Intestinal Absorption – Index
77
red blood cells, see erythrocytes
reflection coefficient, Renkin, 37, 39
refugee camps, oral rehydration therapy in, 44
renal physiology, 17, 36–37, 39–41, 46
renal tubules, 12, 21, 36–37, 40
Renkin reflection coefficient, 37, 39
reticulocytes, 72
reticulocytosis, 63, 72
Rhesus monkeys, 59, 62
rice water, 45
Ringer’s solution, 17, 72
rotavirus gastroenteritis, 45
Royal Children’s Hospital, Melbourne, 45
Royal Free Hospital, London, 50
St Andrews University in Dundee, 4
St Bartholomew’s Hospital, London (Bart’s), 10, 48,
50, 66
St Louis, Missouri, 20, 21, 56
St Mark’s Hospital, London, 47
Schilling test, 55, 56, 58, 60, 72
Science Research Council, 25
scientists, interactions with clinicians, 65–67
S E ATO, s e e South-East Asia Treaty Or g a n i z a t i o n
Second World War, 12, 14
secretion, intestinal, 30, 41–42
segmental perfusion techniques, 8–9
shadow shield technique, 56
sheets, intestinal, 25, 26, 28, 32, 35, 72
see also Ussing chamber
Sheffield, University of, 8, 15, 30, 65, 66
amino acid transport, 49–50
everted sac preparation, 22–26, 30
sodium-coupled glucose transport and, 17, 18,
20–21, 25
Sheff–Smyth technique, 5, 28, 30–31
short bowel, 47
short-circuit current, 25, 29, 72
silver electrodes, 25
Sir William Dunn School of Physiology, Oxford, 16
Smyth and Taylor perfused preparation, 27–28
sodium
dependent galactose uptake, 33
human intubation studies, 37
in oral rehydration solution, 44
solvent drag-mediated absorption, 37–38
transport, 9, 18–21, 29, 38
sodium chloride, 30, 38
sodium-coupled glucose transport (Crane’s
hypothesis), 10, 17–21, 43
background to discovery, 18–21, 25–26
in brush-border membranes, 32, 33, 34
discovery, 17–18
human gut perfusion studies, 37–38, 42
Ussing chamber studies, 29
sodium/glucose (Na+/glucose) cotransporter, 19, 26
sodium–hydrogen exchanger, 38
sodium pump, 18, 34, 47
solvent drag, 19, 37–38, 39, 72
South-East Asia Treaty Organization (SEATO), 46
sprue, tropical, 45, 72
starch digestion, 16
steatorrhoea, 59, 63, 72
idiopathic, see coeliac disease
stream-splitting device, bile, 59
Taiwan, 46
taurine, 57, 62
tea, 64
techniques, investigational, 3–4, 5, 9–10, 21–32,
33–35
see also in vitro studies; in vivo studies; specific 
techniques
toad bladder, 32
Transport Club, 50, 65
triple lumen tube, 35–36
tropical sprue, 45, 72
tryptophan, 40, 51
UNICEF, 43, 44
United Kingdom, re s e a rch in, 17–18, 29, 51, 66–67
United States of America, 29, 36, 65, 67
cholera studies, 46
iron absorption studies, 62–63
peptide transport studies, 51
University College, London, 13, 22, 31
ursodeoxycholic acid, 60
Ussing chamber, 9, 28–30, 32, 47
fluid circulation, 13
modified, 28, 29
see also sheets, intestinal
Ussing model of epithelial polarity, 35
vascularly perfused intestinal preparations, 33
vesicles, membrane, 32–33, 34–35, 39
vitamin B12, 53–57
limit on absorption, 55, 56–57
malabsorption, 54
radiolabelled, 53, 54, 55, 56
site of absorption, 54–55, 58
structural studies, 55–56
test for absorption, see Schilling test
vitamins
fat-soluble, 57, 59
water-soluble, 57
Vmax, 16, 31, 48, 72
volunteers, 37, 38, 51
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water transport, 9, 15, 17, 19
human intubation studies, 37
methods of studying, 28–29
renal tubules, 21
sodium and glucose transport and, 18–21, 37–38
Wellcome Trust, 66, 68
‘whippet disease’, in Dundee, 64
whole-body counter, 56
WHO, see World Health Organization, 43, 44
Wilson and Wiseman everted sac technique, see
everted sac preparation
World Health Organization (WHO), 43, 44
xylose, 15, 19, 26, 37
Year Book of Medicine (1960), 55
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